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Abstract
Dietary polyphenols have been associated with a decreased risk of diseases
such as coronary vascular disease (CVD). However, the health benefits of these
compounds depend on their bioavailability. In this thesis, the phase II enzymes;
uridine diphosphate glucuronosyl transferase (UGT), sulfotransferase (SULT) and
catechol-O-methyltransferase (COMT), which affect bioavailability of polyphenols
were investigated.
Quercetin and (-)-epicatechin are representatives of the flavonol and flavanol
subclasses of polyphenols. Thus, co-consumption of these compounds may provide
interesting information on the role of phase II enzymes on their metabolism and
excretion. Quercetin and (-)-epicatechin are found abundantly in onion and dark
chocolate, respectively. Prior to providing food samples to healthy volunteers, the
content of quercetin in onion soup and also (-)-epicatechin in dark chocolate were
quantified by HPLC-DAD and HPLC-DAD/FLD, respectively. As expected red
onion contained higher total quercetin content than yellow onion. In addition,
homogenisation was an efficient method for extracting quercetin glycosides
compared to vortex and sonication. Thus, red onion was selected to prepare a soup
and found that there were no significant differences in total quercetin content in red
onion soup after preparation (61.7±15.60 mg/ 130 ml soup) and before microwaving
(60.4±9.6 mg/ 130 ml soup) or before microwaving and after microwaving
(59.9±8.2 mg/130 ml soup), p-value = 0.818 and 0.666, respectively. For dark
chocolate, the content of (-)-epicatechin was also analysed and quantified in
different percentages of cocoa from different brands. However, 70% cocoa dark
chocolate was selected for the human study. The content of (-)-epicatechin of 70%
dark chocolate was 92.2±4.4 mg/100g FW, as detected with FLD.
Then, COMT activity was investigated in vitro followed by a pilot study in
vivo. For the in vitro study, (-)-epicatechin was more efficiently methylated
compared to quercetin. In vivo, in urine, the amounts of methylated and the parent
compound of quercetin and (-)-epicatechin after single consumption of red onion
soup, 70% cocoa dark chocolate and co-consumption of both types of food were
underestimated when assessed after enzymatic deconjugation. In addition, this thesis
revealed that the limitation was due to some compounds in urine which inhibited
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sulfatase activity. Because of this, all main metabolites of quercetin and (-)-
epicatechin found in urine without enzymatic hydrolysis were analysed.
Main conjugates of quercetin and (-)-epicatechin predicted to be found in
urine were first synthesised using an enzymatic method prior to use as standards.
Five quercetin conjugates and five (-)-epicatechin conjugates were successfully
synthesised with a sufficient percentage yield. For the first time, 3-O-methyl-
quercetin-di-glucuronides were also produced and detected after glucuronidation of
3-O-methyl-quercetin-glucuronide. In addition, methylated-(-)-epicatechin-
glucuronides and methylated-(-)-epicatechin sulfates were originally synthesised by
(-)-epicatechin-glucuronides and (-)-epicatechin sulfates which were the products of
(-)-epicatechin glucuronidation and (-)-epicatechin sulfation reaction, using COMT
from cytosol pig liver.
Then, the main metabolites of quercetin and (-)-epicatechin excreted in urine
in 27 healthy volunteers were determined and compared between single
consumption and co-consumption. The major metabolite of quercetin found most
often in urine was quercetin glucuronide in single consumption of red onion soup
and co-consumption of red onion and 70% dark chocolate. While, the methylated
form of (-)-epicatechin was the most abundant form detected in urine after single
consumption of 70% dark chocolate and co-consumption of both types of food. In
addition, the % urinary excretion of quercetin was lower than quercetin in both
single and co-consumption. Thus, different types of phase II enzymes (UGT, SULT
and COMT) have a different affinity for substrates, quercetin and (-)-epicatechin,
resulting in different types of the metabolic profiles in urine. However, at these low
level of quercetin and (-)-epicatechin from red onion soup and 70% dark chocolate
did not reveal a huge interact and had a large effect on their metabolism and
excretion.
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HPLC-FLD high performance liquid chromatography coupled with
fluorescence detection
[M-H]- negatively charge molecular ion
m/z mass to charge ratio
mg milligram
min minute(s)
ml millilitre
PAPS 3-phosphoadenosine 5-phosphosulfate
PMSF phenyl methyl sulfonyl fluoride
PNS p-nitrophenyl sulfate
PPB potassium phosphate buffer
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Q quercetin
Q3,4diG quercetin 3, 4-O-diglucoside
Q4G quercetin 4-O-glucoside
SAM S-adenosyl-L-methionine
SIM single ion monitoring
SPE solid phase extraction
SULT sulfotransferase
T taxifolin
TIC total ion count
UDP uridine diphosphate
UDPGA uridine-5-diphospho-glucuronic acid
UGT uridine diphosphate glucuronosyl transferase
UPLC-MS ultraperformance liquid chromatography coupled with
mass spectrometry
µl microlitre
μM    micromolar 
μmol    micromole 
3MeQ 3-methyl quercetin or isorhamnetin
4MeQ 4- methyl quercetin or tamarixetin
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Chapter 1 Literature review
1.1 Introduction
Polyphenols are secondary metabolites found in many types of plant tissue.
Polyphenols are non-nutritive compounds but they are the most abundant class of
antioxidants in the human diet and they have been associated with a decreased risk
of some diseases such as coronary vascular disease (CVD) and other chronic disease
(Scalbert and Williamson, 2000). Quercetin and (-)-epicatechin are major flavonol
and flavanol subclasses and found abundantly in onion and dark chocolate,
respectively. Numerous studies have revealed that consuming onion or dark
chocolate are associated with health benefits. According to the Netherlands Cohort
Study on diet and cancer, Dorant et al. (1996) investigated the relationship between
onion consumption and incidence of stomach carcinoma. They found that the
highest onion consumption (≥ 0.5 onions/day) reduced the risk of stomach 
carcinoma compared with the lowest consumption (0 onions/day) with the 0.50.
Ebrahimi-Mamaghani et al. (2014) revealed that raw red onion consumption seems
to be effective as a cholesterol-lowering food agent in women with polycystic ovary
syndrome. In the case of red onion soup, Hubbard et al. (2006) provided evidence
that a high dose of quercetin as onion soup inhibits platelet aggregation and essential
components of the collagen-stimulated platelet activation pathway, contributing
protective effects against cardiovascular disease. The first human clinical study with
chocolate consumption was performed by Kondo et al. (1996). They found that 35
grams of delipidated cocoa decreased LDL oxidation between 2 and 4 hr after
ingestion, indicating chocolate inhibits LDL oxidation in vivo. Subsequently, a
number of studies reported that intake of dark chocolate improved lipoprotein
profiles (Mursu et al., 2004; Allen et al., 2008; Nanetti et al., 2012). In recent years,
West et al., (2014) stated that high-flavanol cocoa and dark chocolate consumption
improves endothelial function by enhancing vasolidation and reducing stiffness in
arteries in overweight women. In overweight men, dark chocolate consumption also
improves vascular function and leukocyte adhesion factors in blood circulation
(Esser et al., 2014). Additionally, consumption of dark chocolate also has beneficial
effects on insulin, glucose, antioxidant status and oxidative stress responses to
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prolonged exercise and carbohydrate metabolism performance during rest and
exercise (Davison et al., 2012; Stellingwerff et al., 2014).
However, the health benefits of the main flavonoids, quercetin and (-)-
epicatechin, present in onion and dark chocolate depend on their bioavailability.
There are several factors that affect the bioavailability of polyphenols. The phase II
enzymes in detoxification process are other important factors that affect the
bioavailability and the biological effect of flavonoids. Quercetin and (-)-epicatechin
are in different subclasses but these two compounds contain a similar structure
called a catechol ring. In addition, quercetin is generally found in the form of
glycosides form in foods, in contrast to (-)-epicatechin which is found as aglycone.
Thus, prior to absorption and distribution into the human body, quercetin is de-
glycosylated by luminal lactase phlorizin hydrolase and/or within the enterocyte by
cytosolic -glucosidase, resulting in the aglycone form. However, monomeric
flavanols like (-)-epicatechin, they can be directly absorbed in the small intestine
without deglycosylation. Quercetin and (-)-epicatechin are excreted out of the body
in the same way as drugs or toxics using phase II enzymes; uridine diphosphate
glucuronosyl transferase (UGT), sulfotransferase (SULT) and catechol-O-methyl
transferase (COMT). Quercetin and (-)-epicatechin are generally conjugated with
glucuronic acid, sulfate with or without methyl group by uridine diphosphate
glucuronosyl transferase (UGT), sulfotransferase (SULT) and catechol-O-methyl
transferase (COMT), respectively. These compounds are then changed to a variety
of conjugated metabolites and made more water soluble and higher molecular
weight. Conjugated with glucuronic acid have higher solubility in water than
conjugated with sulfate and methyl group, leading to excretion out of the body by
the kidneys and also losing their biological activity at the same time.
The metabolic profile of quercetin or (-)-epicatechin after a single
consumption of flavonoid-rich foods, pure compounds or supplements have been
studied by several research groups. There are two main publications which focus on
the quercetin and (-)-epicatechin metabolites in the circulating system and revealed
that quercetin or (-)-epicatechin has their own pattern of metabolites and
inter-individual variation. First, Mullen et al. (2006) analysed plasma and urine
samples from six human volunteers after the consumption of 270 g of fried red
onions (containing 275 µmol quercetin 3, 4di-O-glucoside and quercetin 4-O-
glucoside). Quercetin metabolites were detected in both plasma and urine collected
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over a 24 hr period by using HPLC with a diode array and a tandem mass
spectrometric detector. However, the metabolic profile of quercetin excreted in urine
was different in the plasma. The quercetin-3-O-glucuronide, two quercetin
glucuronide sulfates, methylquercetin diglucuronide were found in urine but were
absent or present only in small amounts in the blood. Other main metabolites such as
quercetin diglucuronide, isorhamnetin-3-O-glucuronide, and quercetin-3-O-
glucuronide were also found in the urine. The urinary excretion was 12.9 µmol
(4.7% intake). In 2012, Actis-Goretta et al. analysed (-)-epicatechin metabolites in
plasma and urine from 0 to 24 hr after the ingestion of 100 g dark chocolate
(containing 79 mg or 272 µmol of (-)-epicatechin) in five volunteers. (-)-Epicatechin
metabolites were detected in both the plasma and the urine (24 hr collection) by
using the LC–MS/MS–MRM method. (-)-Epicatechin metabolites, including
glucuronides, sulfates, methyl sulfates, and methyl glucuronides, excreted in urine
were detected and were similar to those found in the plasma. The total urinary
excretion of (-)-epicatechin was 20±2% of the intake. Although these two studies
used high amount of quercetin and epicatechin for feeding the volunteers and also
used more sensitive methods to detect all the metabolites in the biological samples,
these studies were only performed using small numbers of volunteers and no
publications studied all the metabolites of quercetin and (-)-epicatechin after co-
consumption. As mentioned before, these two compounds contain similar structure
but they are in different subclasses and have different step of metabolism. Co-
consumption of these compounds may provide interesting information of their
bioavailability in human body.
Thus, in this thesis, the metabolic profile of quercetin and (-)-epicatechin
before and after 24 hr urine collection were analysed. The urinary metabolites are
normally used as biomarkers of polyphenol intake in human. In addition, contrasting
to genes and proteins, metabolites signify downstream biochemical end products
that are closer to the phenotype. Therefore, it is easier to correlate metabolomic
profiles with phenotype compared to genomic, transcriptomic and proteomic
profiles.
The hypothesis of this study is that the interaction between quercetin and (-)-
epicatechin with the phase II enzymes (UGT, SULT, COMT) would happen after
co-consumption of these two compounds from red onion soup and 70% cocoa dark
chocolate leading to change the urinary metabolic profiles in healthy volunteers.
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To achieve the aim of this study, this thesis was divided into 7 chapters. The
first chapter will begin with an introduction of main group of polyphenol named
flavonoids; their structure and occurrence in foods followed by their metabolism and
biological effects. The second chapter was materials and methods related to all
experiments. Then, next four chapters are the research finding in this study. Before
providing food samples, red onion soup and 70% cocoa dark chocolate, to healthy
volunteers the exact amount of quercetin and (-)-epicatechin needed to be quantified
(see in Chapter 3). After that the activity of COMT, one of the phase II enzymes,
was investigated in vitro followed by the in vivo study. The percentage of urinary
excretion of the methylated and the parent compound of quercetin and epicatechin
after single consumption of red onion soup, 70% cocoa dark chocolate and co-
consumption of both types of food were analysed as a pilot study. However, the
amounts of these compounds were underestimated due to limitations in sulfatase
activity. These results were explained in Chapter 4. Then, all main metabolites of
quercetin and (-)-epicatechin predicted to be found in urine were decided to analyse.
However, commercially relevant conjugated quercetin and (-)-epicatechin are not
available. Therefore, main conjugates of these compounds, in different forms, were
synthesised using an enzymatic method (See Chapter 5). Consequently, these
compounds were used as standard compounds in Chapter 6. The main metabolites of
quercetin and (-)-epicatechin excreted in urine were determined and compared
between single consumption and co-consumption of red onion soup and 70% cocoa
dark chocolate. Finally, summary and future perspectives relate to this research area
will be explained in Chapter 7.
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1.2 Flavonoids
1.2.1 General structure and occurrence in foods
Polyphenols are found widely in natural plants and have more than one
phenol unit or building block per molecule in their structures. Polyphenols can be
classified into two groups; non-flavonoids and flavonoids. Flavonoids are identified
by having a common structure consisting of of 15 carbons, two aromatic rings (A
ring and B ring) which are bound together by three carbon atoms (C ring). Thus, the
chemical structures are a C6-C3-C6 skeleton (Figure 1.1). In addition, flavonoids
can be divided into six subclasses according to the variation in the heterocyclic ring
including; flavonols, flavones, isoflavones, flavanones, anthocyanidins and
flavanols. All of these subclasses share the same carbon skeleton but contain
different substituents such as hydroxyl group and sugars presenting naturally as a
glycosides which help to increase the water solubility of flavonoids. In contrast,
others substituents such as methyl group decrease the water solubility of flavonoids.
Figure 1.1: Carbon skeleton of flavonoids (C6-C3-C6)
Flavonoids occur naturally as glycosides rather than aglycones. For example,
flavonols are normally found as glycosides with conjugation occurring
at the 5, 7, 3, 4, and 5 positions. The main flavonol in our diet is quercetin. Other
common flavonols include kaempferol, myricetin, isorhamnetin, tamarixetin, morin
and fisetin. The richest sources of flavonols are onions, apples, and tea. Flavones
have similar structural to flavonols but they lack oxygenation at C-3. For example,
luteolin and apigenin which were identified in sweet red pepper and celery,
respectively. Isoflavones have the B-ring attached at C-3 rather than at the C-2
position. They are found almost exclusively in leguminous plants for example.
daidzein and genistein in soybean. Isoflavones also are classified as phytoestrogens
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because of their structural similarity to estrogen. Flavanones are characterized by the
absence of ∆2,3 double bonds and the presence of a chiral center at C-2 such as 
naringenin and hesperetin. Citrus fruits are the main food source of flavanones.
Flavanols, unlike flavonols, do not exist as glycosides. They are the most complex
subclass of flavonoids, ranging from the simple monomers to the oligomeric and
polymeric proanthocyanidins. The two chiral centers at C2 and C3 of the monomeric
flavanol produce four isomers for each level of B-ring hydroxylation. The main
flavanols are catechins and very abundant in tea. Other sources are red wine and
chocolate. Lastly, anthocyanins are red fruits pigments and found in berries fruits,
grape, plums, red and black currants (Scalbert and Williamson, 2000; Crozier et al.,
2009). Chemical structure and major food sources of each subclass was shown in
Table 1.1.
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Table 1.1: Occurrence of main subclasses of flavonoids in foods
Flavonoid subclass Chemical structure Major food sources
Flavonols Onion, Tea, Apple
Flavones Sweet red pepper, Celery,
Parsley
Isoflavones Soybean
Flavanones Citrus fruit
Flavanols Tea, Red wine,
Chocolate
Anthocyanins Berries, Grape, Plums
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This thesis will focus only on 2 subgroups; the monomeric flavonol,
quercetin and the monomeric flavanol (-)-epicatechin which are major flavonoids
present in the human diet and are easily available as commercial standards. These
two compounds behave as powerful antioxidants and free radical scarvengers and
are able to interact with several key enzymes such as quercetin shows an effective
inhibit lipoxygenase and xanthine oxidase (Duenas et al., 2010). Intestingly, these
two compounds have a similar structure, containing a catechol ring with two
hydroxyl groups that can be modified by uridine diphosphate glucuronosyl
transferase (UGT), sulfotransferase (SULT) and catechol-O-methyl transferase
(COMT) (see Figure 1.2).
Figure 1.2: Structure of quercetin and (-)-epicatechin found mostly in onion and
dark chocolate. They have a similar stucture characterised by a catechol ring.
1.2.2 Quercetin
Quercetin (3, 5, 7, 3, 4-pentahydroxyflavone) is a flavonol-type flavonoid
most abundant in onion and apple, while present in other fruits and vegetables as
well. It is mostly present in foodstuffs as O-glycosides. It means that at least one
hydroxyl group is substituted by various types of sugar. In general, quercetin
glycosides containing a sugar group at the 3-position, for example, quercitrin,
Epicatechin (EC)Quercetin (Q)
‘Catechol ring’
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isoquercitrin, hyperoside and rutin, are commonly distributed in a wide variety of
vegetables. However, in onion, the phenolic group at the 4-position is necessarily
bound by a sugar group and thus its major glycosides are quercetin-4-O--D-
glucoside (Q4G) and quercetin-3, 4-O-β-D-diglucoside (Q3, 4diG) (Murota and
Terao, 2003).
The chemical activities of quercetin can be ascribed to its electron-donating
property (reducing activity) which is due to the presence of a phenolic hydroxyl
group. This property is essential for exerting anti-oxidant activity by scavenging free
radicals. Additionally, the O-dihydroxyl structure at the 3′- and 4′-positions in the B-
ring, the so-called catechol group, is largely responsible for this activity. Murakami
et al, (2008) reported that the hydroxyl groups at the 3′ and 4′-positions in the B-ring 
and the 3-position in the C-ring are responsible for the high reactivity of quercetin
with free radicals. Furthermore, they suggested that quercetin and its analogues act
as anti-oxidants by inhibiting oxidative enzymes such as xanthine oxidase (XOD),
lipoxygenase (LOX) and NADPH oxidase which are also responsible for the
attenuation of oxidative stress as they play key roles in the initial process of free
radical-induced cellular damage. They also explained that quercetin is converted to
O-quinone and the O-semiquinone radical. Then, oxygen molecules can react with
this radical resulting in the production of O2− and H2O2. These reactive oxygen
species (ROS) affect cellular redox signaling pathways and are capable of inducing
cellular oxidative damage. Therefore, quercetin can possibly act as both a pro-
oxidant and an anti-oxidant.
1.2.3 (-)-Epicatechin
(-)-Epicatechin is a flavanol that is commonly present in green teas, red
wine, cocoa products, and many fruits, such as apples. However, cocoa bean has the
highest levels of (-)-epicatechin (43,270 mg/kg fresh weight) and higher than green
tea, which contains about 8,000 mg/kg fresh weight.
1.3 Bioavailability of quercetin and (-)-epicatechin
The bioavailability of dietary flavonoids is limited not only by the structural
diversity of the molecule but it also depends on an enzyme in their metabolism,
microbial-mediated biotransformation and active efflux (Yang, 2008). Though the
bioavailabilities of flavonoids vary between different types of flavonoids, the
- 28 -
absorption and metabolism follow the same concept to all flavonoids. Flavonoid are
metabolized both in tissues through the gut barrier and by the colonic microflora.
Most flavonoids, including quercetin in flavonol subclass, are glycosylated
in food. Therefore, glycosylated flavonoids have to be deglycosylated before
absorption. Duenas et.al (2010) suggested that the first step in quercetin metabolism
is likely to be deglycosylation before absorption in the small intestine. Moreover,
monoglucosides, in which only one glucose molecule is bound to quercetin, such as
isoquercitrin and Q4′G, are absorbed in the small intestine as quercetin aglycone 
following hydrolysis with LPH. Alternatively, they are incorporated into intestinal
epithelial cells via a SGLT-1 pathway. In the case of other glycosides which contain
one sugar other than glucose (such as hyperoside) or disaccharides/oligosaccharides
(such as rutin), absorption occurs in the large intestine as quercetin aglycone through
deconjugation caused by the activity of enterobacteria (Murakami et al 2008).
The sugar is removed by two possible mechanisms. First, it involves the
action of lactase phlorizin hydrolase (LPH) that is present in the brush border of the
small intestine epithelial cells. For a specific substrate like flavonoid-O-β-D-
glucosides, LPH will hydrolyse this substrate into an aglycone. Due to an increasing
of lipophilicity and proximity to the cellular membrane of the aglycone, it then
enters the epithelial cell by passive diffusion (Day et al., 2000). The second
mechanism involves cytosolic -glucosidase (CBG) that is present within the
epithelial cells. In these epithelial cells, the polar glucosides are transported through
the active sodium dependent glucose transporter SGLT1 (O'Leary et al., 2003).
Then, the flavonoid glycosides will hydrolyse to the aglycone by CBG. In the case
of (-)-epicatechin, it is acylated flavonoids which can pass through biological
membranes and absorb without deconjugation. Prior to passage into blood
circulation, simple aglycones are conjugated by glucuronidation, sulfation and
methylation or a combination, using uridine-5-diphosphate glucuronosyltransferase,
sulfotransferases and catechol-O-methyltransferase, respectively. However, some
conjugated flavonoids are probably efflux back to the gastrointestinal tract involving
members of the adenosine triphosphate (ATP)-binding cassette (ABC) family of
transporters; multidrug resistance protein (MRP) and P-glycoprotein. In the case of
quercetin and (-)-epicatechin, the efflux of these compounds involved with multi
resistant protein 2 (MRP2) (O'Leary et al., 2003). After conjugation, the conjugated
metabolites will reach the liver via the hepatic portal vein. In hepatocytes, these
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metabolites will be subjected to further conjugation by phase II enzyme. In addition,
the enterohepatic recirculation may result in some recycling back to the small
intestine through bile excretion. Some flavonoids and conjugated metabolites not
absorbed in the small intestine will pass to the colon and can be absorbed at this site
by the action of the colonic microflora (Crozier et al., 2009). The microflora in the
colon promotes extensive modifications including hydrolysis, ring cleavage, and
dehydroxylation, forming lower molecular weight phenolics (Scalbert and
Williamson, 2000). The routes of dietary flavonoid and the mechanism for the
absorption of flavonoids in the enterocyte are shown in Figure 1.3.
Figure 1.3: The metabolic pathway of a polyphenol. Glucuronidation, sulfation and
methylation occurs at enterocyte and hepatocyte by uridine-5-diphosphate
glucuronosyltransferase (UGT), sulfotransferase (SULT) and catechol-O-
methyltransferase (COMT), respectively.
The conjugation represents a metabolic detoxification process common to
many xenobiotic compounds that restricts their potential toxic effects and facilitates
their biliary and urinary elimination by increased solubility and a higher molecular
weight. Thus, most dietary flavonoids are quickly eliminated in both urine and bile
after ingestion. For quercetin, their metabolites were found in over 20 different
forms in both plasma and urine. In addition, these metabolites were eliminated in
urine at approximately 2–3% of the ingested dose (Mullen et al, 2006). For (-)-
epicatechin, ten forms were found in plasma and fifteen forms were found in urine
with 20±2% of the ingested dose (Actis-Goretta et al, 2012). Comparing between 4
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enantiomers of flavanols, the bioavailability of these stereomers were ranked as (-)-
epicatechin > (+)-epicatechin = (+)-catechin > (-)-catechin on the basis of plasma
concentration and urinary excretion of the aglycones after enzymatic deconjugation
(Ottaviani et al, 2011). Actis-Goretta et al, 2013 also studied the intestinal
absorption and metabolism including the role of biliary and urinary excretion of 50
mg of purified (-)-epicatechin in healthy volunteers by an intestinal perfusion
techinique. They found that approximately 44 % of dose of (-)-epicatechin did not
absorbed but the predominant metabolite as sulfated form (around 80% of total
metabolites analysed) was effluxed back to the intestinal lumen, reached to the large
intestine and further metabolised by the gut microbiota. Additionally, they showed
that (-)-epicatechin was a moderately excreted by bile. The conjugated enzymes
involved in polyphenol metabolism are explained as follows.
1.3.1 Uridine-5-diphosphate glucuronosyltransferase (UGT)
Glucuronidation mainly occurs as a result of the activity of glucuronosyl
transferases with uridine-5-diphospho-a-D-glucuronic acid (UDPGA) as
glucuronide donor. The mechanism involves a nucleophilic attack of the oxygen
nucleophiles (R-OH) or other atoms, such as nitrogen, sulfur and even carbon in the
substrate molecule on the cofactor, leading to O-, N-, S- and C glucuronides,
respectively (Ding et al, 2013). In this case, quercetin and (-)-epicatechin, containing
hydroxyl group in their structures are easily conjugated by glucuronic acid to form
O-glucuronided conjugates.
Human UGTs are classified into four families; UGT1, UGT2, UGT3 and
UGT8, on the basis of amino sequence identify. UGT1A is the major subfamily
responsible for xenobiotic glucuronidation and also show tissue-specific expression.
UGTs variants are functionally different from the wide types. Most notably,
UGT1A1 is a highly polymorphic isoform. Furthermore, the deficiency in its
expression or activity may cause genetic diseases. Recently, UGTs polymorphisms
are systematically identified and newly variant are updated at
http://www.pharmacogenomics.pha.ulaval.ca /sgc/ugt_alleles (Wu et al., 2011).
The effects of UGT polymorphisms on flavonoid clearance have not been
examined. However, several studies showed that UGT polymorphisms affect
glucuronidation and clearance of drugs and other xenobiotic compounds. Then, it is
possible that similar effects may be seen with dietary flavonoids (Lampe, 2009).
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1.3.2 Sulfotransferases (SULT)
The sulfotransferases belong to an emerging superfamily of enzymes that
catalyse the transfer of SO3- to hydroxyl or phenolic groups on susceptible
substrates, or the nitrogen atom of N-substituted aryl or alicyclic compounds, or
pyridine N-oxides, through the sulfating cofactor. SULT catalyses the transfer of
sulfate from adenosine 3′-phosphate 5′-phosphosulfate (PAPS) to flavonoids, 
forming various flavonoid sulfates (Ding et al., 2013). The level of sulfation activity
probably is limited by PAPS availability (Klaassen and Boles, 1997).
SULTs have been identified into two board classes; (1) membrane-bound
SULTs that are responsible for the sulfonation of peptides, proteins, lipids, and
glycosaminoglycans and (2) cytosolic SULTs that are responsible for the
metabolism of xenobiotic and small endogenous substrates such as steroids, bile
acids, and neurotransmitters (Gamage et al., 2005). Like other phase II enzymes,
cytosolic SULTs compose a large superfamily of genes. To date, cytosolic SULTs
have been classified into five families and share less than 40% similarity base on
amino acid sequence. SULT1 and SULT2 families are the largest and responsible
for sulfation of endo- and exogenous compounds (Kauffman, 2004).
Genetic variants in SULT genes with associated functional differences in the
translated protein have been identified. Single-nucleotide polymorphisms in
SULT1A1 and SULT2A1 are common and have been associated with altered
response to therapeutic agents and sex steroid concentrations, respectively. In vitro
study with recombinant SULT1A1 have been shown that the SULT1A1*2 variant is
less effective than SULT1A1*1 at conjugating resveratrol, apigenin, and
epicatechin. However, the influence of SULT1A1 on phytochemicals metabolism
still remains to be evaluated in vivo (Lampe, 2009).
1.3.3 Catechol-O-methyltransferase (COMT)
COMT is an Mg2+ -dependent enzyme which catalyses the transfer of a
methyl group to a hydroxyl group of catechol ring at 3 or 4 position, resulting in 3
methylated or 4 methylated product. In this catalytic reaction, S-adenosyl-L-
methionine acts as a methyl donor, and then it will be changed to S-adenosyl
homocysteine (Figure 1.4). COMT has a variety of substrates. These can be divided
into two groups; endogenous substrate such as catecholamines neurotransmitters and
catechol estrogens, and exogenous substrate catecholic drugs and dietary catechols.
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The general function of COMT is to eliminate the biologically active or toxic
catechols and some hydroxylated metabolites. For example, COMT introduces a
methyl group to the catecholamine and thus inactivates catecholamine
neurotransmitters (dopamine, epinephrine and norepinephrine) or converts the
catechol estrogen to the inactive methoxy derivative (2-MeOE2 and 4-MeOE2).
Figure 1.4: Catalytic reaction of COMT, Mg2+ dependent enzyme. COMT catalyses
the transfer of a methyl group from AdoMet (S-adenosyl-L-methionine) to a 3 or 4
hydroxyl group on a substrate, containing catechol ring. (AdoHcy= S-adenosyl
homocysteine)
COMT is encoded by a single gene with two different transcription start
sites; at the P1 and P2 promoters. The COMT gene is localised on chromosome 22,
band q11.22-23 (Figure 1.5). The shorter mRNA from the P2 promoter encodes a
soluble COMT (S-COMT). The longer mRNA from the P1 promoter encodes
mainly a membrane-bound COMT (MB-COMT) but to some extent S-COMT
(Tunbridge et al., 2006). MB-COMT has higher substrate affinity but lower catalytic
activity than S-COMT. Additionally, the MB-COMT is predominantly expressed in
brain neurons whereas S-COMT is predominantly expressed in other tissues, such as
liver, blood, and kidney (Chen et al., 2004).
Catechol ring Methylated product
COMT
AdoMet AdoHcy
Mg2+
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Figure 1.5: COMT gene located on chromosome 22, band q11.22-23. It consists of
six exons and has two promoters (sequences in grey are unique to the longer
mRNA). P1 promoter and P2 promoter encodes MB-COMT and S-COMT,
respectively. (Adapted from: Tunbridge et al., 2006; Tammimaki and Mannisto
2010)
Human COMT activity varies among individuals. Only three of the COMT
mutants have been studied for their enzymatic activity and functional differences
with the wild-type COMT (Bai et al, 2008) but the most well known mutant has two
co-dominant alleles (G and A) in exon 4 of the COMT gene that influence the amino
acid structure (Val or Met) at codon 108 in S-COMT or 158 in MB-COMT
(rs165688 or rs4680, respectively). This variant causes the enzyme to be more
thermolabile, structurally less stable, and has at least 40% lower enzyme activity
than normal (Tammimaki and Mannisto 2010). Hence, the COMT enzyme activity
is genetically polymorphic with a trimodal distribution; high activity in Val/Val
genotype, intermediate activity in Val/Met genotype, and low activity in Met/Met
genotype (Hosak, 2007). At present, a total of 14 polymorphisms are listed in the
NCBI SNP database for the coding regions (exons) of the human COMT gene, and
each of them are single point mutations (Table 1.2). In addition, the allele frequency
of COMT polymorphism in different group of population is shown in Table 1.3.
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Table 1.2: The COMT polymorphisms listed in the NCBI SNP database
(http://www.ncbi.nlm.nih.gov/SNP) (Bai et al, 2008).
Amino acid positions Amino acid residue Effect on the catalytic
activity
(S/MB) Wild-type Mutant of the enzyme
-/9 L F Unknown
(unpublished)
-/34 C S Unknown
(unpublished)
12/62 H Ha No change
22/72 A S Lower catalytic activity
and
reduced thermostability
23/73 Q Qa No change
42/92 V M Unknown
(unpublished)
52/102 A T Reduced
thermostability
62/112 L La No change
84/134 A Aa No change
86/136 L La No change
96/146 A V Unknown (unpublished)
108/158 V M Reduced thermostability
149/199 P L Unknown (unpublished)
153/203 L La No change
a These nucleic acid mutations will not alter the amino acids that are encoded by the
altered codons
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Table 1.3: The allele frequency of COMT polymorphism in different group of
population (adapted from Palmatier et al., 1999).
Population N Genotype distribution Allele
frequencies
Reference
H/H H/L LL H L
Japanese 153 74 70 9 0.71 0.29 Kunugi et al
1997a
109 46 47 16 0.64 0.36
Caucasian 173 40 88 45 0.48 0.52 Hoda et al
1996
139 32 70 37 0.46 0.54
Finnish 76 14 35 27 0.42 0.58 Syvanen et al
1997
158 39 80 39 0.5 0.5
Chinese 62 37 19 6 0.75 0.25 Xie et al 1997
70 44 21 5 0.78 0.22
North American
Mixed European
148 49 73 26 0.58 0.42 Karayiorgo et
al 1997
73 14 36 23 0.44 0.56
United Kingdom 78 20 33 25 0.47 0.53 Daniels et al
1996
78 20 36 22 0.49 0.51
North American
Mixed European
87 30 44 13 0.6 0.4 Strous et al
1997
54 12 28 14 0.48 0.52
Chinese 99 52 40 7 0.73 0.27 Chen et al
1997
177 92 72 13 0.72 0.28
North American
Mixed Europeana
129 31 70 28 0.51 0.49 Karayiorgo et
al 1998
North American 157 45 72 40 0.52 0.48
Japanese 150 58 77 15 0.64 0.36 Ohmori et al
1998
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Population N Genotype distribution Allele
frequencies
Reference
H/H H/L LL H L
150 81 56 13 0.73 0.27
North American
Mixed European
87 30 44 13 0.6 0.4 Lachman et al
1997
63 20 35 8 0.6 0.4
Spanish 113 35 57 21 0.57 0.43 Gutierrez et al
1997
88 31 38 19 0.57 0.43
Han Chinese 98 66 29 3 0.82 0.18 Li et al 1997
93 44 41 8 0.69 0.31
European 121 29 62 30 0.49 0.51 Kunugi et al
1997b
169 42 85 42 0.5 0.5
Japanese 135 58 59 18 0.65 0.35 Ohara et al
1998
75 19 48 8 0.57 0.43
40 15 22 3 0.65 0.35
North Americana 87 30 44 13 0.6 0.4 Lachman et al
1996a
North American,
European, Hispanic
25 — — — 0.36 0.64
13 — — — 0.38 0.62
8 — — — 0 1
North American 124 23 63 38 0.44 0.56 Vandenbergh
et al 1997
41 16 13 12 0.55 0.45
185 58 83 44 0.54 0.46
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North American
White, Hispanic
28 12 11 5 0.63 0.38 Lachman et al
1998
27 3 15 9 0.39 0.61
Numerous epidemiological studies have examined an association between
COMT polymorphism and health effect. Several studies showed that the
val108/158met COMT polymorphism has been positively associated with
neuropsychiatric conditions and a number of diseases such as breast cancer (Doyle,
2004). For example, differences in COMT activity relate to L-dopa level, resulting
in Parkinson’s disease susceptibility in difference ethnic groups (Tai and Wu, 2002).
The low activity allele is also associated with progression and lymph node
metastasis of breast cancer in Japanese women. In postmenopausal women, Wang et
al., 2010 showed that carrying COMT-LL genotype contributes to estrogen-induced
carcinogenesis of breast cancer. Additionally, other studies also showed that this
polymorphism relates to coronary events. Happonen et al., (2006) examined the
function of COMT gene on the risk of acute coronary events by modifying the effect
of coffee intake. They found that heavy coffee consumption increases the incidence
of acute coronary events in men with low COMT activity. In 2007 the same research
group suggested that Val158Met polymorphism is associated with increased risk of
acute coronary events and it may interact with high serum total homocysteine levels.
Moreover, Annerbrink et al., (2010) suggested that the single nucleotide
polymorphism is associated with various phenotypes, including different aspects of
cognitive function, obesity and also blood pressure. Wang et al., (2007) supported
that COMT polymorphisms play a role in large increases in BMI in obesity.
However they showed that there was a significant association with Leu136Leu
polymorphism but not for the Val158Met polymorphism. In the case of blood
pressure, Annerbrink et al., (2008) found that Val158Met polymorphism associate
with systolic and diastolic blood pressure, heart rate and body fat distribution in a
sample of middle-aged Swedish men.
1.4 Biological activity of quercetin and (-)-epicatechin
During transfer across the enterocyte, and subsequently in the liver, the
quercetin aglycone is immediately metabolized into its conjugated forms. The
important step in quercetin metabolism seems to be methylation to 3-O-methyl-
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quercetin (isorhamnetin), the primary metabolite or 4-O-methyl-quercetin
(tamarixetin), a second metabolite. The methylation process may change the
biological activity of quercetin because the hydroxyl group of quercetin is
substituted, resulting in a decrease in the antioxidant activity of the parent
compound. However, its metabolite (3-O-methyl-quercetin or 4-O-methyl-
quercetin) still retain significant antioxidant/scavenging activity better than -
tocopherol. It is probably because of their stability (Duenas et al., 2011). This can be
supported by Jaramillo et al., 2010. They suggested that the absorption and
metabolic stability of methylated flavonoids are significantly increased when
compared with unmethylated parent molecules, thus, 3-O-methyl-quercetin is to be
a higher bioavailability than quercetin. Furthermore, they showed that 3-O-methyl-
quercetin inhibited cell growth and induced both apoptosis and necrosis in human
colon cancer cells hence it may have clinical significance with therapeutic and
chemopreventive capabilities. However, another study showed that only quercetin,
not its O-methylated metabolites, exerts protective effects against H2O2
cardiotoxicity and its action involves the modulation of PI3K/Akt and ERK1/2
signalling pathways (Angeloni et al., 2007).
The same as quercetin, O-methylation of the catechol B-ring resulted in a
decrease of the antioxidant activity with regards to the parent compounds. However,
the methylated metabolites still retain significant radical scavenging activity at pH
7.4. Some studied showed that (-)-epicatechin and its 3'-O-methyl (-)-epicatechin
against UVA-induced damage and cell death in cultured human skin fibroblasts
(Basu-Modak et al., 2003). Furthermore, Steffen et al. (2007) revealed that
epicatechin scavenged O2- but its O-methylated metabolites prevented O2- generation
through inhibition of endothelial NADPH oxidase activity, resulting in improvement
of the bioactivity of NO.
There is consistent evidence from population studies that quercetin can
reduce the risk of cardiovascular disease. In the case of (-)-epicatechin, the
population data are less consistent. However, in intervention studies, flavan-3-ol–
rich foods and beverages, such as tea and cocoa, consistently improve endothelial
function. In the short-term effect, (-)-epicatechin diminished NO elimination
through NADPH oxidase as caused by O-methylated-(-)-epicatechin metabolites
(Figure 1.6). In the longer-term effect, (-)-epicatechin may additionally include
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elevated generation of NO as a consequence of a higher cellular level of active
eNOS protein (Steffen et al., 2007; 2008).
Figure 1.6: Inhibition of NADPH oxidase by O-methylated (-)-epicatechin
metabolites (Adapted from: Steffen et al. 2007; 2008)
Additionally, several biomarkers related to (-)-epicachin or quercetin and its
methylated metabolites have been studied (Table 1.4) and the summary is presented
in Figure 1.7.
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Table 1.4: Biomarkers related to (-)-epicachin or quercetin and its methylated
metabolites
Compounds Cell
system
Concentration Biomarkers References
(-)-Epicatechin
and/or its
methylated
metabolites
Human
dermal
fibroblasts
Up to 30 µM - MMT reduction
for mitochondrial
function
- Annexin-V binding
staining for cell
death
- Caspase-3 activity
for apoptosis
(Spencer et
al., 2001)
Human
skin
fibroblasts
1-50 µM - MMT assay and
confirmed by NR
assay for
mitochondrial
function
- AV and PI staining
for cell death
(Basu-
Modak et
al., 2003)
Mouse
Primary
cortical
neurons
100- 300 nM - Immunoblotting
for detecting protein
kinase signalling
pathway (ERK and
PI3K)
(Schroeter
et al.,
2007)
Human
umbilical
vein
endothelial
cells
(HUVEC)
10 µM - NO and also
cGMP level
(Steffen et
al., 2007)
Human
umbilical
vein
endothelial
cells and
cell lysates
10 µM - O2- release
- NADPH oxidation
activity
(Steffen et
al., 2008)
Human
and rat
plasma
2.1- 42.8 µM - Nitrotyrosine
formation
(Natsume
et al.,
2008)
- 41 -
Twelve
healthy
male
subjects
200 mg (-)-
epicatechin
dissolved in
300 ml water
- Endogeneous NO
production (S-
nitrosothiols, Nitrite,
Nitrate)
- F2 isoprostanes
(Loke et
al., 2008a)
Table 1.4: Biomarkers related to (-)-epicachin or quercetin and its methylated
metabolites (Continued)
Compounds Cell
system
Concentration Biomarkers References
Quercetin
and/or its
methylated
metabolites
Rat aorta 1- 10 µM - Contractile
response to
phenylephrine or
acetylcholine for
endothelial
function
- Superoxide
production and
localize in vascular
wall
- P47phox
expression by
western blot and
localization by
immuno-
histochemical
(Sanchez et
al., 2007)
Human
peripheral
monocytes
and
neutrophil
s
0-10 µM Production of pro-
inflammatory
eicosanoids
- Leucotrien B4
(LTB4 )
- Prostaglandin E2
(PGE2 )
Antioxidant
activity
- Formation of lipid
hydroperoxides and
F2 isoprostanes
(stable biomarker
for lipid
peroxidation)
(Loke et al.,
2008b)
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Quercetin
and/or its
methylated
metabolites
Rat aorta 10 µM - Contractile
response to
phenylephrine or
acetylcholine for
endothelial
function
- Superoxide
production and
localize in vascular
wall
- P47phox and
P22phox expression
- Protein kinase C
(PKC)
(Romero et
al., 2009)
Macropha
ge cell
line, U937
30 µM - Nitric oxide
inhibitory activity
- Catalase activity
- Cytokine
production: tumour
necrosis factor-α 
(TNF- α), 
Interleukin 6 (IL-
6), Interleukin 1
(IL-1)
(Okoko and
Oruambo,
2009)
Colon
adenocarci
noma cell
line,
HCT-116
0- 100 µM - MTT assay for
cell viability
- Annexin V and
necrotic (PI) for
apoptosis
(Jaramillo et
al., 2010)
Murine
macropha
ge cell
line,
RAW264.
7
0, 10-100 µM The expression of
proinflammatory
marker
- TNFα 
- Cytokines (iNOS,
IL1β, IL6 and 
MIP1α 
(Boesch-
Saadatmandi
et al., 2011)
Human
aortic
endothelia
l cells
0- 15 µM - TNFα induced 
cellular adhesion
molecule (ICAM-1,
E-selectin, VCAM-
1) and release of
monocyte
chemotactic
protein-1 (MCP-1)
(Lotito et
al., 2011)
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Figure 1.7: Biomarker of (-)-epicatechin (A), quercetin (B) and its methylated
metabolites on a cellular level.
A.
B.
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Generally, reactive species like ROS and RNS were produced in human body
from several sources such as NADPH oxidase, the complex I and II in mitochondrial
transport chain etc. These reactive species were controlled and balanced by
antioxidants. When the level between reactive species and antioxidants are
imbalance, it may cause oxidative stress. At the low level of ROS, it may has an
effect on cell signalling or cellular messengers. While at the high level of ROS, it
may leads to cytotoxicity, apoptosis and cell death, respectively. In addition,
oxidative stress can induce by some stressors such as t-BOOH, oxidised LDL, H2O2,
angiotensin-II, endothelin-1 etc. The effect of (-)-epicatechin, quercetin and/or its
methylated metabolites on cytoprotectvie effects were studies by several research
groups (Table 1.3). The oxidative stress was induced to different types of cells by
different stressors, depending on the aim of each study. Then, the biological effects
of (-)-epicatechin, quercetin and/or its metabolites were analysed using several types
of biomarkers. In Figure 1.7A, a parent compound of (-)-epicatechin acts as a radical
scavenger of superoxide while its methylated form acts like a aponin or NADPH
oxidase inhibitor. Then, the production of superoxide was decreased, resulting in
NO preservation and relating to the higher level of cGMP. The cGMP is 2nd
messenger response for the vasolidatory. When cGMP was increased, the
vasolidation also was higher and can monitored by the flow mediated dilation or
FMD. In addition, in the normal condition the oxidative stress can induces apoptosis
and cell death by losing mitochondrial function, increasing caspase-3 and annexin-V
binding protein. However, after pre-treatment human dermal fibroblast cells with 30
µM of (-)-epicatechin or 3´-methylated (-)-epicatechin prior to the addition of 50
µM of H2O2, this study showed that (-)-epicatechin and its methylated form
significantly attenuated the loss of mitochondrial function and caspase-3 activity and
these compounds also increased live cells (Spencer et al., 2001). In Figure 1.7B,
quercetin and its methylated act as NADPH oxidase inhibitor similar to (-)-
epicatechin and methylated (-)-epicatechin. In addition, after inducing cellular
adhesion molecules (ICAM-1, E-selectin, VCAM-1) by TNF or tumour necrosis
factor, quercetin, 3´- and 4´- methylated quercetin were equal effectively inhibited
the expression of cellular adhesion molecules. Thus, this result indicated that the
methylation of the catechol group of the B-ring of quercetin did not alter their anti-
inflammatory activity (Lotito et al., 2011). Furthermore, in the normal condition
angiotensin induced the phosphorylaion of cytoplasmic P47 subunit leading to
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NADPH oxidase activation. However, quercetin and 3´-methylated quercetin can
inhibit the overexpression of P47 subunit so the endothelial dysfunction was
prevented (Sanchez et al., 2007). Another stressor like endothelin-1 can up-regulates
of P47phox subunit and produced superoxide. However, quercetin and 3´-methylated
quercetin prevented the increasing of vascular O2- production from uncoupled eNOS
and NADPH oxidase through down-regulation of P47phox expression (Romero et al.,
2009).
1.5 Aim and Objectives
The aim of this study was to investigate the metabolism and excretion of
quercetin and (-)-epicatechin and their metabolites after co-consumption of onion
and dark chocolate in healthy human. This will be achieved by the following
objectives:
1) Quantification and comparison the amount of quercetin in yellow onion
and red onion by HPLC-DAD.
2) Preparation a large batch of onion soup, re-quantification and comparison
the amount of quercetin in this soup after preparation, before microwaving and after
microwaving by HPLC-DAD.
3) Quantification the amount of (-)-epicatechin in different percentage of
cocoa dark chocolate and also the selected 70% cocoa dark chocolate by HPLC
DAD/FLD.
4) Evaluation the COMT activity in vitro using (-)-epicatechin or quercetin
as substrates and extracted enzyme from pig liver cytosol.
5) Investigation the COMT variation in a small group of human volunteers
by analysing urinary excretion of quercetin, (-)-epicatechin or its methylated forms
after single consumption of red onion soup, 70% cocoa dark chocolate and co-
consumption of both types of food by β-glucuronidase and sulfatase deconjugation 
and HPLC-MS analysis.
6) Investigation sulfatase activity using a commercial substrate and products,
p-nitrocatechol sulfate (PNCS) and p-nitrocatechol (PNC).
7) Synthesis main metabolites of quercetin and (-)-epicatechin expected to be
found in urine using enzymatic method and analysing by HPLC-MS.
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8) Analysis main metabolites of quercetin and (-)-epicatechin excreted in
urine in 27 healthy volunteers after single consumption of red onion soup, 70%
cocoa dark chocolate and co-consumption of both types of food by UPLC-MS.
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Chapter 2 Materials and Methods
2.1 Materials
2.1.1 Standard flavonoids
Quercetin (Q) was purchased from Sigma Aldrich (Dorset, UK). Quercetin 3,
4-O-diglucoside (Q3,4diG), quercetin 4-O-glucoside (Q4G), isorhamnetin
(3MeQ), tamarixetin (4MeQ), (-)-epicatechin (EC), daidzein (D) and taxifolin (T)
were purchased from Extrasynthése (Genay, France). Ethyl gallate (EG) was
purchased from Apin Chemicals Ltd (Oxfordshire, UK). All standards were of
HPLC purity (above 98 %).
2.1.2 Food samples
Fresh yellow and red onions were purchased from a local supermarket
(ASDA, Leeds, UK) prior to direct analysis or soup preparation. After red onion
soup preparation, the soup samples were kept at -20ºC.
For dark chocolate, a preliminary sample (70% Cocoa Dark Chocolate,
Lindt) was already available in the laboratory but others (Dark Chocolate French
70% Cocoa, Thorntons; the Best 85% Cocoa Dark Chocolate, Morrisons; excellence
90% Cocoa Dark Supreme Noir, Lindt) was obtained from a local supermarket
(Morrisons, Leeds). Dark Chocolate French 70% Cocoa (Thorntons) was selected
for use in human study. Then, the same batch of this 70% cocoa dark chocolate
(batch number L120208) was purchased online through thorntons.co.uk from
Thorntons PLC and kept at -20ºC.
2.1.3 General equipment
General equipment used in this study are as follows: First, two decimal
balance (Percisa) and four decimal balance (Adventurer Analytical balance, Ohaus)
were used for weighing some samples and chemicals or standards, respectively.
Second, a Millipore Q water purifying system (Millipore, Hertfordshire, UK) was
used to provide ultrapure, nuclease free water (≥18.2 MΩ cm at 25°C) both 
analytical purposes and as a mobile phase for HPLC and LC-MS. Third, for
centrifugal evaporation, a Genevac (EZ-2 plus model; Fisher Scientific Ltd,
Leicestershire, UK) was used for drying samples or standards. Fourth, pH meter
(Hobiba compact pH meter, B-212 model) was used for buffer preparation. Fifth,
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vortex (Vortex Genie 2, Scientific Inductries) was used for mixing samples.
Additionally, microcentrifuge (MicroCL 17 Centrifuge, Thermo) and centrifuge
(5810R, Eppendorf) were used for separating mixed solutions or samples. Finally,
the water bath (NE2D Unstirred Digital Water Baths, Clifton Range®) and shaking
water bath (GLS Aaqua 12 Plus, Grant) were used for sonicating HPLC solvent and
incubating enzymatic synthesis reactions, respectively.
2.2 Methods for quantification of quercetin and (-)-epicatechin content in
food
2.2.1 Determination of quercetin and its glycosides in onion
To compare the amount of quercetin in yellow and red onion, both types of
these onions were used.
2.2.1.1 Freeze-drying preservation process
Freeze-drying (lyophilisation) is a dehydration process generally used to
preserve an unstable compound or make samples more convenient for
transportation. Freeze-drying was done by freezing the sample followed by reducing
the surrounding pressure to allow the frozen water in the sample to sublimate,
changing directly from the solid phase to the gas phase. To preserve some quercetin
glycosides in fresh onion, in this study freeze-drying process used prior to quercetin
glycoside extraction.
One bulb from yellow or red onion was skinned and chopped to increase the
surface area prior to freezing. One hundred grams of each fresh sample was
immediately frozen by putting in the freezer at -80°C for about 2 hr, and then freeze-
dried using the “CoolSafe 55-9” at -55°C. The chopped onion samples were checked
every 2 hr until dry. Each sample then was weighed again. Next, freeze-dried onions
were finely ground into a powder with a coffee grinder. The grinder was primed
with a small amount of onion from the freeze-dried sample, 2.5 g of yellow onion or
3.8 g of red onion, before grinding 10 g of each sample. To grind the sample, coarse
level (No.12), the mid-level (No.6) and fine level (No. 1) were used in that order.
The onion powder was weighed again (8.99 g for white onion and red 9.01 g for red
onion). The percentage lost was calculated (10.1% for yellow onion and 9.9% for
red onion). Finally, the onion powder was then kept in a 50 ml tube and stored at -
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20°C. This method was adapted from published methods (Pérez-Gregorio et al.,
2011, Mullen et al., 2004, Price and Rhodes, 1997).
2.2.1.2 Extraction of quercetin glycoside by homogenisation or sonication
To compare which extraction method is better to extract quercetin and its
glycosides from fresh onion, homogenisation or vortex followed by sonication was
tested in this step.
2.2.1.3 Homogenisation
To prepare 150 ml of extraction solution, 2.6 mg of ascorbic acid (MW=
175.12 g/mol) and 3.8 mg of diadzein (MW 254.25 g/mol) were added to 150 ml of
70% methanol. The solution was then mixed by stirring. The homogeniser was first
cleaned with milliQ water before homogenising each sample. One g of each dry
onion powder was homogenised in 10 ml of 70% methanol containing 100 µM
ascorbic acid and 100 µM internal standard (diadzein) for 1 min using a Polytron
PT1600E. During homogenisation, the onion sample was kept on ice. The mixture
was then centrifuged (Eppendorf 5801R) at 3000xg at 4°C for 15 min. The
supernatant was collected and the pellet further extracted and centrifuged two more
times. The three supernatants (approximately 27.5 ml) were combined and reduced
to dryness under vacuum using Genevac (setting a maximum temperature at 37°C
and using HPLC fraction program for about 2-3 hr and followed by aqueous
program for 2-3 hr). The dried extract was re-dissolved in 10 ml of 50% ethanol in
water, vortexed and kept at -20°C before analysis by HPLC.
2.2.1.4 Vortex and sonication
To prepare 100 ml of extraction solution, 1.7 mg of ascorbic acid (MW=
175.12 g/mol) and 2.5 mg of diadzein (MW 254.25 g/mol) were added to 70 ml of
70% methanol and then the volume adjusted to 100 ml. The solution was then
mixed. One g of each onion dry powder was mixed with 10 ml of 70% methanol
containing 100 µM ascorbic acid and 100 µM internal standard (diadzein), vortexed
for 2 min followed by sonicating at 25-27°C for 10 min. The samples were then
mixed briefly again before centrifugation at 3000xg at 4°C for 15 min. The
supernatant was collected and the pellet further extracted and centrifuged two more
times. The three supernatants (approximately 27.5 ml) were combined and reduced
to dryness in vacuum using a Genevac (Max. temperature = 37°C, program = HPLC
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fraction, overnight). The dried extract was re-dissolved in 10 ml of 50% ethanol in
water, vortexed and kept in -20°C before analysis.
2.2.1.5 Standard preparation of quercetin-3, 4-O-diglucoside, quercetin-4-O-
glucoside and quercetin
To prepare 200 µM of stock mixture, 125 µl of 1.6 mM Q3,4G (1 mg in 1 ml
of 50% ethanol in MiiliQ water), 90.9 µl of 2.2 mM Q4G (1 mg in 10 µl of DMSO
and 990 µl of absolute ethanol) and 66.7 µl of 3 mM quercetin (1 mg in 10 µl of
DMSO and 990 µl of absolute ethanol) were mixed and then adjusted to 1000 µl
with 50% ethanol in MilliQ water. To prepare 1000 µM of diadzein (as internal
standard), 256.4 µl of 3.9 mM of diadzein stock (1 mg in 1 ml of absolute ethanol)
was mixed with 743.6 µl 50% ethanol in MilliQ water. Subsequently, nine dilutions
of standard sample with internal standard were prepared as shown in Table 2.1.
Table 2.1: Preparation of standard mixtures of quercetin-3,-4-O-di-glucoside,
quercetin-4-O-glucoside and quercetin dissolved in 50% ethanol. Each standard
contained a final concentration of 100 µM daidzein (as an internal standard).
Standard
No.
Final
conc.
(µM)
[Standard mixture]
(200 µM)
(µl)
50% Ethanol
in milliQ water
(µl)
[Daidzein]
(1000 µM)
(µl)
Total volume
of each
standard
(µl)
1 100 200 160 40 400
2 75 150 210 40 400
3 50 100 260 40 400
4 25 50 310 40 400
5 10 20 340 40 400
6 7.5 15 345 40 400
7 5 10 350 40 400
8 2.5 5 355 40 400
9 1 2 358 40 400
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2.2.1.6 Sample preparation
For homogenisation samples, 1 µl of re-constituted sample from 2.2.1.2.1 was
diluted with 99 µl of 50% ethanol in MilliQ water (ratio 1:100) before preparing the
sample as shown in Table 2.2.
For vortex and sonication samples, 10 µl of re-constituted sample from
2.2.1.2.2 were diluted with 90 µl of 50% ethanol in MilliQ water (ratio 1:10) before
preparing the sample as shown in Table 2.2.
Table 2.2: Reaction mixture for non-spiked and spiked samples. Each sample
contained a final concentration of 100 µM daidzein (as an internal standard). For
spiked sample, a final concentration of 100 µM of mix standards, quercetin-3,4-O-
di-glucoside, quercetin-4-O-glucoside and quercetin, were added into the reaction.
Reaction mixture
Final
conc.
Volume (µl)
(µM) non-spike spike
Diluted onion samples in 50% ethanol - 100 100
1000 µM diadzein 100 40 40
200 µM of mix standards (Q3,4’diG, Q4’G, Q) 100 - 200
Solvent A (MilliQ water and 0.1% formic acid) - 260 60
Total volume 400 400
2.2.1.7 Determination of quercetin and its glycoside in yellow and red fresh
onion by high performance liquid chromatography-diode array detection
(HPLC-DAD)
Reversed phase HPLC with diode array detection (Agilent technologies 1200
series, Binary SL) was used to analyse samples. For diode array detection (DAD), a
variable wavelength (from 190 to 400 nm) of UV-visible spectra was scaned and
recorded. It consisted of a solvent degassing unit, binary pump, autosampler,
thermostatic column oven and diode array detector. The column, a ZORBAX
Eclipse XDB-C18, 4.6x50 mm, 1.8 µm, 582 μl column volume (Agilent 
Technologies) was used in this study. Solvent A was composed of milli Q water and
0.1% formic acid. Solvent B was composed of acetonitrile and 0.1% formic acid.
These two solvents were prepared using the following procedure. For solvent A,
about 900 ml of water was added to a 1000 ml volumetric flask. Then, 1000 μl of 
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formic acid was added and the volume was adjusted to 1000 ml. The solvent A was
mixed until it was homogeneous. This solvent A was transferred to a 1000 ml bottle.
Solvent B was prepared as a similar method. About 900 ml of acetonitrile was added
to 1000 ml volumetric flask. Then, 1 ml of formic acid was added and the volume
was adjusted to 1000 ml with milli Q water. Solvent B was mixed until it was
homogeneous and transferred to 1000 ml bottle. To protect it from UV light, the
solvent B bottle was covered by aluminium foil. To remove air bubbles, both
solvents were placed in the sonicator for approximately 30 minutes before
performing HPLC. The optimal condition for quercetin analysis was modified from
Morand et al (1998), initiated at 15% of solvent B, kept further for 2 min of 15%
solvent B and increased linearly to reach 40% at 22 min, kept steady at this 40% for
2 min, the percentage of solvent B was finally increased to 90% at 25 min for 3 min
before initial starting conditions at 29 min and were resumed for 5 min to re-
equilibrate the column for the next injection. The total method length was 34 min.
The flow rate and the injection volume were 0.5 ml/min and 10 µl, respectively.
2.2.1.8 Onion soup preparation
To prepare a meal rich in quercetin, red onion, which had a higher level of
quercetin than yellow and white onion, was used to prepare a soup. Onion soups
were prepared in the same manner on the same day in one batch and then frozen at -
20°C. Six kilograms of peeled red onions were weighed. Each bulb was then
chopped into a quarter and put into a blender (Kenwood Gourmet, PT800) to make
small pieces. To make a stock, chicken flavour food seasoning powder (18g/1L of
water) was pre-dissolved in 12 L of water before boiling it. The blended onion was
then added to the chicken stock, stirred, covered and left to simmer for 7 min. To
make the soup more homogenous, a large homogenizer (Mixer emulsifier, Silverson,
Model AXL, UK) was used. The soup was left to cool, and then 130 ml portions
were aliquoted into a clip and lock plastic container. Some onion soup was used to
analyse quercetin content on the day of preparation, and others were kept frozen
at -20°C until use (see Figure 1). On the day of use, the portions of soup were
defrosted and then reheated in a microwave. Thus, the content of onion soup before
and after reheating in a microwave also was analysed.
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2.2.1.9 Determination of quercetin and its glycoside in red onion soup by high
performance liquid chromatography-diode array detection (HPLC-DAD)
1 2
3 4
5 6
7 8
Figure 2.1: Onion soup preparation. 1 Red onions were peeled and weighed. 2. Each
bulb was chopped into a quarter. 3 and 4 Put into a blender to make small pieces. 5 The
stock was made followed by adding blended red nion into it and left to simmer for 7
min. 6 Soup was transferred anot er containe an homogenised after cooling down.
7 and 8 aliquoted and place in a clip and lock plastic container.
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To test the quercetin content of the red onion soup from 2.2.1.6 before
feeding to volunteers, three type of red onion soup (on the day of preparation, from
freezer before or after reheating in microwave) were used to re-analyse the quercetin
content. Five millilitres of each type of red onion soup was put into 50 ml tubes in
duplicate. For the sample from the freezer (-20C), this sample was defrosted by
putting at room temperature followed by heating with or without microwaving for 1
min. Then, two volume of extraction solution (dissolved in absolute methanol or
70% methanol) was added to each sample. In total, there were 2 tubes of red onion
soup on the day of preparation in absolute methanol solution or in 70% methanol, 2
tubes of defrosted sample before putting in microwave in absolute methanol solution
or in 70% methanol and 2 tubes of defrosted sample after putting in microwave in
absolute methanol solution or in 70% methanol. The samples were then mixed
briefly using a vortex mixer for 2 min then centrifuged at 3000xg at 4°C for 15 min.
The supernatant was collected and the pellet further extracted and centrifuged two
more times. The three supernatants were combined and reduced to dryness under
vacuum using Genevac (Max. temperature = 37°C, program = HPLC fraction,
overnight). The dried extract was re-dissolved in 5 ml of 50% ethanol in water,
vortexed and then analysed by HPLC-DAD as described in section 2.2.1.5.
2.2.1.10 Data analysis
All data are presented as mean ± standard deviation and results are expressed
as mg/100 g of fresh weight and mg of quercetin equivalents. To compare the
content of quercetin glucosides and total quercetin between the two different types
of onion; yellow and red onion, independent t-test was used, while, dependent or
paired t-test was used to compare the content of quercetin glucosides and total
quercetin between different types of extraction method; homogenisation and vortex
followed by sonication. For red onion soup, the content of quercetin glucosides and
total quercetin between after preparation and before microwaving or before
microwaving and after microwaving and between extracting with absolute methanol
and 70% methanol were compared by dependent or paired t-test. The SPSS program
was used with all comparisons at 95% confidence interval.
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2.2.2 Determination of (-)-epicatechin in dark chocolate
The preliminary study consisted of testing the efficiency of the extraction
method and comparing the content of (-)-epicatechin in different % cocoa in various
commercial brands of dark chocolate. Four brands of dark chocolate; 70% cocoa
dark chocolate (Thorntons and Lindt), 85% cocoa dark chocolate (Morrisons) 90%
cocoa dark chocolate (Lindt), were extracted and analysed for their content of (-)-
epicatechin. As a result of those analysed, 70% French dark chocolate (Thorntons,
batch number L120208) was selected and the content of (-)-epicatechin of this type
of chocolate was analysed once more prior to performing the human study.
2.2.2.1 Removal of the lipid from dark chocolate
Dark chocolate was milled with a grinder (Krups F203 Grinder) then 5 g of
this chocolate sample was placed into a 50 ml centrifuge tube in duplicate. To
remove the lipid fraction from dark chocolate, each tube was filled with hexane to
the 45 ml mark and capped tightly. To completely disperse and dissolve, these
samples were vortexed for at least 1 min before sonicating at 50°C for 5 min. They
were then vortexed briefly followed by centrifuging for 5 min at 3000xg at room
temperature. The hexane was decanted into a suitable waste container. The pellet
was kept and the previous step repeated twice more. The residual hexane was then
evaporated from the defatted solid fraction in a fume cupboard overnight.
2.2.2.2 (-)-Epicatechin extraction
To extract epicatechin from the defatted solid fraction, acetone water acetic
acid (AWAA) extraction solution was prepared by combining 70 ml of HPLC grade
acetone with 29.5 ml of milliQ water and 0.5 ml of glacial acetic acid
(70%:29.5%:0.5%). Then, 2 g of defatted chocolate was weighed into a 15 ml
centrifuge tube and 5 ml of AWAA added. It was mixed by shaking by hand then
vortexing for at least 2 min to completely disperse the chocolate. The sample was
sonicated at 50°C for 5 min, vortexed briefly and then centrifuged for 5 minutes at
3000xg. Finally, the supernatant was passed through a conditioned strong cation
exchange SPE cartridge. To prepare the SPE, 5 ml of HPLC grade water was passed
through the SPE column. To avoid samples diluted with water, 2 ml of supernatant
was loaded onto the SPE cartridge and released to waste at a low flow rate. After the
level of supernatant was above SPE bed, the valve of SPE was closed followed by
taking the SPE cartridge out. To force some supernatant inside, the needle was taken
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out followed by opening the SPE. To collect the sample, a 17 mm, 0.2 µm PTFE
filter was placed at the end of the cartridge and then 1 ml of supernatant was loaded
onto the SPE cartridge. The sample then was pushed through the SPE cartridge
using the syringe plunger and syringe adaptor. Finally, the eluent was collected in a
1.5 ml Eppendorf tube and kept at 4°C in preparation for the next step.
2.2.2.3 Standard (-)-epicatechin (EC) preparation
To prepare 2000 µM of epicatechin stock solution for 800 µl, 470.8 µl of 3.4
mM epicatechin in AWAA (1 mg/ml) was mixed with 329.2 µl of AWAA. To
prepare 1000 µM of daidzein stock solution for 1000 µl, 0.3 mg of diadzein was
weighed and dissolved in 1 ml of absolute ethanol. Then, seven standards sample of
epicatechin were prepared using Table 2.3.
Table 2.3: Preparation of standards (-)-epicatechin dissolved in extraction solution
(AWAA). Each standard contained a final concentration of 100 µM daidzein (as an
internal standard).
Standard
No.
Final
conc.
(µM)
[Standard epicatechin]
(2000 µM)
(µl)
Extraction
solution
(AWAA)
(µl)
[Daidzein]
(1000 µM)
(µl)
Total volume
of each
standard
(µl)
1 1000 200 160 40 400
2 750 150 210 40 400
3 500 100 260 40 400
4 250 50 310 40 400
5 100 20 340 40 400
6 50 10 350 40 400
7 10 2 358 40 400
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2.2.2.4 Sample preparation
Extracted dark chocolate was prepared with and without spiking using reaction
mixtures as shown in Table 2.4 prior to inject on to the HPLC system.
Table 2.4: Reaction mixture for non-spiked and spiked samples. Each sample
contained a final concentration of 100 µM daidzein (as an internal standard). For
spiked sample, a final concentration of 500 µM of standard (-)-epicatechin was
added into the reaction.
Reaction mixture
Final
conc.
Volume (µl)
(µM) non-spike non-spike
Extracted dark chocolate samples - 100 100
1000 µM diadzein in absolute ethanol 100 40 40
2000 µM of standards epicatechin 500 - 100
AWAA extraction solution - 260 160
Total volume 400 400
2.2.2.5 Determination of (-)-epicatechin in dark chocolate by high
performance liquid chromatography-diode array detection/ fluorescence
detection (HPLC-DAD/HPLC-FLD)
Reversed phase HPLC with diode array detection/fluorescence detection
(Agilent technologies 1200 series, Quaternary) was used to analyse samples. The
same type of column, solvent A and solvent B in section 2.2.1.5 were used in this
study. The condition for epicatechin analysis was performed as follows; initiated at
5% of solvent B and increased to reach 10% within 5 min, 30% within 20 min, 50%
for 7 more min, the percentage of solvent B was finally increased to 90% at 32 min
and kept steady at this 90% for 4 min before back to initial starting conditions (5%
of solvent B) at 37 min and were resumed for 3 min to re-equilibrate the column for
the next injection The total method length was 40 min. The flow rate and the
injection volume were 0.3 ml/min and 5 µl, respectively. In fluorescence detector
mode, epicatechin was excited at 230 nm and detected by emission at 321 nm.
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2.2.2.6 Data analysis
All data are presented as mean ± standard deviation and results are expressed
as mg/100 g of fresh weight. The different between the content of (-)-epicatechin in
70% dark chocolate detected with DAD and FLD mode were compared using
independent t-test at 95% confidence interval, SPSS program.
2.3 Methods for catechol-O-methyltransferase (COMT) in vitro
2.3.1 COMT extraction from pig liver
Pig liver COMT was extracted using the method adapted from Tilgmann et
al, 1990.
All steps were performed at 4C. 50 g of pig liver was weighed and
homogenized in 150 ml of 0.05 M sodium phosphate, pH 7.2 and 0.2 mM phenyl
methyl sulfonyl fluoride (PMSF) using a blender. The homogenate was separated
into centrifuge tubes (approximately 40 ml for each tube). These homogenates were
vortexed and then let stand in an ice bath for approximately 10 min. Then, the first
centrifugation was performed at 10000xg for 25 min followed by the second
centrifugation at 30000xg for 25 min. Supernatants were collected and the amount
of protein were measured using Coomassie (Bradford) Protein Assay Kit (Thermo
Scientific). Then supernatants were aliquoted into 1.5 ml microcentrifuge tube (1 ml
of each 1.5 ml microcentrifuge tube). Finally, all extracted enzyme were kept at -
20C for further COMT assay.
2.3.2 COMT assay
COMT assay was performed by the method adapted from Penning, 1979.
COMT from pig liver was assayed with (-)-epicatechin (EC) or quercetin (Q) as the
methyl acceptor. The standard incubation mixture consisted of: 0.05 M Tris-HCI
buffer, pH 7.9, 1 mM S-adenosyl-L-methionine (SAM) dissolved in milliQ water
(need to prepare fresh), 1 mM MgC12 dissolved in milliQ water, 1 mM EC dissolved
in absolute ethanol or 1 mM Q dissolved in absolute ethanol containing 1%
Dimethyl sulfoxide (DMSO), 1 mM dithiothreitol (DTT) dissolved in milliQ water
(prepared fresh) and 0.25 ml of the partially purified COMT (200-400 µg of protein)
(Table 2.5). Negative controls were prepared by omitting substrate or COMT. The
reaction was started by adding the enzyme and terminated after carried out at 37C
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for 10 min in water bath by adding 2 volumes of absolute ethanol and 1 mM
ascorbic acid followed by cooling on ice for 2 min. All samples were centrifuged at
10,000xg for 1 min. Supernatant was collected and filtered prior injected on the
HPLC. In this study, 1 mM daidzein dissolved in milliQ water containing 1%
DMSO also was added as the internal standard.
Table 2.5: The reaction mixtures of COMT assay using (-)-epicatechin or quercetin
as a substrate. Negative control was prepared by omitting substrate or enzyme.
Reaction mixture Final Volume (µl)
Conc. No 1 mM No
Substrate Substrate Enzyme
MilliQ water _ 182.5 177.5 265
1 M Tris-HCl buffer, pH 7.9 0.05 M 25 25 25
10 mM Daidzein 1 mM 50 50 50
10 mM SAM (S-adenosyl-L-methionine) 1 mM 50 50 50
10 mM MgCl2 1 mM 50 50 50
50 mM Epicatechin or 50 mM Quercetin 1 mM - 10 10
10 mM DTT (Dithiothreitol) 1mM 50 50 50
0.125 mg/ml Extracted COMT enzyme
from pig liver
0.02
mg/ml 87.5 87.5 -
Absolute ethanol 6% 5 0 0
Total volume 500 500 500
2.3.3 Determination of (-)-epicatechin, quercetin and its methylated forms by
HPLC-DAD
HPLC-DAD was used to analyse (-)-epicatechin, quercetin and its
methylated forms in samples from section 2.3.2. The HPLC system, the type of
column, the type of solvent and also solvent preparation were described in section
2.2.1.5. The HPLC condition for analysis of (-)-epicatechin and its methylated forms
was as follows; initiated at 5% of solvent B and increased to reach 10% within 5
min, 30% within 20 min, the percentage of solvent B was finally increased to 90% at
25 min and kept steady for 4 min before returning back to initial starting conditions
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at 30 min, which were resumed for 3 min to re-equilibrate the column for the next
injection. The total method length was 33 min. The flow rate and the injection
volume were 0.5 ml/min and 10 µl, respectively. The HPLC condition for analysis
of quercetin and its methylated forms was the same as described in section 2.2.1.5.
2.4 Methods for enzymatic synthesis of the main quercetin and (-)-
epicatechin conjugates found in urine
2.4.1 Glucuronidation of (-)-epicatechin or quercetin
Glucuronidation reagents were composed of (1) HEPES buffer solution
containing 31.25 mM N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) or 
HEPES (Fisher Scientific UK, Cas No. 7365-45-9), 100 mM MgCl2 anhydrous (Cas
No. 7786-30-3) and 2 mM ascorbic acid acid (Sigma UK, Cas No. 50-81-7) in the
portion 8:1:1 and the pH was adjusted to 7.2 with 2N NaOH. (2) 5 mg alamethicin
(Sigma UK, Cas No. 27061-78-5) dissolved in 1 ml of 25 mM HEPES. (3) 10 mM
uridine 5-diphosphoglucuronic acid trisodium salt (UDPGA, Sigma UK, Cas No.
63700-19-6) dissolved 25 mM HEPES. (4) 20 mM saccharolactone dissolved in 25
mM HEPES. (5) a substrate, 4 mM (-)-epicatechin (Sigma UK, Cas No. 490-46-0)
dissolved in MilliQ water or 4 mM quercetin (Sigma UK, Cas No. 117-39-5)
dissolved in dimethyl sulfoxide (DMSO). (6) the source of glucuronidase obtained
from pig liver microsome available in the laboratory.
Briefly, pig liver homogenate was prepared according to Gibson et al., 1994
with slightly modification by Xu 2011. Fresh pig liver purchased from Morrison
Supermarket (Leeds, UK) was immediately placed in ice-cold 0.25 M sucrose to
rinse off excess blood. The tissue was then blotted dry, weighed and added to four
times of its weight of 0.25 M sucrose to make 20% (w/v) homogenate. The tissue
was finely chopped with scissors and homogenised with Potter-Elvehjem Tissue
Grinder with Teflon Pestle (55 mL, Wheaton), which was dipped into ice bath. The
homogenate was then centrifuged in a refrigerated centrifuge (Beckman J2-HS
Centrifuge) to isolate subcellular fractions at 12,500 g for 15 min and the
supernatant was carefully decanted. The microsomal tissue fraction was then
prepared by calcium precipitation method. Aliquots of 50 ml of post-mitochondrial
supernatant was mixed with 0.5 mL of 88 mM CaCl2 and left to stand on ice for 5
min, with occasional swirling. The mixture was centrifuged at 27, 000g for 15 min,
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the supernatant was discarded and the pellet was resuspended in 2.5 mL of 0.05 M
Tris-Cl, pH 7.5 containing 10 mM EDTA and 20% glycerol. The protein
concentration was quantitated by Bradford protein assay (8.35g protein /mL). The
final microsomal tissue fraction was then aliquoted in 250 μL per tube and stored at 
-80 °C for further assay.
To synthesise (-)-epicatechin or quercetin glucuronides, the pre-incubation
mixture comprised of 40 µl of HEPES buffer solution (pH 7.2), 20 µl of 5 mg/ml
alamethicin (UGT activator), 20 µl of 10 mM UDPGA (Glucuronic acid donor), 5 µl
of 20 mM saccharolactone (a β-glucuronidase inhibitor) and 20 µl of substrate, 4 
mM of (-)-epicatechin in milliQ water or 4 mM of quercetin in DMSO, were placed
into 1.5 ml microcentrifuge tube followed by pre-incubated at 37C for 5 min. To
initiate the glucuronidation reaction, 5 µl of pig microsomal suspension (8.35 g
protein/ml) was added to the reaction mixture. The total volume was 110 μl. In 
addition, negative control samples (without substrates or enzyme from pig
microsomal suspension) also were prepared and treated the same way as samples.
Then, all samples were incubated in a 37C water bath for 4 hr. Next, the reaction
mixture was stopped by the addition of 200 μl of ice cold methanol containing 1.6 
mM ascorbic acid and cooled on ice for 15 min. The precipitated protein was
removed by centrifugation at 17000xg at 4C for 15 min. The supernatant was then
taken and placed into a new 1.5 ml microcentrifuge tube. To dispose of precipitated
protein from the sample, the previous centrifugation step was repeated once more.
Finally, the supernatant was dried under centrifugal evaporation using HPLC
fraction and lamp off program (approximately 45 min) and kept in -20C before use.
In addition, to synthesise 3-O-methylated quercetin glucuronide, a
commercial compound, 3-O-methylated quercetin (isorhamnetin) was used as a
substrate.
2.4.2 Sulfation of (-)-epicatechin or quercetin
Sulfation reagents were composed of (1) 250 mM potassium phosphate
buffer (PPB) containing 250 mM dipotassium hydrogen phosphate, K2HPO4 (Sigma
UK, Cas No. 7758-11-4) and 250 mM potassium dihydrogen phosphate, KH2PO4
(Sigma UK, Cas 7778-77-0) in the portion 8:2 and the pH was adjusted to 7.4 with
5.6 mM ascorbic Acid (Sigma UK, Cas No. 50-81-7). (2) 1.97 mM adenosine 3-
phosphate 5-phosphosulfate lithium, PAPS (Sigma UK, Cas No. 109434-21-1)
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dissolved in 250 mM PPB. (3) 200 mM p-nitrophenyl sulfate potassium salt, PNS
(Sigma UK, Cas No. 6217-68-1) dissolved in milliQ water (had to prepare fresh). (4)
5 mM DL-Dithiothreitol, DTT (Sigma UK, Cas No. 3483-12-3) dissolved in milliQ
water (need to prepare fresh). (5) 100 mM sodium sulphite, Na2SO3 (Sigma UK, Cas
No. 7757-83-7) dissolved in milliQ water. (6) a substrate, 4 mM (-)-epicatechin, EC
(Sigma UK, Cas No. 490-46-0) dissolved in MilliQ water or 4 mM quercetin, Q
(Sigma UK, Cas No. 117-39-5) dissolved in DMSO. (7) The source of sulfatase
obtained from pig liver cytosol suspension available in the laboratory.
Briefly, pig liver cytosolic suspension was prepared using a modified version
of a method by Campbell et al., 1987. Fresh pig liver purchased locally was placed
in an ice-cold 250 mM sucrose solution to remove excess of blood. The liver was
blotted dry and a sample of 13 g aliquot was finely chopped with scissors then
homogenised with 50 mL of ice-cold Tris-HCl buffer (50 mM, pH 7.5) using a hand
blender. The homogenate was separated in a refrigerated centrifuge (Beckman
JA25.50; High Wycombe, UK) at 12,200 rpm for 10 min at 4°C. The resulting
supernatant was decanted and further centrifuged for 90 min at 17,000 rpm at 4°C.
The final supernatant was recovered, aliquoted and stored at -80°C for further use.
To synthesise (-)-epicatechin or quercetin sulfates, the pre-incubation
mixture comprised of 15 µl 250 mM potassium phosphate buffer (pH7.4), 2.5 µl of
1.97 mM PAPS, 5 µl of 200 mM PNS, 10 µl of 5 mM DTT, 5 µl of 100 mM
Na2SO3 and 1 µl of substrate, 4 mM of (-)-epicatechin in milliQ water or 4 mM
quercetin in DMSO, were placed into a 1.5 ml microcentrifuge tube followed by
pre-incubation at 37C for 5 min. To initiate the sulfation reaction, 12.5 µl of pig
liver cytosol suspension (85.6 mg protein/ml) was added to the reaction mixture.
The total volume was 51 μl. In addition, negative control samples (without 
substrates or enzyme from pig microsomal suspension) were also prepared and
treated the same way as test samples. Then, all samples were incubated in a 37C
water bath for 4 hr. Subsequently, the reaction mixture was stopped by adding 100
μl of ice-cold acetonitrile and cooling on ice for 15 min. The precipitated protein 
was removed by centrifugation at 17000xg at 4C for 15 min. The supernatant was
then taken and placed into a new 1.5 ml microcentrifuge tube. To dispose of all
precipitated protein from the sample, the previous centrifugation step was repeated
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once more. Finally, the supernatant was dried under centrifugal evaporation using
HPLC fraction and lamp off program for 15 min and kept in -20C before use.
2.4.3 Methylation of (-)-epicatechin, quercetin, (-)-epicatechin glucuronides or
(-)-epicatechin sulfates
Methylation reagents were the same as described in Table 2.5 of section
2.3.2 with small modification. These reagents were composed of milliQ water, 500
mM Tris-HCl (pH 7.4), 10 mM SAM, 10 mM MgCl2, 5 mM DTT, 4 mM substrate
((-)-epicatechin, quercetin, (-)-epicatechin glucuronides or (-)-epicatechin sulfates)
and catechol-O-methyltransferase obtained from pig liver extraction in section 2.3.1.
To synthesise methylated-(-)-epicatechin or quercetin, all reaction mixtures;
7.5 µl of milliQ water, 25 µl of 500 mM Tris-HCl (pH 7.4), 25 µl of 10 mM SAM,
30 µl of 10 mM MgCl2, 50 µl of 5 mM DTT, 62.5 µl of 4 mM substrate and 50 µl of
pig liver cytosol suspension were placed into 1.5 ml microcentrifuge tube. The total
volume was 250 μl. In addition, negative control samples (without substrates or 
enzyme from pig microsomal suspension) also were prepared and treated the same
way as samples. Then, all samples were incubated in a 37C water bath for 1 hr. The
reaction mixture was then stopped by adding 2 volumes of absolute methanol
contain 1% ascorbic acid followed by keeping on ice for 2 min. The precipitated
protein was removed by centrifugation at 17000xg at 4C for 15 min. The
supernatant was then taken and placed into a new 1.5 ml microcentrifuge tube.
Finally, the supernatant was dried under centrifugal evaporation using HPLC
fraction and lamp off program and kept in -20C before use.
Furthermore, methylated-(-)-epicatechin glucuronides and methylated-(-)-
epicatechin sulfates were synthesised using dried (-)-epicatechin glucuronides and (-
)-epicatechin sulfates from section 2.4.1 and 2.4.2 as a substrate.
2.4.4 Determination of total conjugated form yield
The % yields of conjugated forms were calculated according to the equation
as shown below.
The % yield = ௉௘௔௞௔௥௘௔௢௙௖௢௡௝௨௚௔௧௘௦
௉௘௔௞௔௥௘௔௢௙(௖௢௡௝௨௚௔௧௘௦ା௔௚௟௬௖௢௡௘) x 100
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2.5 Methods for urine analysis
2.5.1 Human subjects and study design
This study was approved by MEEC Faculty Research Ethics Committee,
University of Leeds (Ethics reference: MEEC 11-041, Appendix B). All healthy
volunteers (18 to 60 years of age, 18.5 and 24.99 kg/m2 BMI) who were white
Caucasians, non-smokers, took no dietary supplements or medication, had no GI
tract, metabolic and chronic diseases and were not pregnant or lactating gave their
written informed consent and participated in this study. Fifty participants were
aimed to recruit at the beginning but only twenty seven subjects were positive
response to participate and complete this human study. Subject’s characteristics
show in Table 2.6.
Table 2.6: Subject’s characteristics
Parameters (units)
Male (n=6) Female (n=21)
Mean±SD Range Mean±SD Range
Age (years) 28±11 20-50 26±9 18-55
Weight (kg) 73±8 63-82 60±6 52-75
Height (cm) 181±9 170-194 166±7 153-176
BMI (kg/m2) 22±3 19-25 22±1 19-25
The study consisted of 3 instances of a single-dose of food with 0-24 hr urine
collection. In addition, Latin Square Design was used in this study. Some volunteer
started to consume onion soup or 70% cocoa dark chocolate or both for the first day
study followed by the rest of food samples in order for two more times. In the case
of consuming onion soup for the first day study, for example, volunteers avoided
quercetin and (-)-epicatechin rich food (see Appendix A) for 24 hr and observed
over-night fasting for 12 hr before the study day. On day 1 study, volunteers were
asked to void their bladder immediately after waking, and then to drink a glass of
water (200-300 ml). Approximately an hour later, the volunteers again voided their
bladder and this time urine was collected in the baseline-labelled urine container at
the School of Food Science and Nutrition. Soon after the baseline urine collection,
the volunteers were asked to consume onion soup (containing 50 g of onion)
provided along with toast and butter for breakfast in the School of Food Science and
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Nutrition. The time of consumption was recorded. Urine was then collected in a
labelled urine container from 0-24 hr. All other foods consumed during the day were
recorded using 24 hr dietary record (see Appendix A). Volunteers were asked to do
the same procedure as day 1 study but 45 g of dark chocolate or onion soup and 45 g
of dark chocolate together was provided to volunteers instead of onion soup for day
2 or day 3 study, respectively. Each study day was separated by at least 2 days, and
each volunteer completed the study within 3 weeks
2.5.2 Urine collection and acellular urine
Approximately 3 g of ascorbic acid was placed into the clean urine collection
bottle. Then, volunteers collected the urine samples at specified time in the
designated urine containers. Urine samples were transported to the lab within 12 hr
of the collection where they processed within 24 hr before being frozen at -20°C.
Upon arrival, the volume of the specimen was measured by reading the scale on the
urine container, and 2x50 ml aliquots taken. These aliquots were centrifuged at
2000xg, 4°C for 10 min to remove insoluble materials and cellular debris. After that
the supernatant was carefully decanted to within approximately 1-2 ml of the cell
pellet. Finally, the samples were labelled and stored at –20°C until analysis. The
sediment of the centrifuged urine specimen was decontaminated before disposal by
adding a disinfectant (1 % Virkon solution, 2x5 g tablet/l, in accordance with the
manufacturer’s guidelines) to the sediment and leaving overnight. The sediment was
then discarded in the clinical waste bags.
2.5.3 Enzyme hydrolysis method
The urine was defrosted and vortexed. One ml of baseline or 24 hr urine
sample was pipetted into 15 ml centrifuge tube (in triplicate for each biological
sample). Then, 10 µl of internal standard (1 mg/ml of diadzein stock solution in
absolute ethanol, final concentration 10 µg/ml) was added to each tube of urine
followed by 150 µl of 0.2 M sodium phosphate buffer, pH 7.0 containing 5 U of β-
glucuronidase (from Escherichia coli type IX-A) dissolved in 0.1 M sodium
phosphate buffer pH 7 with 1 mg/ml BSA and 0.03 U of sulfatase (from Aerobacter
aerogenes type IV) dissolved in 0.1 M sodium phosphate buffer pH 7 with 1 mg/ml
BSA. Next, urine samples were incubated in a shaking water bath at 37ºC, 100 rpm
for 2 hrs. One ml of ethyl acetate (1:1 v/v urine/ethyl acetate) was added to urine
sample, vortexed for 2 min and centrifuged at 20ºC, 3000xg for 5 min. Supernatant
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on the upper layer was collected and then the previous extraction step was repeated
twice. Collected supernatant of each tube (approximately 3 ml) was dried in by
centrifugal evaporation (lamp off, low BP mode) for 2 hr. Dried urine samples were
reconstituted by adding 15 µl of solvent B (ACN and 0.1% formic acid), 83 µl of
solvent A (MilliQ water and 0.1% formic acid) containing 100 µM ascorbic acid and
2 µl of 500 µM taxifolin in 50% ethanol. All samples were then vortexed for 2 min
and centrifuge at 20ºC, 3000xg for 5 min. Supernatant of each sample was removed
carefully and placed into amber HPLC vials prior to direct injection on LC-MS (see
Section 2.5.8).
2.5.4 New enzyme hydrolysis conditions
A new enzyme hydrolysis condition, changing type of buffer, source and
amount of enzyme and increasing the unit of enzyme, was used to analyse quercetin,
(-)-epicatechin and its methylated metabolites in urine samples. The ABSS buffer at
pH 5 was used instead of 0.2 M sodium phosphate buffer, pH 7.0. This buffer was
composed of 20 g of ascorbic acid, 0.11 g of EDTA, 6.24 g of NaH2PO4 and 7.12 g
of Na2HPO4 in total volume 100 ml and adjusted to pH 5 with 1 M NaOH. In
addition, the unit of enzyme also was increased from 5 U to 200 U for β-
glucuronidase and from 0.0 3U to 5 U and up to 20 U for sulfatase. The same source
β-glucuronidase (Escherichia coli type IX-A) in section 2.5.3 was still used in this
section. However, the source of sulfatase was changed from Aerobacter aerogenes
type IV to Abalone entrails type VIII.
To perform an enzyme hydrolysis, all urine samples were defrosted and
vortexed. Then, 200 µl of each urine sample was placed into 1.5 ml microcentrifuge
tube followed by adding 200 µl of ABSS buffer, pH 5 containing 10 µl of 0.1 mg/ml
daidzein dissolved in 0.2M sodium acetate buffer pH 5 (as an internal standard), 8 µl
of 25KU/ml of β-glucuronidase dissolved in 75 mM sodium phosphate buffer pH 
6.8 with 1 mg/ml BSA (final unit was 200U), 10 µl of 25 KU/ml sulfatase dissolved
in 0.2 M Sodium acetate buffer, pH 5 (final unit was 5 U) and 172 µl of ABSS, pH
5. The ratio of urine sample to ABSS buffer, pH 5 was 1:1. All samples and reagents
were handled on ice throughout extraction. Then, each sample was reverse mixed
thoroughly, vortexed and incubated at 37ºC in a shaking water bath (100 rpm) for 1
hr. The reaction mixture was stopped by adding 200 µl of cold ethyl acetate. The
sample was vortexed again for 30 sec before centrifuging at 17,000xg for 1 min at
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room temperature. The upper layer was collected into a new 1.5 ml microcentrifuge
tube then the previous extraction step was repeated twice. The combined extracts
were dried under nitrogen and kept at -20ºC until analysis.
For analysis, the dried sample was re-dissolved with 10 µl of 0.1mg taxifolin
in 1 ml of solvent A (5%ACN + 0.1% formic acid + milliQ water) containing 100
µM ascorbic acid and 90 µl of solvent A (5%ACN + 0.1% formic acid + milliQ
water) containing 100 µM ascorbic acid. The samples were vortexed, centrifuged at
17,000xg for 1 min at RT before pipetting into amber HPLC vials and injected
directly into LC-MS (see Section 2.5.8).
2.5.5 Urine concentration using freeze dryer
Due to the low percentage urinary excretion of quercetin and (-)-epicatechin
detected in Chapter 4, accompanied by a low amount of quercetin and (-)-
epicatechin spiked with synthetic conjugated standard in 24 hr urine samples in
Chapter 5, the baseline and 24 hr urine samples were first concentrated by freeze-
drying before analysis.
All urine samples from day 1, 2 and 3 of 27 volunteers (both baseline and 24
hr samples) were taken from -20ºC, defrosted by placing in the fridge overnight and
vortexed before use. Five ml of each urine sample was placed into 15 ml centrifuge
tube (duplicate for both baseline and 24 hr urine samples) followed by adding 62.5
µl of 0.1 mg/ml ethyl gallate in milliQ water (internal standard). After that these
samples were kept in -80ºC prior to freeze drying. Urine samples from -80ºC were
placed into flasks (around 15 tubes per/flask) then attached to a quick seal valve of
freeze dryer (Virtis Benchtop Freeze dryer, Model Sentry 2.0, SP Scientific) and
freeze dried for approximately 12 hr. Freeze dried urine samples were kept in -20ºC
before analysis.
2.5.6 Concentrated urine preparation for LC-MS
Freeze dried urine samples from section 2.5.7 were re-constituted with 500
µl of 50% ethanol in milliQ water followed by vortexing and sonicating until
completely dissolve. Then, samples were centrifuged at 3000xg, 4ºC for 10 min.
Next, 400 µl of sample was transferred and placed into a pre-weighted 1.5 ml
microcentrifuge tube. To eliminate ethanol from concentrated urine samples, these
samples were then placed into a N2 dryer for approximately 30 min (or until the
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level of solution in samples left approximate 200 µl). These samples were then post-
weighed prior to filtering with a 4 mm syringe filter 0.2 um ptfe (CRMA4-SF-02T,
VWR International) and pipetted into amber HPLC vials. Subsequently, these
samples were analysed by injecting two times per each sample onto UPLC-MS (see
Section 2.5.9).
2.5.7 HPLC-MS
High performance liquid chromatography coupled with mass spectrometry
(HPLC-MS) is a method for analysing and identifying flavonoid metabolites at the
physiological levels because it is highly sensitive and applicable to complex
mixtures like urine. Thus, this analytical method was used in this study. HPLC-MS
analysis was performed on HPLC-2010C HT system (Shimadzu Scientific
Instruments) coupled to a LCMS-2020 single quadrupole liquid chromatograph
mass spectrometer equipped with electrospray ionization (ESI). Separation was
achieved on a ZORBAX Eclipse XDB-C18, 4.6x50 mm, 1.8 µm, equipped with
ZORBAX Eclipse XDB-C18 guard cartridge, 4.6 x 12.5 mm, 5 µm (Agilent
Technologies). Mobile phases constituted water (solvent A) and acetonitrile (solvent
B), both acidified with 0.1% formic acid. The separation was achieved with the
following gradient program: time 0.01 min, controller start; time 2 min, 15% solvent
B; time 22 min, 40% solvent B; time 23 min, 90% solvent B; time 27 min, 90%
solvent B; time 28 min, 15% solvent B; time 32 min, 15% solvent B; 32.01 min,
controller stop. Mass spectrometric data were collected between 0.00 and 32.01 min.
The flow rate was 0.5 ml/min and the injection volume, 10 μl. It has been reported 
that the negative mode was more sensitive than the positive mode. For example,
quercetin and its derivatives were detected with the negative mode more sensitive
than detected with positive mode, approximately ten times (Mullen et al., 2004).
Thus, in this study MS analyses were performed in the negative mode, with nitrogen
as nebulizer gas flow 1.5 l/min and drying gas (15 l/min), interface temperature
350°C, DL temperature 250°C, heat block 200°C and interface voltage set at −3.5 
kV. The most intense product ion of each compound were recorded for total ion
count (TIC) and single ion monitoring (SIM). Chromatographic data were recorded
and integrated using Labsolutions LC-MS software.
To analyse quercetin, (-)-epicatechin and its methylated form from section
2.5.3, the separate [M-H]- ion at m/z 301 for quercetin, at 315 for 3-O-methyl
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quercetin and 4-O-methyl quercetin, at 289 for (-)-epicatechin, at 303 for 3-O-
methyl (-)-epicatechin and taxifolin, at 175 for ascorbic acid and at 253 for daidzein
were selected.
2.5.8 UPLC-MS
Ultraperformance liquid chromatography coupled with mass spectrometry
(UPLC-MS) provides shorter chromatographic cycle and higher sensitivity than
conventional analytical methods. Thus, this analytical method was used in this
study. Analyses were carried out on a Nexera UPLC system (Shimadzu Scientific
Instruments), coupled to a LCMS-2020 single quadrupole liquid chromatograph
mass spectrometer equipped with electrospray ionization (ESI). Separation was
achieved on a KinetexTM C18 column (2.6 μm, C18, 100A), size 150 x 2.1 mm 
(Serial No. 530411-87, Phenomenex, Cheshire, UK) equipped with a KrudKatcher
Classic HPLC in-Line Filter, 0.5 µm Depth Filter (Part No. AF 0-5725,
KrudKatcher), operating at 30°C. Mobile phases constituted 95%:5%, milliQ water:
acetonitrile (solvent A) and 95%:5% acetonitrile: milliQ water (solvent B), both
acidified with 0.1% formic acid. The separation was achieved with the following
gradient program: 0.01, 0% B flow to waste; time 3 min, 0% B flow to PDA and
MS; time 20 min, 15% B; time 50 min, 25% B; time 54 min, 100%; time 57 min
flow to waste; time 57-61 min held at 100%, time 63 min back to 0% B; and a 7 min
post run re-equilibration at 0% B. Mass spectrometric data were collected between 0
and 70 min. The flow rate was 0.26 ml/min and the injection volume, 10 μl. MS 
analyses were performed in the negative mode, with nitrogen as nebulizer gas flow
1.5 l/min and drying gas (15 l/min), interface temperature 350°C, DL temperature
250°C, heat block 200°C and interface voltage set at −3.5 kV. The most intense 
product ion of each compound were recorded for total ion count (TIC) and single ion
monitoring (SIM). Chromatographic data were recorded and integrated using
Labsolutions LC-MS software.
To analyse enzymatically synthesised quercetin and (-)-epicatechin
conjugates (section 2.4) and also quercetin, (-)-epicatechin and the main metabolites
excreted in urine samples from volunteers (section 2.5.7), the separate [M-H]- ion at
383 for methyl-(-)-epicatechin-sulfate, at 465 for (-)-epicatechin-glucuronide, at 369
for (-)-epicatechin-sulfate, at 479 for methyl-(-)-epicatechin-glucuronide, at 303 for
3-O-methyl-(-)-epicatechin and taxifolin, at 381 for qquercetin-sulfate, at 477 for
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quercetin-glucuronide, at 491 for isorhamnetin-glucuronide, at 289 for (-)-
epicatechin, at 301 for quercetin, at 315 for 3-O-methyl-quercetin and 4-O-methyl
quercetin, at 197 for ethyl gallate, at 175 for ascorbic acid at 653 for quercetin-
diglucuronide, at 667 for methyl-quercetin-diglucuronide were selected.
2.6 Method for determining sulfatase activity using commercial substrate
(PNCS) and product (PNC)
A model substrate and product of sulfatase called p-nitrocatechol sulfate
(PNCS) and p–nitrocatechol (PNC) were used to estimate the sulfatase activity.
0.001 µmol of p-nitrocatechol sulfate were added to milliQ water, ABSS buffer, pH
5 and baseline urine, respectively. Then, this substrate was hydrolysed without or
with 20 U of sulfatase (Abalone entrails type VIII) at 37C for 1 hr. After that, this
reaction was stopped by adding 2 volumes ice-cold acetonitrile and placed in on ice
bath for 15 min. Next, the reaction mixture was centrifuged at 17,000 g for 15 min
and the supernatant was then transferred into a new 1.5 ml microcentrifuge tube.
The centrifugation step was performed one more time. Finally, the supernatant was
transferred and placed into amber HPLC vials prior directly injected to LC-MS (see
Section 2.5.7). One unit of this enzyme will hydrolyse 1.0 µmol of p-nitrocatechol
sulfate per hr at pH 5.0 at 37C (30 min assay). Thus, there was enough sulfatase to
hydrolyse p-nitrocatechol sulfate in this reaction.
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Chapter 3 Quantification of Quercetin and (-)-Epicatechin Content in
Food
3.1 Abstract
Onion and dark chocolate are rich dietary sources of quercetin and (-)-
epicatechin, respectively. The main aim of this chapter was to determine the content
of quercetin in onion soup using HPLC-DAD and also (-)-epicatechin in dark
chocolate using HPLC-DAD/FLD in preparation for a human bioavailability study.
Prior to selecting the type of onion to prepare an onion soup, two main quercetin
glucosides, quercetin-3,4-di-O-glucoside (Q3,4diG) and quercetin-4--glucoside
(Q4G), from freeze dried yellow and red onion were extracted and compared. As
expected red onion contained higher total quercetin content than yellow onion:
414±83 mg/ 100 g FW for red onion and 325±63 mg/100 g FW for yellow onion (p-
value = 0.353). However, the content was very dependent on the method of
extraction. For re-suspended freeze-dried ground onion powder, homogenisation
was an efficient method for extracting quercetin glycosides compared to vortex and
sonication. Thus, red onion was selected to prepare a soup containing 50 g of red
onion per portion (130 ml). To determine the heat stability of quercetin in red onion
soup, three different cooking methods were examined, and it was found that there
were no significant differences in total quercetin content in red onion soup after
preparation (61.7±15.60 mg/ 130 ml soup) and before microwaving (60.4±9.6 mg/
130 ml soup) or before microwaving and after microwaving (59.9±8.2 mg/130 ml
soup), p-value = 0.818 and 0.666, respectively. The total levels of quercetin
glucosides, expressed as quercetin equivalents, ranged from 25.1±3.6 to 33.1±1.8
mg per portion of soup. In dark chocolate, the content of (-)-epicatechin was also
analysed and quantified in different percentages of cocoa from different brands:
114.7 mg/ 100 g FW for 90% cocoa, 123.3 mg/ 100 g FW for 85% cocoa and 109.1
mg/ 100 g FW for 70% cocoa. Although 90% and 85% cocoa dark chocolate
contained a higher content of (-)-epicatechin than 70% cocoa, 70% cocoa dark
chocolate was less bitter and so was selected for the human study. The content of
(-)-epicatechin of 70% dark chocolate of selected brands from the same batch was
then analysed prior to feeding to volunteers. It was 92.2±4.4 mg/100g FW, as
detected with FLD. To sum up, based on the content of quercetin and (-)-
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epicatechin, one portion of red onion soup (containing 109 µmol of quercetin in 130
ml) and a half bar of 70% dark chocolate (containing 167 µmol of (-)-epicatechin in
45 g) were analysed for subsequent feeding to healthy volunteers as described in
Chapter 4.
3.2 Introduction
Onion is one of the richest sources of quercetin and is commonly consumed
in Western countries. For example, in The Netherlands, 16 mg of quercetin was
mostly consumed per day from approximately 25 mg/day of total flavonol
(quercetin, myricetin and kaempferol) and flavone (luteolin and apigenin) (Hertog et
al., 1993). In addition, onions and apples were the most common sources of
flavonoid intake in the United States, Finland, former Yugoslavia and Greece and
highly negatively correlated to heart disease mortality (Hertog et al., 1995). Hertog
et al. (1992) reported that the highest content of quercetin was found in the edible
part of onions (28.4-48.6 mg/100 g FW) followed by kale (11 mg/100 g FW), apples
(2.1-7.2 mg/100 g FW), tea infusion (1-2.5 mg/100 g FW) and red wine (4-16
mg/L). In onions, the amount of quercetin varies depending on the colour and type.
According to the USDA Database for flavonoid content, yellow onions contain 21.4
mg/100g FW which is in the same range as found by Tsushida and Svzuki (1996)
and Makris and Rossiter (2001); 22.7 mg/ 100 g FW and 30 mg/100 g FW,
respectively. The mean content of quercetin in raw yellow onion is also reported in
the Phenol Explorer Database; 36.0 mg/100 g FW for quercetin-3,4-di-O-glucoside,
23.5 mg/100 g FW for quercetin-4-O-glucoside and 0.3 mg/100 g FW for
quercetin,. In red onions, the same USDA Database reported that quercetin was
present at 33.4 mg/100 g FW, whereas the Phenol Explorer Database stated that the
mean quercetin -3,4di-O-glucoside, quercetin-4-O-glucoside and quercetin contents
were 101.3, 43.7 and 1.3 mg/100 g FW, respectively. This information shows that
red onion contains a higher amount of quercetin then yellow onion. Furthermore,
Crozier et al. (1997) found 20.1 mg/100 g of quercetin in red onion which was
higher than in white onion (18.5-63.4 mg/ 100 g). Additionally, the outer layers have
a higher level of quercetin than the inner layers, i.e. it decreases from the outside to
the inside. Therefore, a whole bulb of the edible part of the onion was used in this
study. During cooking or processing, quercetin aglycone may increase or decrease.
For example, quercetin glycosides in cooked onion were not degraded but leached
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into the cooking water. Frying an onion with oil and butter for 40 min did not
change the total flavonoid content, but the quercetin derivatives were not
specifically mentioned. Microwave cooking without water for 1 min increased 50%
of total quercetin content probably due to better extractability (Ioku et al., 2001).
Hence, onion soup, which still contains quercetin glycosides in the boiling water,
seems to be a better source of quercetin than fried onion and so was used in this
study.
Chocolate is an abundant source of (-)-epicatechin, representing more than
35% of the total polyphenol content in cocoa bean. In addition, it is a well-liked and
highly consumed product, with around 58% and 43% of European people eating
milk chocolate and dark chocolate, respectively (Cooper et al., 2008). In the US,
people prefer milk chocolate and approximately 87% prefer to consume as a form
containing nuts, wafer or fruit than consuming as pure chocolate (Vinson et al.,
2006). Chocolate is made from cocoa liquor, prepared from fermented and roasted
cocoa bean. There are various types of chocolate such as dark chocolate, milk
chocolate and white chocolate. Dark chocolate commonly contains more cocoa
liquor than milk chocolate. However, there is no cocoa liquor in white chocolate.
The higher cocoa liquor in dark chocolate, containing more flavonoids, may also
have a better biological effect than in milk chocolate because the intestinal
absorption of flavonoids is supposedly inhibited by the milk contained in it (Serafini
et al., 2003). The polyphenol content reflected the percentage of cocoa content in
chocolate. Therefore, a high percentage of cocoa in dark chocolate appears to have
the highest content of polyphenols (Cooper et al., 2008). However, there are
exceptions depending on the method of processing. This argument is supported by
Langer et al. (2011) that the labelled cocoa content of the chocolate did not
consistently match analysed levels of polyphenols. Several research groups reported
the content of (-)-epicatechin in dark chocolate. Arts et al. (2000) found (-)-
epicatechin level at 32.7-50.3 mg/100 g in dark chocolate (54% cocoa) and lower
but still substantial levels in milk chocolate (34% cocoa). Other researchers such as
Cooper et al. (2007) reported that (-)-epicatechin was in the range of 7.1-194.2
mg/100 g, while Andres-Lacueva et al. (2008) found a range from 11.6-73.0 mg/100
g. In the Phenol Explorer database, the mean (-)-epicatechin content was 70.4
mg/100 g FW. Recently, Langer et al, 2011 tested different brands of chocolate and
found that all dark chocolates tested contained higher levels of total flavanols than
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milk or white chocolate; 93.5-651.1 mg of (-)-epicatechin equivalent/100 g for dark
chocolate, 40.6 mg of (-)-epicatechin equivalent/100 g for milk chocolate and 0.0
mg of (-)-epicatechin equivalent/100 g for white chocolate.
The main aim of this chapter was to determine the content of quercetin in
onion soup using HPLC-DAD and also (-)-epicatechin in dark chocolate using
HPLC-DAD/FLD. First, due to the different content of quercetin in different types
of onion, the amount of quercetin in two different types of freeze dried yellow and
red onion powder were analysed and compared. Then, red onion, which contains a
higher amount of quercetin than yellow onion, was selected to prepare onion soup.
As mentioned previously, cooking methods may affect the content of quercetin, the
bioavailability and finally the biological effects. Thus, the content of quercetin in red
onion soup was quantified again after preparation and before and after heating in a
microwave. In dark chocolate, the content of (-)-epicatechin was also analysed and
quantified in different percentages of cocoa from different brands. Finally, since the
amount of (-)-epicatechin can vary depending on the manufacturer of the chocolate,
the amount of (-)-epicatechin from the same batch of selected 70% dark chocolate
was analysed again prior to feeding to volunteers. The content of these flavonoids
was then used for calculating a percentage of intake of the human bioavailability
study in the next chapter.
3.3 Materials and Methods
See Section 2.2
3.4 Results
3.4.1 Determination of quercetin content in freeze-dried yellow and red onion
As stated above, different types of onions contain different amounts of
quercetin. Thus, the quercetin contents of yellow and red onions were analyzed and
compared. Quercetin-3,4-di-O-glucoside and quercetin-4-O-glucoside are major
quercetin glucosides and identified in freeze-dried yellow and red onion powder by
HPLC-DAD. They were eluted at 3.6 min for quercetin-3,4-di-O-glucoside and
10.0 min for quercetin-4-O-glucoside at the maximum wavelength of 370 nm in
comparison with retention times (Figure 3.1) and diode array spectra of their
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commercial standards (Figure 3.2). In this case, daidzein was used as an internal
standard and eluted at a retention time of 13.3 min with a maximum wavelength of
280 nm (chromatogram not shown). In Figure 3.2, the maximum wavelength of
quercetin-3,4-di-O-glucoside was shifted followed by quercetin-4-O-glucoside
because quercetin-3,4-di-O-glucoside has a greater degree of conjugation than
quercetin-4-O-glucoside, resulting in a larger shift of the maximum wavelength.
These shifts also related to the retention time of each compound in Figure 3.1. The
amount of quercetin was analysed on a molar basis using a standard curve of
authentic compounds (Figure 3.3). Standard curves were constructed for each
standard sample at nine concentrations. The regression analysis showed that the on-
column amount, ranging from 10 to 1000 pmol was linearly correlated with a peak
area of R2 = 0.9970 for quercetin-3,4-di-O-glucoside, R2 = 0.9999 for quercetin-4-
O-glucoside and R2 = 1 for quercetin. In addition, some extracted onion samples
were spiked with compounds to confirm identity. The percentage recovery of
quercetin-3,4-di-O-glucoside and quercetin-4-O-glucoside is shown in Table 3.1.
The results indicated that the recovery for red onion was higher than yellow onion in
the case of quercetin-3,4-di-O-glucoside but not quercetin-4-O-glucoside. In
addition, homogenization had a better percentage recovery than vortex and
sonication.
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Figure 3.1: HPLC chromatograms showing analysis of the main quercetin
glycosides of freeze dried onion: (a) standard compounds composed of quercetin-
3,4-di-glucoside (Q3,4diG), quercetin-4-O-glucoside (Q4G) and quercetin (Q),
each 100 µM with an injection volume of 10 µl (1 nmol per injection) (b) yellow
onion (c) red onion.
Figure 3.2: UV absorption spectra of quercetin standards; quercetin 3,4-di-
glucoside, quercetin 4-O-glucoside and quercetin. Spectra were produced by
scanning the standard in 50% ethanol between 240 and 400 nm using diode array
detection.
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Figure 3.3: Standard curves of quercetin-3,4-di-glucoside, quercetin-4-O-
glucoside and quercetin for quantification in freeze dried yellow and red onion.
Table 3.1: Recovery of quercetin-3,4-di-glucoside and quercetin-4-O-glucoside in
extracted yellow and red onion, spiking with 100 µM of each standard prior to
injection into HPLC.
Extracted
samples
% Recovery
Homogenization Vortex and sonication
Quercetin-3,4-di-
O-glucoside
Quercetin-4-
O-glucoside
Quercetin-3,4-di-
O-glucoside
Quercetin-4-
O-glucoside
Yellow onion 114.5±3.5 100±0.0 110.5±0.7 95.0±1.4
Red onion 119.5±7.8 99.5±0.7 113.0±0.0 95.5±0.7
The summary of quercetin content in freeze-dried yellow and red onion is
shown in Table 3.2 and Figure 3.4. These data illustrate the difference in quercetin
content of freeze-dried yellow and red onion using two different extraction methods,
homogenisation and vortex followed by sonication. It can be seen that red onion
contains a higher total amount of quercetin than yellow onion in both extraction
methods (in homogenization, p-value between yellow and red onion is 0.353 while,
in vortex and sonication p-value is 0.092). Only the amount of quercetin-4-O-
glucoside in red onion, extracting with vortex and sonication, was significantly
different in yellow onion (p-value = 0.044). The total quercetin content was
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413.8±82.9 mg quercetin glucosides/100 g FW or 217.3±44.4 mg quercetin
equivalent/100 g FW for red onion and 325.4±63.1 mg quercetin glucosides/100 g
FW or 165.2±32.4 mg quercetin equivalent/100 g FW for yellow onion. In addition,
extracting quercetin with homogenisation apparently produced a higher total amount
of quercetin than vortexing followed by sonication by approximately 4-5 times.
However, there were no significant differences between quercetin-3,4-di-O-
glucosides, quercetin-4-O-glucoside and total quercetin content in yellow onion or
in red onion extracted with homogenisation and vortex and sonication. The p-value
of quercetin-3,4-di-O-glucoside, quercetin-4-O-glucoside and total quercetin
content compared between homogenisation and vortex and sonication in yellow
onion were 0.102, 0.143, 0.108 respectively. For red onion, the p-value was 0.125
for quercetin-3,4-di-O-glucoside content, 0.202 for quercetin-4-O-glucoside and
0.144 for total quercetin content, comparing between homogenisation and vortex
and sonication.
Table 3.2: Different content of quercetin-3,4-di-O-glucoside, quercetin-4-O-
glucoside and total quercetin content in yellow and red onion, using two different
extraction methods, homogenisation and vortex followed by sonication.
Method
Q content (mg/100 g FW) Q equivalent (mg/100 g FW)
Quercetin-
3,4di-O-
glucoside
Quercetin-
4-O-
glucoside
Total
Quercetin-
3,4di-O-
glucoside
Quercetin-
4-O-
glucoside
Total
Homogeni
sation
Yellow 272.2±51.0 53.1±12.2 325.4±63.1 130.7±24.5 34.5±7.9 165.2±32.4
Red onion 304.1±55.6 109.7±27.3 413.8±82.9 145.9±26.7 71.3±17.7 217.3±44.4
Vortex
and
Sonication
Yellow 54.3±1.4a 16.0±0.2a 70.3±1.6a 26.0±0.7a 10.4±0.1a 36.5±0.8a
Red onion 70.1±10.5a 37.0±6.5b 107.1±16.9a 33.6±5.0a 24.1±4.2a 57.7±9.2a
(Results are expressed as mean ± standard deviation. Different superscripts indicate significant
different of quercetin 4-O-glucoside content between yellow and red onion extracted with vortex and
sonication (p-value <0.05), p-value of a,b is 0.044)
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3.4.2 Determination of quercetin content in red onion soup
Red onion, which contains a higher amount of quercetin than yellow onion,
was selected to prepare onion soup and test the effect of microwave cooking on
quercetin content in the soup. The quercetin content in red onion soup was
quantified again after preparation, before and after heating in a microwave for 1
min. Additionally, extraction efficiencies of two different types of extraction
solution, absolute methanol and 70% methanol, were tested. After soup preparation
and before and after microwave cooking, quercetin was still present as glycosides,
quercetin-3,4-O-di glucosides and quercetin-4-O-glucoside, were similar to freeze-
dried yellow and red onion (Figure 3.5). Again, quercetin content in red onion soup
was quantified using a standard curve (Figure 3.6). Seven standards of mix quercetin
glycosides and quercetin were prepared in the same way as Table 1 in Section
2.2.1.1.3 after that the standard curves were constructed. The regression analysis
showed that the on-column amount, ranging from 10 to 1000 pmol, was linearly
correlated with the peak area with R2 = 0.9993 for quercetin-3,4-di-O-glucoside, R2
= 1 for quercetin-4-O-glucoside and R2 = 1 for quercetin. The total quercetin
content of red onion soup (from 50 g fresh weight) varied from 25.1±3.6 to 33.1±1.8
mg quercetin equivalents/130 ml (Table 3.3). Compared to the quercetin content of
50 g freeze-dried red onion in Table 2, this amount was still in the same range. In
addition, there were no significant differences in total quercetin content in red onion
soup after preparation (61.7±15.60 mg/ 130 ml soup) and before microwaving
(60.4±9.6 mg/ 130 ml soup) or before microwaving and after microwaving
(59.9±8.2 mg/130 ml soup), p-value = 0.818 and 0.666, respectively (Figure 3.7)
(using paired t-test at 95% confidence interval, SPSS program). However, the
amount of quercetin-4-O-glucoside and total quercetin in red onion soup after
microwaving were significantly different between extracted with absolute methanol
or 70% methanol solution (p-value = 0.021 and 0.0478). The ratio of quercetin-3,4-
di-O-glucoside to quercetin-4-O-glucoside after preparation, before and after
microwave cooking were 2.6±0.0:1, 2.4±0.1:1 and 2.3±0.1:1. It was slightly
different, indicating heat stability of quercetin in onion after heating in a microwave
oven for 1 min. Finally, the extraction method using absolute methanol and 70%
methanol seemed to provide the same level of recovery yields.
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Figure 3.4: HPLC chromatograms showing analysis of the main quercetin
glycosides of red onion soup at 370 nm: (a) standard compounds composed of
quercetin-3,4 di-O-glucoside, quercetin 4-O-glucoside and quercetin (b) after
preparation (c) before microwaving (d) after microwaving.
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Figure 3.5: Standard curves of quercetin-3,4-di-O-glucoside, quercetin-4-O-
glucoside and quercetin for red onion soup quantification.
Table 3.3: Different content of quercetin-3,4-di-O-glucoside, quercetin-4-O-
glucoside and total quercetin content in red onion soup (130 ml) after 3 different
cooking methods, using two different extraction solutions, absolute or 70%
methanol.
Treatment Q content, mg/130 ml Q equivalent, mg/130 ml
Quercetin-
3,4-di-O-
glucoside
Quercetin-
4-O-
glucoside
Total Quercetin-
3,4-di- O-
glucoside
Quercetin
- 4-O-
glucoside
Total
Absolute methanol
After preparation 40.2±12.4 15.6±4.0 55.8±16.4 19.3±5.9 10.1±2.6 29.4±8.5
Before microwaving 44.8±2.4 17.8±0.9 62.6±3.4 21.5±1.2 11.6±0.6 33.1±1.8
After microwaving 32.3±5.0a 14.8±1.9a 47.1±6.9a 15.5±2.4a 9.6±1.2a 25.1±3.6a
70% methanol
After preparation 44.5±10.8 17.2±4.8 61.7±15.6 21.3±5.2 11.2±3.1 32.5±8.3
Before microwaving 42.3±5.1 18.2±4.5 60.4±9.6 20.3±2.4 11.8±2.9 32.1±5.4
After microwaving 42.1±6.4a 17.8±1.7b 59.9±8.2b 20.2±3.1a 11.6±1.1a 31.8±4.2a
(Results are expressed as mean ± standard deviation. Different superscripts indicate significant
different of quercetin 4-O-glucoside and total quercetin content after microwaving between extracted
with absolute or 70% methanol (p-value < 0.05), p-value of a,b for quercetin 4-O-glucoside is 0.021
and for total quercetin is 0.047)
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3.4.3 Determination of (-)-epicatechin content in dark chocolate
The amount of (-)-epicatechin in chocolate with different percentages of
cocoa (90%, 85% and 70% cocoa) from different brands were quantified and
compared using HPLC-DAD/FLD. (-)-Epicatechin was separated at 15.4 min at a
maximum wavelength of 280 nm using a diode array detector and at 15.6 min at Ex
= 230, Em = 321 using a fluorescence detector. There were 114.7 mg/ 100 g FW for
90% cocoa, 123.3 mg/ 100 g FW for 85% cocoa and 109.1 mg/ 100 g FW for 70%
cocoa. Although 90% and 85% cocoa dark chocolate contained a higher content of
(-)-epicatechin than 70% cocoa, 70% cocoa dark chocolate was less bitter and so
70% cocoa chocolate was selected and quantified for the human study in the next
step. Typical chromatograms of (-)-epicatechin in 70% dark chocolate detected by
DAD and FLD are shown in Figure 3.8. Seven standards of (-)-epicatechin were
prepared as in Table 2.3 in Section 2.2.2.3 then the standard curves were
constructed. The regression analysis showed that the on-column amount, ranged
from 50 to 5000 pmol for the DAD mode and 50 to 3750 pmol for FLD were
linearly correlated with the peak area with R2 = 0.9912 for (-)-epicatechin detected
with DAD and R2 = 0.9992 for (-)-epicatechin detected with FLD, respectively. For
the DAD mode, the limit of detection and quantification were calculated from the
regression linear of Figure 3.9A and there were 635 and 2117 pmol while, the limit
of detection and quantification of the FLD mode were 9 and 31 pmol (Figure 3.9B).
From these results, FLD has a lower limit of detection and quantification than DAD
or is more sensitive to detect a low amount of (-)-epicatechin in the same sample
than DAD, resulting a higher (-)-epicatechin content determined by use of the FLD
mode. The content of (-)-epicatechin was calculated based on the standard curve in
Figure 3.9. (-)-Epicatechin was determined as 81.2±8.5 mg/100g FW detected using
DAD and 92.2±4.4 mg of (-)-epicatechin/100g FW detected using FLD and shown
in Table 3.4. The content of (-)-epicatechin in 70% dark chocolate detected using the
DAD mode showed no difference compared with the FLD mode (using an
independent t-test, p-value = 0.247).
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Figure 3.6: HPLC chromatograms showing analysis of (-)-epicatechin with 70%
dark chocolate with DAD at 280 nm (A) and with FLD at Ex = 230, Em = 321 (B);
(a) standard epicatechin (EC), (b) in 70% dark chocolate.
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Figure 3.7: Standard curve of (-)-epicatechin for 70% dark chocolate
quantification.
Table 3.4: (-)-Epicatechin content in 70% dark chocolate using HPLC-DAD or FLD
Detector
(-)-Epicatechin content in 70% dark chocolate
(mg/100g FW)
DAD 81.2±8.5
FLD 92.2±4.4
3.5 Discussion
The amount of quercetin in onion varies depending on bulb colour and type.
The findings in this study shows that yellow onion contains lower amounts of
quercetin than red onion. For yellow onion, the amount of quercetin was 272.2±51.0
mg/100 g FW for quercetin-3,4-di-O-glucoside, 53.1±12.2 mg/100 g FW for
quercetin -4-O-glucoside or 325.4±63.1 mg/ 100g FW in total. Price and Rhodes
(1997) identified the main flavonoids in four varieties of onion bulb; white, brown,
hybrid pink and red skinned varieties by freezing in liquid nitrogen and freeze-
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drying prior to analysis. They confirmed that quercetin-3,4-di-O-glucoside is the
main component, ranging from 5-130 mg/100 g FW, followed by quercetin-4-O-
glucoside, ranging from 3.6-39.4 mg/100 g FW and quercetin but at low levels in all
four types. For yellow onion, they found 111.7 mg/100g of quercetin-3,4 di-O-
glucoside, 36 mg/100g of quercetin-4-O-glucoside, 3.9 mg/100g of quercetin or
151.6 mg/100g in total. This data revealed that the total amount of yellow onion in
our study is higher than those reported by Price and Rhodes (1997) by around 2
times. The maximum quercetin content in yellow onion in our study also showed
that it is higher than the quercetin content reported in both USDA (21.4 mg
quercetin/100 g FW) and the maximum Phenol Explorer Database (135.8 mg/100 g
FW for quercetin-3,4-di-O-glucoside, 83.0 mg/100 g FW for quercetin-4-O-
glucoside) by approximately 2 times. However, the minimum value of quercetin-
3,4di-O-glucoside and quercetin-4-O-glucoside are still in the range of the Phenol
Explorer Database (Table 3.5).
Prior to determining quercetin and its glycosides in onion in our study, a
freeze-drying preservation process was performed (Price and Rhodes, 1997). Some
different steps were used and compared to Price and Rhodes (1997). First, a whole
bulb of onion was skinned and chopped into small pieces then immediately frozen
by putting in the freezer at -80ºC so samples were easier to grind to a powder for the
next step, while, Price and Rhodes (1997) cut five bulbs of onion into quarters and
then they were frozen by immersion in liquid nitrogen. Another difference is the
extraction. Although this study used 70% methanol as an extraction solution in Price
and Rhodes (1997), here 100 µM ascorbic acid also was added into the extraction
solution to preserve all quercetin glycosides. In addition, all extraction processes
were performed on ice to prevent degradation of quercetin glycosides. These are
possible reasons why the amount of quercetin in yellow onion found in this study
was higher than that found by Price and Rhodes (1997). Thus, it is important to
consider this in every single step prior to conducting an estimation of content.
For red onion, the level of quercetin (304.1±55.6 mg/100 g FW for
quercetin-3,4-di-O-glucoside, 109.7±27.3 mg/100 g FW for quercetin-4-O-
glucoside and 413.8±82.9 mg/100 g FW in total) is clearly higher than the total
quercetin levels stated in the USDA database (33.4 mg/100 g FW) by approximately
12.5 times. For Phenol Explorer Database comparison, the minimum content of both
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quercetin-3,4-di-O-glucoside and quercetin-4-O-glucoside are in the range of the
Phenol Explorer Database but the maximum value of quercetin-3,4-di-O-glucoside
is out of the range (higher around 1.5 times) except for quercetin-4-O-glucoside
(Table 3.5).
Table 3.5: Comparison of quercetin glycosides found in yellow and red onion
between this study and the Phenol Explorer Database
Onion
types
This study
(mg/100 g FW)
Phenol Explorer Database
(mg/100 g FW)
Votex and
sonication
Homogenisation Average Min Max
Standard
deviation
Yellow
Q3,4diG 54.3±1.4 272.2±51.0 36.0 11.4 135.8 49.5
Q4G 16.0±0.2 53.1±12.2 23.5 13.8 83.0 16.2
Red onion
Q3,4diG 70.1±10.5 304±55.6 101.3 20.2 207.5 58.9
Q4G 37.0±6.5 109.7±27.3 43.7 30.0 114.3 21.2
Again, there were several possible reasons affecting quercetin content in
onions, for example plant distribution and variety, seasonal variation, light and
climate, food preparation and processing. The data from the Phenol Explorer
database was obtained by collecting data from different publications. Each study
may have used different types of onion from different areas and also different
techniques when preparing and analysing samples, resulting in different quercetin
content. A freeze-drying step prior to determining quercetin glycoside content was
used in this study and may be another important reason why found the quercetin
content was higher compared to other publications. The freeze-drying step may
assist in altering the structure of tissue making it easier for quercetin extraction in
the next step. This reason is supported by Perez-Gregorio et al. (2011). They
elucidated that the freeze-drying process increases the extraction of flavonoids up to
32% for flavonols and 25% for anthocyanins in red onion.
Our study also revealed that red onion is a good source of quercetin and it
contains a higher amount of quercetin glucosides than yellow onion similar to most
publications except Crozier et al. (1997). They found that red onion (20.1 mg/ 100g)
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contains less quercetin than white onion (18.5-63.4 mg/100 g). In this case Crozier
analysed only one type of red onion and determined the content of quercetin by acid
hydrolysis of quercetin conjugates. This acid condition may not be suitable or
completely hydrolyse all conjugates in red onion, leading to underestimation of the
quercetin content. Variation of quercetin content in onion may probably be genetic
in origin and storage factors. Patil et al. (1995) analysed quercetin content of 55
yellow, 3 pink, 6 red and 11 white onions and found different levels, ranging from
0.021 to 28.6 mg/ 100 fresh weight. It was apparent that the total quercetin content
varied about 1360-fold. They also studied the effect of storage conditions on the
variation of total quercetin content and found that total quercetin content of bulbs
changes significantly at 24ºC compared to other treatments (5ºC, 30ºC and
controlled atmosphere for 0, 1, 2, 3, 4 and 5 months), rising in mid-storage and
dropping later. Thus, from this evidence, it is clear that colour may not be the only
criterion affecting total quercetin content, but also genetic origin and storage factors.
Cooking processes are another factor which should be considered and may affect the
content of quercetin, the bioavailability and finally the biological effects. Price et al.
(1997) studied the effect of boiling for 15 min of a composition of quercetin
glucosides in red and brown-skinned onions and found 12% of quercetin-3,4-di-O-
glucoside and 13% of quercetin-4-O-glucoside leaching into the cooking water but
no free quercetin. Rodrigues et al (2009) also reported that quercetin glycosides of
onions are lost during boiling for 30 min and leached into the boiling water without
being degraded at 37% for quercetin-3,4-di-O-glucoside and 29% for quercetin-4-
O-glucoside. Additionally, they found that boiling for 60 min had more serious
effects because of the degradation of quercetin derivatives (53% and 44% for
quercetin-3,4-di-O-glucoside and quercetin-4-O-glucoside, respectively). However,
in this study, the boiling step was used for only 7 min in preparing red onion soup.
Then, onion glucosides in onion soup probably will not be lost or degraded in large
amounts and it will remain in the water. Therefore, onion soup seems to be a better
source of quercetin. The content of quercetin in red onion soup was quantified again
after preparation and before and after heating in a microwave oven (data shown in
Table 3.3). There were no significant differences in total quercetin content in red
onion soup after preparation (61.7±15.6 mg/ 130 ml soup), or before (60.4±9.6 mg/
130 ml soup) and after microwaving (59.9±8.2 mg/130 ml soup) as a result of a
short microwave cooking time (only 1 min). Rodrigues et al. (2009) showed that
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moderate microwave cooking (450 watt for 4 min) did not affect the quercetin
content, but intense microwaving (750 watt for 4 min) treatment caused flavonol
losses of 16% and 18% for quercetin-3,4′-di-O-diglucoside and quercetin-4′-O-
glucoside, respectively. Thus, to warm onion soup for only 1 min before giving to
volunteers in the next experiment did not cause losses of quercetin in large amounts.
In dark chocolate, the content of (-)-epicatechin determined in this study was
81.2±8.5 mg/100g FW for DAD mode and 92.2±4.4 mg/100g FW for FLD mode.
The content of (-)-epicatechin in 70% dark chocolate detected using the DAD mode
showed no difference compared with the FLD mode, p-value = 0.247. It also was in
the same range as (-)-epicatechin levels reported in the Phenol Explorer Database
(average content is 70.4 mg/100 g FW and ranging from 32.7-125 mg/100 g FW)
and the research of Langer et al, 2011 which ranged from 93.5-651.1 mg of (-)-
epicatechin equivalent/100 g for dark chocolate. Thus, the amount of (-)-epicatechin
in our study is consistent with other publications.
3.6 Conclusion
In summary, the findings of this study showed that red onions contain a
higher amount of quercetin than yellow onions in agreement with most publications.
Although cooking processes such as microwaving have an effect of the quercetin
content of the onions, this study revealed no significant differences between red
onion soup after preparation and before and after microwaving for 1 min. For (-)-
epicatechin content in dark chocolate, different percentages of cocoa dark chocolates
were studied but 70% cocoa dark chocolate was then used in this study. Using
higher than 70% of cocoa dark chocolate may negatively affect the taste perception
of volunteers. Although, FLD is more sensitive to detecting a low amount of (-)-
epicatechin than DAD, resulting in a higher (-)-epicatechin content determined using
the FLD mode, but the amount of (-)-epicatechin measuring in the same 70% cocoa
dark chocolate sample is the same for both detection method. The dose of quercetin
and (-)-epicatechin supplied by red onion soup (containing 109 µmol of quercetin in
130 ml) and 70% dark chocolate (containing 167 µmol of (-)-epicatechin in 45 g)
was then applied for the human bioavailability study in the next chapter.
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Chapter 4 Determination of Quercetin, (-)-Epicatechin and Their
Methylated Forms in Urine Samples After Enzyme Hydrolysis
4.1 Abstract
Catechol-O-methyl transferase is an important phase II enzyme that affects
the bioavailability of quercetin or (-)-epicatechin. The activity of this enzyme also
varies between people because of genetic variation. Thus, it is interesting to study
the COMT variation in individuals and relate this to the bioavailability of quercetin
or (-)-epicatechin in healthy volunteers. The main aim of this chapter was to study
the COMT activity and the metabolism of two dietary flavonoids, quercetin or (-)-
epicatechin. A preliminary study of COMT activity was first tested in vitro prior to
performing a pilot study in vivo. In humans, COMT activity was measured by the
ratio of total urinary methylated quercetin or (-)-epicatechin to its aglycone excreted
in urine after consumption of onion soup (containing 109 µmol of quercetin in 130
ml) or dark chocolate (containing 167 µmol of (-)-epicatechin in 45 g), or both of
them together. Baseline and 24 hr urine samples from some subjects were
hydrolysed by β-glucuronidase and sulfatase to release aglycone and methylated 
forms followed by HPLC-MS analysis. The result from the in vitro study showed
that the conversion rate and COMT activity of (-)-epicatechin (9.1 pmol/min, 827
pmol/mg protein/min) was higher than quercetin (1.3 pmol/min and 126 pmol/mg
protein/min). In the human study, the urinary excretion of quercetin, 3-O-
methylated quercetin and 4-O-methylated quercetin were 0.70, 0.18 and 0.07% after
onion soup intake. In comparison, there was 0.38% urinary excretion of (-)-
epicatechin after 70% cocoa dark chocolate intake and no 3-O-methylated (-)-
epicatehcin and 4-O-methylated (-)-epicatechin were detected in urine. These
results were unchanged after co-consumption of both type of food and low
compared to publications (Manach et al., 2005). A limiting factor may be enzyme
hydrolysis using β-glucuronidase and sulfatase. Although new hydrolysis conditions 
were tested, the urinary excretion of quercetin and (-)-epicatechin was still low, and
so variation of COMT activity in individuals cannot be compared. After in vitro
assays, it was revealed that the amount of quercetin, (-)-epicatechin and their
methylated forms were underestimated due to some compounds in urine which
inhibited sulfatase activity. Thus, glucuronidase or sulfatase cannot be used for
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quantitative urine analysis and so the approach was modified and the intact
conjugated metabolites of quercetin and (-)-epicatechin excreted in the urine will be
analysed in (Chapter 6) instead.
4.2 Introduction
As explained in Chapter 1, phase II enzymes (UGT, SULT and COMT) are
an important factor influencing bioavailability of flavonoids. In the case of COMT,
during passage of flavonoids across the intestinal tract and to the liver through blood
circulation, COMT will add a methyl group from the co-factor SAM to a hydroxyl
group of the catechol ring of flavonoids at the 3 or 4 position, resulting in a 3-O-
methylated or 4-O-methylated product. The extent of this chemical change can
affect the bioavailability and the biological effects of flavonoids. Some studies
suggested that this modification probably reduced the biological effect of the parent
compound (Duenas et al., 2011); whereas other studies suggested that the
metabolites may have superior benefits for health (Jaramillo et al., 2010; Basu-
Modak et al., 2003; Steffen et al., 2007). For example, Duenas et al. (2011) showed
that quercetin metabolites, quercetin 3-O-sulfate, quercetin 4-O-sulfate, quercetin
3-O-glucuronide and isorhamnetin 3-O-sulfate decreased the antioxidant activity,
investigated by ABTS and FRAP assays, comparing to the parent compound.
However, an O-methylated metabolite (-)-epicatechin, 3-O-methylated epicatechin,
was shown to inhibit NADPH oxidase activity in human umbilical vein endothelial
cells, resulting in improved function of vascular endothelium (Steffen et al., 2008).
COMT activity was originally analysed in vitro by Axelrod and Tomchick
(1958). For a COMT substrate like dietary catechol flavonoids, some research
groups have shown that these exogenous substrates are methylated by COMT faster
than endogenous substrates in vitro. For example, quercetin, a subclass of dietary
flavonoid, and fisetin, a structural analogue of quercetin, are rapidly O-methylated
by cytosolic COMT, with rates two to three times higher than for both catechol
estrogens and catecholamines, because quercetin and fisetin have a higher affinity
for COMT than the endogenous substrates. (Zhu et. al. 1994; 2000). Zhu et al.
(2000) also studied several common catechol-containing tea polyphenols which
contain a catechol structure and share certain degrees of structure similarity to
quercetin and fisetin. They found that common tea polyphenols such as (-)-
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epicatechin, (+)-epicatechin, (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-
epigallocatechin gallate are rapidly O-methylated by human placental cytosolic
COMT. In addition, in 2004 they showed that tea polyphenols, quercetin and fisetin
were strong inhibitors of O-methylation of 2- and 4-hydroxyestradiol by cytosolic
COMT from human liver. The same research group showed that major
polyphenolic components present in coffee, chlorogenic acid and caffeic acid, act as
inhibitors in the human liver and placental COMT-mediated O-methylation of
catechol estrogens with mix mechanism, competitive and non-competitive inhibition
(Zhu et al, 2009). Additionally, Zhu et al, (2010) further determined cytosolic
COMT activity for the O-methylation of catechol estrogen. They found that there
are positive correlations between the sensitivity of human placenta COMT to heat
inactivation and to inhibition by EGCG but an inverse correlation between heat
inactivation and inhibition by quercetin. They suggested that the differences in
inhibition probably were due to different mechanisms of COMT inhibition involved.
In addition, COMT inhibition may enhance the biological effect of the green tea
polyphenol EGCG in human breast cancer cells (Landis-Piwowar et al., 2010).
For COMT activity in vivo, the relationship between tea catechins
consumption, COMT genotype and risk of breast cancer in Asian-American women
had been reported by Wu et al. (2003). They found that people who carried the low
activity COMT allele, yielded less O-methylation resulting in a less efficient in
elimination of tea catechins, and a reduced breast cancer risk after tea catechin
consumption. However, Shrubsole et al. (2009) revealed that the same COMT
genotypes did not affect the relationship between green tea consumption and breast
cancer risk among pre- and postmenopausal women in a Chinese population. Miller
et al. (2012) showed that COMT genotype did not intensely affect EGCG absorption
and metabolism. Recently, Lorenz et al. (2014) also revealed that a high dose of
EGCG from supplement does not impair COMT activity in vivo. However, in the
case of (-)-epicatechin, no any publication has reported the effect of COMT activity
on the absorption and metabolism after cocoa or cocoa product consumption. In the
case of quercetin, Wang et al. (2012) reported that quercetin is not only increased
the cellular absorption and decreased methylation of EGCG in vitro but this
flavonoid also enhanced of total and non-methylated EGCG in lung, kidney and
liver of severe combined immunodeficient mice after administration of brewed
green tea and quercetin supplement. In addition, this study suggested that the
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combination of quercetin and green tea may enhance the tumour inhibitory effect of
green tea polyphenols.
Therefore, the different COMT activity levels in individuals possibly may
affect the different amounts of polyphenol circulating throughout the human body.
In addition, in the case of quercetin and (-)-epicatechin combination, quercetin
which acts as a COMT inhibitor may increase or decrease methylation of (-)-
epicatechin during the absorption and hepatic steps, influencing biological activity.
Thus, it is necessary to study the COMT variation in individuals and relate this to
the bioavailability of quercetin or (-)-epicatechin in healthy volunteers. The main
aim of this chapter was to study the correlation between COMT activity and the
metabolism of two dietary flavonoids, quercetin or epicatechin. The preliminary
study of COMT activity was first tested in vitro prior to performing a pilot study in
vivo. In humans, COMT activity was estimated by measuring the ratio of total
urinary methylated quercetin or (-)-epicatechin to aglycone excreted in urine after
consumption of onion soup (containing 109 µmol of quercetin in 130 ml) or dark
chocolate (containing 167 µmol of (-)-epicatechin in 45 g), or both of them together.
However, the free form of quercetin and (-)-epicatechin could not be found in urine
but were transformed into glucuronidated, sulfated and methylated conjugates. Then,
β-glucuronidase and sulfatase were used to hydrolyse the glucuronidated and 
sulfatated forms into methylated forms and its aglycone prior to determination by
LC-MS. Furthermore, several factors that affected the enzyme hydrolysis condition
were studied and the optimal condition was used to analyse urine sample in a small
group of volunteers.
4.3 Materials and Methods
See Section 2.3 for catechol-O-methyltransferase (COMT) in vitro, section
2.5.1-2.5.4 for urine analysis and section 2.6 for determining sulphatase activity
using commercial substrate (PNCS) and product (PNC).
- 93 -
4.4 Results
4.4.1 COMT activity in vitro
4.4.1.1 (-)-Epicatechin as a substrate of COMT
COMT activity was first tested in vitro prior to estimation in vivo. COMT
can be found in several tissues, but is highest in liver and kidney. In this study, pig
liver was used as a source of COMT, since it has high activity, and is feasible, cheap
and easier to handle than human liver. There was approximately 125 ug/ml or 0.125
mg/ml protein content in supernatant, extracting from pig liver.
For COMT assay using (-)-epicatechin as a substrate, eight reaction mixtures
of COMT assay were prepared according to Table 2.5. The first two samples were
used as control samples and the other assays were varied by incubation time. After
that, samples were injected onto the HPLC using the optimal gradient for
epicatechin separation (see Section 2.3.3). In this assay, (-)-epicatechin was O-
methylated by COMT and two metabolites of (-)-epicatechin, 3-O-methylated-(-)-
epicatechin and 4-O-methylated-(-)-epicatechin, were produced. The retention time
were approximately 13.6 and 14.9 for 3-O-methylated-(-)-epicatechin and 4-O-
methylated-(-)-epicatechin, respectively (Figure 4.1). Furthermore, as expected, the
amount of 3-O-methylated-(-)-epicatechin and 4-O-methylated-(-)-epicatechin was
higher with increasing the incubation time. The chromatogram of samples and
positive control are shown in Figure 4.1.
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Figure 4.1: Chromatogram of (-)-epicatechin and its metabolite (3-O-methylated (-)-
epicatechin and 4-O-methylated (-)-epicatechin) after different incubation time (A:
negative control, B-G: COMT assay, incubated at 10 min, 20 min, 30 min, 40 min, 50
min and 60 min, respectively). For B to G, the left panels are an original chromatogram
and the right panels are magnified.
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Figure 4.2: Chromatogram of (-)-epicatechin and its metabolite (3-O-methylated (-)-
epicatechin and 4-O-methylated (-)-epicatechin) after different incubation time (A:
negative control, B-G: COMT assay, incubated at 10 min, 20 min, 30 min, 40 min, 50
min and 60 min, respectively). For B to G, the left panels are an original chromatogram
and the right panels are magnified (Continued).
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For the rate of COMT, the amount of 3-O-methylated-(-)-epicatechin
and 4-O-methylated-(-)-epicatechin were calculated using the equation from the (-)-
epicatechin standard curve. Then, the conversion rate of COMT was constructed as
shown in Figure 4.2.
Figure 4.3: Conversion rates of COMT. The slope of the upper and the lower curve
represented conversion rate for 3-O-methylated-(-)-epicatechin and 4-O-
methylated-(-)-epicatechin, respectively.
For 3-O-methylated form, there was 9.1 pmol/min, whereas, the conversion
rate of 4-O-methylated-(-)-epicatechin was relatively low (1.3 pmol/min). This data
showed that 3-O-methylated-(-)-epicatechin had an overall conversion rate higher
than 4-O-methylated-(-)-epicatechin.
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4.4.1.2 Quercetin as a substrate of COMT
Using quercetin as a substrate, COMT O-methylated quercetin to produce 3-
O methylated quercetin (retention time = 19.892 min and a small peak of 4-O
methylated quercetin, eluting later). The chromatogram of samples and positive
control are shown in Figure 4.3 and Figure 4.4, respectively.
Figure 4.4: Chromatogram of quercetin and its metabolite (3MeQ) in assay (B). A
is negative control. The left panels are an original chromatogram and the right
panels are magnified.
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Figure 4.5: Chromatogram of 100 µM each standard; daidzein (D), quercetin (Q),
3-O-methyl quercetin (3MeQ) and 4-O-methyl quercetin (4MeQ) detected at 302
nm (A) and 370 nm (B).
The formation rate of -O-methylated quercetin and COMT activity were
126 pmol/mg protein/min and 1.4 pmol/min, respectively. Next, the study focused
on the methylated products of COMT in human body.
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4.4.2 COMT activity in vivo
After assessing the COMT activity in vitro, it also was then estimated in
vivo. The COMT activity was analysed by measuring the ratio of product to
substrate or the ratio of total methylated of quercetin or (-)-epicatechin to its
aglycone in this case. After single consumption of onion soup, 70% cocoa dark
chocolate and co-consumption onion soup and 70% cocoa dark chocolate in
different days, the baseline and 24 hr urine were then collected from healthy
volunteers. 5 U of β-glucuronidase (E. coli, type IX-A) and 0.03 U of sulfatase (A.
aerogenes, type IV) in 0.2 M sodium phosphate buffer, pH 7.0 were used to release
the parent aglycone and methylated forms before quantifying by LC-MS (see
Section 2.5.7). The amount of quercetin, (-)-epicatechin and their methylated
products were identified and quantified based on HPLC retention time and MS
analysis using standard curves of quercetin, (-)-epicatechin and their 3-O-
methylated or 4-O-methylated forms dissolved in baseline urine (Figure 4.5). The
regression analysis of each standard curve showed that the on-column amount,
ranging from 20 to 100 pmol, was linearly correlated with a peak area ratio of each
standard to taxifolin (act as internal standard II) of R2 = 0.9685 for quercetin, R2 =
0.9204 for 3-O-methyl quercetin, R2 = 0.9776 for 4-O-methyl quercetin, R2 =
0.9998 for (-)-epicatechin, R2 = 0.9850 for 3-O-methyl (-)-epicatechin and R2 =
0.9802 for 4-O-methyl (-)-epicatechin.
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Figure 4.6: Standard curves of (a) quercetin (b) 3-O-methyl quercetin (c) 4-O-
methyl quercetin (d) (-)-epicatechin (e) 3-O-methyl (-)-epicatechin and (f) 4-O-
methyl (-)-epicatechin dissolved in baseline urine.
The percentage urinary excretion of each compound was calculated by the
amount excreted divided by the amount ingested and multiplied by 100. From this
equation, the percentage urinary excretion of quercetin, (-)-epicatechin and its
methylated forms was calculated and is shown in Table 4.1. In day 1, quercetin and
its methylated forms; 3-O-methylated and 4-O-methylated quercetin, were excreted
in urine after red onion soup intake. The percentages of excretion in urine were
0.70%, 0.18% and 0.07%, respectively. In day 2, only (-)-epicatechin was detected
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in urine (0.38% of dose) after single consumption of 70% cocoa dark chocolate.
After co-consumption in day 3, the percentage urinary excretion of quercetin, (-)-
epicatechin and their methylated forms were similar to results in day 1 and day 2 but
the percentage of excretion was higher by approximately 2 fold.
The total percentage of urinary excretion of quercetin (0.95%) and (-)-
epicatechin (0.38%) found in this subject was then compared with other publications
(Table 4.2). The percentage of total quercetin in urine was in the reported range but
the urinary excretion of total (-)-epicatechin was lower by around 7 times.
Table 4.1: The percentage of urinary excretion of quercetin, (-)-epicatechin and its
methylated forms
% Urinary excretion
Compounds Day 1 study Day 2 study Day 3 study
red onion soup
consumption
70% cocoa dark
chocolate
consumption
both
consumption
Quercetin 0.70 - 1.10
3-O-Methyl quercetin 0.18 - 0.28
4-O-Methyl quercetin 0.07 - 0.16
(-)-Epicatechin - 0.38 0.72
3-O-Methyl (-)-epicatechin - nd nd
4-O-Methyl (-)-epicatechin - nd nd
Table 4.2: The percentage urinary excretion adapted from Monach et al., 2005.
These were converted to correspond to a supply of 50 mg aglycone equivalent.
Compound
%Urinary excretion (Manach et al., 2005)
Mean Range
Quercetin glucosides 2.5±1.2 0.31-6.4
(Epi)catechin 18.5±5.7 2.1-55.0
- 102 -
Some factors which may possibly affect enzyme hydrolysis or stability of
analysed compounds such as pH, efficiency of extracted solvent and the different
solvents for reconstitution more considered and tested. Firstly, the pH of 0.2M
sodium phosphate buffer or solvent B in different urine preparation step was
prepared and measured (Table 4.3). The pH in Table 4.3 shows that the pH of tube
No 2, a mixture between 150 µl of 0.2 M Sodium phosphate, pH 7.0 and 1 ml of
50% Ethanol in milliQ water was 8.2. This condition may degrade quercetin in the
reaction. For other tubes (No 3, 4, 5), the pH are in acid condition which be able to
preserve compounds from degradation.
Table 4.3: The pH of 0.2 M sodium phosphate buffer or solvent B in different urine
preparation step
Tube
No.
Reaction mixture pH
1 150 µl of 0.2 M Sodium phosphate, pH 7 7
2 150 µl of 0.2 M Sodium phosphate, pH 7.0 8.2
+ 1 ml of 50% Ethanol in milliQ water
3 Solvent B (Acetronitrile + 0.1% Formic acid) 4.4
4 Solvent B (Acetronitrile + 0.1% Formic acid) 2.6
+ Solvent A (MilliQ water + 0.1 Formic acid)
containing 100 µM ascorbic acid
5 Solvent B (Acetronitrile + 0.1% Formic acid) 2.6
+ Solvent A (MilliQ water + 0.1% Formic acid)
containing 100 µM ascorbic acid
+ 500 µM Taxifolin in 50% Ethanol in milliQ water
Secondly, 1 µM quercetin, 1 µM (-)-epicatechin and 1 µM daidzein (internal
standard) were prepared in 50% ethanol and extracted with and without ethyl acetate
prior to analysis by LC-MS. Then, the peak area of each sample was compared
(Figure 4.6). Extracting quercetin, (-)-epicatechin and daidzein with ethyl acetate
produced a higher yield than without ethyl acetate extraction. Lastly, the different
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solvents, 50% ethanol in milliQ water and 15% solvent B, were used to prepared 1
µM EC then directly injected to LC-MS and the peak area of these two samples
were compared. The peak area of (-)-epicatechin dissolved in 50% ethanol in milliQ
water and in 15% solvent B were 376,049 and 372,922 which was not different.
Figure 4.7: Efficiency of extracted solvent, ethyl acetate, on quercetin (Q), (-)-
epictechin (EC) and diadzein (D) extraction
From these results, ethyl acetate for quercetin, (-)-epicatechin and daidzein
extraction and 50% ethanol in water or 15% solvent B for reconstitution seems not
to have any effect on the stability of analysed compounds in different urine
preparations, except pH in hydrolysis condition may cause the activity of enzyme
and the stability of some compounds. Therefore, the type of buffer used for enzyme
hydrolysis needs to re-considered and changed. A new enzyme deconjugation
method optimised by Dr Kayleigh Clarke was then applied in this section. The
ABSS buffer at pH 5 was used instead of 0.2 M sodium phosphate buffer, pH 7.0.
However, this pH condition is optimal for a different type of β-glucuronidase and 
sulfatase activity. Then, sulfatase, not glucuronidase, was changed from Aerobacter
aerogenes type IV to Abalone entrails type VIII. In addition, the low amount of
deconjugated enzyme in the hydrolysis reaction may possibly be another reason
causing a low amount of (-)-epicatechin and no methylated (-)-epicatchin to be
detected in urine. Thus, the unit of enzyme also was increased from 5 U to 200 U for
β-glucuronidase and from 0.03 U to 5 U and up to 20 U for sulfatase, according to 
Saha et al, 2012. The units of enzyme were varied and tested in urine sample of
0.00E+00
2.00E+06
4.00E+06
6.00E+06
8.00E+06
1.00E+07
1.20E+07
1.40E+07
1 µM Q in
50% EtOH
1 µM EC in
50% EtOH
1 µM D in
50% EtOH
Pe
ak
ar
ea
without ethyl acetate
with ethyl acetate
- 104 -
volunteer No 004 after single consumption of 70% dark chocolate. The result in
Table 4.4 is shown that 200 U of β-glucuronidase (Escherichia coli type IX-A) and
20 U of sulfatase (Abalone entrails type VIII) are better to hydrolyse (-)-epicatechin
metabolites in urine than other conditions. However, only (-)-epicatechin and 4'-O-
methylated-(-)-epicatechin were detected after enzyme deconjugation and no 3'-O-
methylated-(-)-epicatechin was detected.
Table 4.4: The amount of (-)-epicatechin, 3'-O- methylated-(-)-epicatechin and 4'-
O- methylated-(-)-epicatechin (nmol) after hydrolyse with vary unit of β-
glucuronidase (Escherichia coli type IX-A) and sulfate (Abalone entrails type VIII).
Volunteer 004
Units of enzyme (U) The amount of compounds (nmol)
β-glucuronidase Sulfatase EC
3'-O-
MeEC
4'-O-
MeEC
Total EC
0 0 nd nd nd nd
5 0.03 nd nd nd nd
200 5 1019 nd 464 1483
200 20 1786 nd 1289 3074
 After that, this condition, 200U of β-glucuronidase (Escherichia coli type
IX-A) and 20U of sulfatase (Abalone entrails type VIII), was used to analysed (-)-
epicatechin and its methylated metabolites in more volunteers to check whether the
% urinary excretion in these volunteers were in the same range of volunteer No 004
or not. Again, only (-)-epicatechin was detected in urine after enzyme deconjugation
and no any methylated forms of (-)-epicatechin found in urine. The % urinary
excretions of these volunteers were shown in Table 4.5.
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Table 4.5: The urinary excretion of (-)-epicatechin after 70% dark chocolate intake
in selected volunteers
Volunteer Number % of dose (-)-epicatechin
003 1.8
004 1.1
117 2.1
118 1.0
120 2.3
Although the amount of enzyme was increased, the % urinary excretion of (-
)-epicatechin was unaffected. As mentioned previously, the % urinary excretion
reported by (-)-epicatechin of Manach et al. (2005) was hugely wide-ranging from
Śřto ŝŝŘbecause the data originated from various types of food and not only from
cocoa. Baba et al., 2000 demonstrated that urinary excretion of total (-)-epicatechin
was 29.8±5.3% for chocolate intake and 25.3±8.1% for cocoa intake. In addition,
Actis-Goretta et al. (2012) showed that the total urinary excretion of (−)-epicatechin 
is 20±2% after consuming 100 g of Nestlé Noir 70% chocolate containing 79 mg of
(−)-epicatechin (272 µmol), 26 mg of (±)-catechin, and 49 mg of procyanidin B2. 
The present study provided a half bar of 70% dark chocolate (containing 167 µmol
of (-)-epicatechin in 45 g) then the expected % of urinary excretion in urine should
be around 12%, calculated based on the Actis-Goretta et al. study. However, the %
urinary excretion analysed from some volunteers in this study showed that it is
lower than the expected amount around 6 times. It is proposed that β-glucuronidase 
and sulfate did not hydrolyse completely. Something in urine may possibly inhibit
enzyme activity, and this was assessed in the next section.
4.4.3 The limitation of sulfatase activity
In 2012, Saha demonstrated that epicatechin sulfate and methylepicatechin
sulfates, both in urine and as the authentic compounds, are poor substrates for six
commercial sulfatases (Helix pomatia Type H-1 or H-2, Patella vulgate Types IV or
V, Aerobacter arerogenes Type VI or Abalone entrails Type III) after incubation
with 20 U of these sulfatase and 200 U of β-glucuronidase for 2 hr at pH 5.0. 
- 106 -
Therefore, the efficiency of sulfatase used in this study was investigated. Sulfated
quercetin and (-)-epicatechin were synthesised from commercial quercetin or (-)-
epicatechin and then these synthesised compounds were used as substrates for
sulfatase hydrolysis. For quercetin sulfation, quercetin was converted to quercetin
sulfate by SULT from pig liver cytosol. The sulfuryl group of the universal sulfuryl
group donor, adenosine-3-phosphate-5-phosphosulfate (PAPS) was transformed to
the hydroxyl group of quercetin by SULT, resulting in quercetin sulfate. For (-)-
epicatechin sulfation, similar enzymatic reaction was prepared but (-)-epicatechin
was used as a substrate instead of quercetin. In addition, control samples, sulfation
reaction mixtures without cytosol pig liver, were also prepared. After enzymatic
synthesis, sulfated quercetin and (-)-epicatechin were analysed by LC-MS using the
total ion current (TIC) and selected-ion monitoring (SIM) mode (at specific m/z- =
381 for quercetin sulfate and at m/z- = 369 for (-)-epicatechin sulfate). The
chromatogram of quercetin sulfate and (-)-epicatechin sulfate are shown in Figure
4.7 and Figure 4.8, respectively. In Figure 4.7A, quercetin and quercetin sulfate
were found in (a) no enzyme and quercetin sulfation sample when detecting with
TIC mode. However, in SIM mode (m/z- = 381) in Figure 4.7B, only quercetin
sulfate was detected (b). In Figure 4.8, two forms of (-)-epicatechin were generated
and detected in both TIC (a) and SIM (b) mode. Again, no (-)-epicatechin was found
in SIM mode (m/z- = 369). Next, the % yields of these products were calculated
according to the equation in section 2.4.4.
There were 82% yield for sulfated quercetin and 96% yield for sulfated
epicatechin. Subsequently, some of these sulfated samples were dried and added to
ABSS buffer, pH 5 with or without 20 U of sulfatase (Abalone entrails type VIII)
and varied the incubation time (for 1, 2, 3 and 4 hr). The sufatase hydrolysis result is
presented in Figure 4.9.
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Figure 4.8: Chromatogram of quercetin and quercetin sulfate in TIC mode (A) and
specific m/z- at 381 (B). (a) No cytosol pig liver added to the sulfation reaction
(control) (b) sulfated quercetin synthesised from sulfation reaction.
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Figure 4.9: Chromatogram of (-)-epicatechin and (-)-epicatehin sulfate in TIC mode
(A) and specific m/z- at 369 (B). (a) No cytosol pig liver added to the sulfation
reaction (control) (b) sulfated (-)-epicatechin synthesised from sulfation reaction.
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Figure 4.10: Peak area of sulfated quercetin (A.) and sulfated (-)-epicatechin (B.)
after hydrolyse without or with 20 U of sulfatase (Abalone entrails type VIII) at
different incubation times (1, 2, 3 and 4 hr)
The result in Figure 4.9 shows that there are no differences between the
amount of sulfated forms of quercetin and (-)-epicatechin without or with sulfatase.
It seems sulfatase does not hydrolyse, sulfated quercetin and (-)-epicatechin, and so
these substrates remain in the reaction.
Finally, a model substrate, p-nitrocatechol sulfate (PNCS) was used to test
sulfatase activity. 0.001 µmol of p-nitrocatechol sulfate were added to milliQ water,
ABSS buffer and baseline urine, respectively. Then, this substrate was hydrolysed
with or without 20 U of sulfatase (Abalone entrails type VIII) at 37C for 1 hr and
processed by the same procedure as above. One unit of this enzyme will hydrolyse
1.0 µmol of p-nitrocatechol sulfate per hr at pH 5.0 at 37C. Thus, there was enough
sulfatase to hydrolyse p-nitrocatechol sulfate in this reaction. In general, p-
nitrocatechol sulfate was hydrolysed to p–nitrocatechol and sulfate after treatment
with sulfatase (Figure 4.10). In Figure 4.10A and 4.10D, (a) is a substrate, p-
nitrocatechol sulfate, added to milliQ water and (b) is a product, p-nitrocatechol,
added to milliQ water. These two samples act as positive controls, eluting at 9.7 min
for p-nitrocatechol sulfate and 10.7 min for p–nitrocatechol. In Figure 4.10B and
4.10E, p-nitrocatechol sulfate was dissolved in ABSS buffer and hydrolysed to p-
nitrocatechol after treatment with sulfatase (d). Thus, a high amount of product was
observed. However, there are some substrates still left in the reaction. Without
sulfatase treatment (c), a tiny peak of p-nitrocatechol also was observed. It is
A. B.
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possible due to the degradation of p-nitrocatechol sulfate during sample preparation.
In baseline urine (Figure 4.10C and 4.10F), sulfatase can hydrolyse p-nitrocatechol
sulfate to p-nitrocatechol but not completely (f). A little peak of product was
observed and substrate still found in the reaction. In addition, unidentified peaks
were also observed in this chromatogram. This peak may be a product of other
biological compounds, still remaining in urine and acting as a sulfatase inhibitor.
Thus, the evidence from this study strongly indicates that some compounds in urine
inhibit sulfatase activity.
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Figure 4.11: Sulfatase reaction. p-Nitrocatechol sulfate was hydrolysed to p-nitrocatechol
and sulfate by sulfatase (above). Chromatogram of model substrate (PNCS) and product
(PNC) of sulfatase (A), (D) added in milliQ water (B), (E) added in ABSS buffer and (C),
(F) added in baseline without and with sulfatase treatment. Chromatogram A, B and C are
1X magnification (in the left panel) and D, E and F are 10X magnification (in the right
panel).
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4.5 Discussion
The main aim of this chapter was to study the correlation between COMT
activity and the metabolism of two dietary flavonoids, quercetin or (-)-epicatechin.
The preliminary study of COMT activity was first tested in vitro prior to performing
a pilot study in vivo.
4.5.1 COMT activity in vitro
The main finding in this section is that (-)-epicatechin was O-methylated by
COMT from pig liver into two forms; 3-O-methylated-(-)-epicatechin and 4-O-
methylated-(-)-epicatechin with a conversion rate 9.1 pmol/min and 1.3 pmol/min,
respectively. Thus, this data showed COMT preferred to add a methyl group onto
the 3 than 4 position. These data agree with the previous result studied by Zhu et al,
2000. They found that the major monomethylated metabolite of (-)-epicatechin is the
3-O-methyl isomer whereas the minor metabolite is 4-O-methyl isomer. COMT
activities in this present study were 827 pmol/mg protein/min for 3methylated
epicatechin and 122 pmol/mg protein/min for 4methylated epicatechin. The rate for
the O-methylation of epicatechin by pig liver COMT is different to the reported for
O-methylation of tea polyphenol by human placental cytosolic COMT (150-500
pmol/mg of protein/min) (Zhu et al, 2000). This is probably because other factors
such as different substrates, incubation conditions and COMT enzyme source
influence enzyme activity (Pihlavisto and Reenila, 2002).
For COMT with quercetin as a substrate, the COMT activity was 126
pmol/mg protein/min. According to Zhu et al (1994), who also studied the O-
methylation of quercetin, fisetin, catechol estrogen and catecholamines by either pig
liver or hamster kidney, quercetin was rapidly O-methylated, and the O-methylation
rate was higher than catechol estrogen and catecholamine in both tissues. COMT
activity was 14,870 pmol/mg protein/min for pig liver and 200 pmol/mg protein/min
for hamster kidney. The COMT activity in this study was lower than the previous
studied of Zhu et al. more 118 times. The possible explanation is that the sources of
both COMT studies were different. This study used a crude COMT extracted from
pig liver whereas the study of Zhu et al. used commercial COMT which is more
purified. Additionally, Zhu et al (1994) also showed that the main methylated
product of COMT assay using quercetin as a substrate was 3-O-methylated
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quercetin. They found about 97% of 3-O-methylated quercetin recover in urine of
hamster. Thus, these data is in good agreement with our study. The reason for
favouring 3-O-methylation over 4-O-methylation is that 4-O-hydroxyl group
approaches the adenosyl-L-methionine and unfavorable position with the
hydrophobic protein residues of the catalytic site (Mannisto et al, 1999).
In this study, the conversion rate and enzyme activity of (-)-epicactechin
were higher than quercetin. (-)-Epicatechin is probably a better substrate for O-
methylation by COMT from pig liver extracted in this study than quercetin. Thus the
result from this section showed that an extract of pig liver displayed a COMT
enzyme activity towards (-)-epicatechin and quercetin, producing their methylated
products; 3-O-methylated (-)-epicatechin and 4-O-methylated (-)-epicatechin, and
3-O-methylated quercetin in vitro. Then, COMT from pig liver probably have the
same action of COMT in human liver. Thus, COMT activity in human body needs to
be analysed.
4.5.2 COMT activity in vivo
In human, COMT activity was estimated by determining quercetin, (-)-
epicatechin and its methylated metabolites in urine samples after β-glucuronidase 
and sulfatase enzyme hydrolysis followed by calculating the ratio of total urinary
methylated quercetin or (-)-epicatechin to corresponding aglycone in urine after
single consumption of onion soup or dark chocolate and co-consumption both. In
this study, quercetin and its methylated forms, 3-O-methylated and 4-O-methylated
quercetin, were detected in urine after enzyme hydrolysis in both single and co-
consumption studies. The percentage of total quercetin excreted in urine in this
study (0.95%) was still in the range when compared to Manach et al. (2005), ranging
from 0.31%-6.4%. Compare to Mullen et al. (2006), they provided 270 g fried red
onion (containing 275 μmoles of quercetin) to volunteers, resulting in 12.9 μmole of 
total quercetin excreted in urine or 4.7% of intake but this study provided red onion
soup, containing 109 µmol of quercetin in 130 ml, was to volunteers. The amount of
intake in this study was lower that Mullen’s study approximately 2.5 times. Thus, it
is reasonable that the total quercetin excretion in this study was lower than Mullen’s
study. In addition, the total % urinary excretion of 3-O-methylated and 4-O-
methylated quercetin after onion soup intake was 0.25%, while, Mullen et al (2006)
revealed that there was 0.91% urinary excretion of isorhamnetin-3-glucuronide and
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isorhamnetin-4-glucuronide. Thus, providing a higher dose to volunteers seems
produce a higher % in urine.
For urinary (-)-epicatechin, only (-)-epicatechin was detected in urine and
not 3-O-methylated and 4-O-methylated (-)-epicatechin. The possible reasons why
the percentages of quercetin, (-)-epicatechin and its methylated urinary metabolites
in this study were lower than other publications may due to; the low dose of food
samples were provided to volunteers, the low amount of deconjugated enzyme using
in the hydrolysis reaction or these flavonoids were poor substrates for sulfatase
(Saha et al, 2012), the matrix effect from urine sample, and these flavonoids maybe
less excreted into urine but still retain in the body and derive greater biological
effects (Inoue-Choi M, 2010). There were possible solutions to solve these
problems. In case the low dose of food sample, the larger amount of urine sample
probably need to use for urine analysis. In the case of the low amount of
deconjugated enzyme in the hydrolysis reaction, the unit of enzyme needs to be
varied or increased. In addition, other urine analysis method such as non-enzymatic
hydrolysis can be used. However, this non-enzymatic hydrolysis method is suitable
for analysing all conjugated metabolites excreted in urine. In the case of matrix
effect in urine, sample preparation techniques such solid phase extraction or protein
precipitation probably need pior inject the sample to LC-MS. In addition,
chromatographic or mass spectrometric condition needs to be optimized to reduce
the matrix effect. In this study, the standard curves were performed in baseline urine
and extracted as the same condition of 24 hr urine sample so this procedure also
useful for evaluating the matrix effect urine sample.
In this study, some factors that may affect enzyme hydrolysis condition or
stability of analysed compounds were tested and a new deconjugation method was
used to analyse urine samples. Only (-)-epicatechin was detected in volunteers with
a low percentage, ranging from 1.0-2.3% urinary excretion. As mentioned
previously, though the unit or amount of enzyme in deconjugation reaction was
increased but it was not alter or increase the % urinary excretion of (-)-epicatechin.
In addition, β-glucuronidase and sulfate seems hydrolysed (-)-epicatechin 
metabolites in urine but incomplete. This result is in agreement with previously
result reported by Saha et al 2012. Although, they used 20U of sulfatase and 200U
of β-glucuronidase from variety source of enzyme and also varied the incubation 
time. They found that approximately 90% of various form of (-)-epicatechin
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glucuronide was hydrolysed. In addition, no commercial sulfatases were effective to
hydrolysed (-)-epicatechin sulfates or methyl-(-)-epicatechin-sulfates in urine. Thus,
something in urine may possibly inhibit enzyme activity. This assumption was
supported by Taylor, 2005. They suggested that the presence of interfering
compounds and also the type of conjugated forms in urine have influence on the
ability of enzymatic hydrolysis. Then, the activity of enzyme needs to investigate in
the next step.
4.5.3 The limitation of sulfatase activity
In this study, synthetic quercetin sulfate and (-)-epicatechin sulfates were
used to test a sulfatase activity. However, sulfatase seems not hydrolyse these
substrates adding in the ABSS buffer into their products because there were
indifferent between the peak area of substrates hydrolysed without and with
sulfatase. In addition, different amount of synthetic (-)-epicatechin sulfates also was
spiked into baseline urine and extracted the same way as 24 hr urine sample. Again,
there were not different between the peak area of substrates hydrolysed without and
with sulfatase (data not shown). Saha et al, 2012 also used authentic (-)-epicatechin,
3-methylated-(-)-epicatechin and 4-methylated-(-)-epicatechin spike into urine and
test sulfatase activity. They claimed that none of sulfates test was effectively
hydrolyse but no data was shown. Moreover than this, the present study used p-
nitrocatechol sulfate (PNCS) and p–nitrocatechol (PNC), a model substrate and
product of sulfatase to investigate its activity. The result in Figure 4.10 was
originally confirmed that some compounds in urine inhibit the sulfatase activity for
flavonoids determination in urine. This observation agrees with the results obtained
by Graef, (1975). They found that incubation of urine with β-glucuronidase and 
arylsuphatase from Helix pomatia results in the incomplete hydrolysis of urinary
steroid conjugates due to inhibitors of these enzymes, presenting in urine. They also
revealed that these inhibitors can be separated from the steroid conjugates by
chromatography of the urine onto a specific column prior to perform enzymatic
hydrolysis using optimal condition.
Sulfatases play an important role in regulating the sulfation states in
biological systems (Hanson, 2004). Sulfatase or arylsulfatase enzymes (aryl-sulfate
sulphohydrolase, EC 3.1.6.1) catalyse hydrolysis of phenolic sulfate esters to a
phenolic compound and sulfate ion. There were two major types of arylsulfatase
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enzymes occur in man; Type I enzyme (arylsulfatase C) and Type II enzymes
(arylsulfatase A and B). For type II isoenzymes, it has been reported that their
sensitivity was inhibited by various anionic species, including sulfite, sulfate, and
phosphate (Bostick, 1978). Chruszcz, 2003 also stated that arylsulfatase A is
inhibited by phosphate by forming a covalent bond with the active site 3-oxoalanine
of this enzyme. For arylsulfatase B, Rao, (1984) purified this enzyme from rabbit
liver and found that it is also competitively inhibited at modest concentrations by a
variety of phosphate esters derived from amino acids, amines and simple sugars.
In the case of urine, it consists of inorganic salts (such as Na+, K+, PO42- and
SO42-), urea, creatinine and uric acid. Although urine is a biological fluid that more
clean compare to plasma but the inorganic ion, phosphate and sulfate, in these
samples have been reported that are potential substances to inhibit the ability of
enzyme hydrolysis of steroid sulfate conjugates of (Shibasaki, 2001). However,
Shibasaki (2001) suggested that removal this ion from the urine before enzyme
hydrolysis may increase the rate of hydrolysis but some steroids also lost during the
removal step. One more important factor may cause the sulfatase activity need to be
considered. It is the type of buffers, 0.2 M Sodium phosphate buffer, pH 7 and
ABSS, pH 5, using in enzyme hydrolysis condition in this study. These two buffers
contain NaH2PO4 and Na2HPO4. Although there is equilibrium between the acid and
its conjugate base in the buffer solution but some factors probably influent the
stability of this equilibrium, resulting in an access ion of PO42- and possibly
inhibiting sulfatase activity.
4.6 Conclusion
An extract of pig liver displayed COMT activity towards (-)-epicatechin and
quercetin, producing their methylated products; 3-O-methylated-(-)-epicatechin, 4-
O-methylated-(-)-epicatechin and 3-O-methylated-quercetin. In addition, the
conversion rate and enzyme activity of (-)-epicatechin in this study were higher than
quercetin.
The low percentage urinary excretion of quercetin, (-)-epicatechin and their
methylated forms in urine samples is underestimated due to limitations in sulfatase
activity. The result from sulfatase activity showed that interfering substances in
urine probably inhibit its activity.
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To avoid this underestimation and lost the important information of natural
metabolites circulating in human body, deconjugation of quercetin and (-)-
epicatechin metabolites in urine sample by co-treatment with β-glucuronidase and 
sulfatase cannot be used but all conjugated metabolites of quercetin and (-)-
epicatechin found in the urine must be analysed directly. However, to identify and
quantify these metabolites, all conjugated quercetin and (-)-epicatechin found in
urine must firstly be synthesised.
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Chapter 5 Enzymatic Synthesis of the Main Quercetin and (-)-
Epicatechin Conjugates Found in Urine
5.1 Abstract
On the basis of the results in Chapter 4, sulfatase does not sufficiently
hydrolyse urinary metabolites of quercetin and (-)-epicatechin to the aglycone and
methylated forms. Consequently, this will lead to lower amounts of compounds in
urine, resulting in underestimation. Thus, enzyme treatment was not used in the next
study but instead all conjugated metabolites of quercetin and (-)-epicatechin found
in the urine were analysed. To identify and quantify all metabolites excreted in urine
samples, standard compounds must first be synthesised. Thus, the main aim of this
chapter was to synthesise major conjugates of quercetin and (-)-epicatechin found in
urine and used as a reference for urine analysis in Chapter 6. For synthesis of
quercetin conjugates, quercetin was used as a substrate to produce quercetin
glucuronides and quercetin sulfates by uridine diphosphate glucuronosyl transferase
(UGT) from microsomal pig liver and sulfotransferase (SULT) from cytosol pig
liver. In the case of 3-O-methyl-quercetin-glucuronides, they were produced by
using a commercial substrate, 3-O-methyl-quercetin (or isorhamnetin). In the
glucuronidation reaction of quercetin-glucuronides and 3-O-methyl-quercetin-
glucuronides, quercetin-di-O-glucuronides and 3-O-methyl-quercetin-di-
glucuronides were also produced and detected, respectively. For synthesis of (-)-
epicatechin conjugates, (-)-epicatechin was used as a substrate to produce (-)-
epicatechin-glucuronides, (-)-epicatechin-sulfates and methylated-(-)-epicatechin,
respectively. The same source of enzymes for quercetin glucuronidation and
sulfation were used for (-)-epicatechin glucuronidation and sulfation. For
methylated-(-)-epicatechin-glucuronides and methylated-(-)-epicatechin sulfates
synthesis, they were produced by (-)-epicatechin-glucuronides and (-)-epicatechin
sulfates which were the products of (-)-epicatechin glucuronidation and (-)-
epicatechin sulfation reaction, using COMT from cytosol pig liver. In summary, five
quercetin conjugates and five (-)-epicatechin conjugates, the major metabolites
found in urine, were successfully synthesised using the enzymatic method in this
present study with a sufficient percentage yield of synthesised conjugates. Based on
the retention time and the specific mass to ion ratio of each conjugate (e.g.
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98.9±0.2% for methylated-(-)-epicatechin-sulfates, 79.3±0.7% for quercetin
glucuronides, 62.1±0.4 for (-)-epicatechin glucuronides), it was reasonable to
conclude that all enzymatic syntheses of quercetin and (-)-epicatechin were correct
and so able to be used as standard compounds for urine analysis in Chapter 6.
5.2 Introduction
 To estimate the bioavailability of polyphenols in a biological system, β-
glucuronidase and sulfatase enzymes are generally used to release the parent
aglycone. Then, the aglycone is quantified by HPLC or LC-MS. However, on the
basis of the results in Chapter 4, sulfatase does not hydrolyse sufficiently and this
will lead to lower amounts of compounds, resulting in underestimation.
Additionally, glucuronidase and sulfatase cause loss of vital information on natural
conjugates. Numerous supportive evidences also showed that the polyphenol
metabolites in the circulation system (concentration from nM to µM) have other
biological effects compared to their parent compounds (Crozier et al. 2009). Thus,
enzyme treatment using glucuronidase or sulfatase was not used to hydrolyse
conjugated forms of quercetin or epicatechin to aglycone in urine samples in this
study but instead all conjugated metabolites found in the urine were analysed. To
identify and quantify all metabolites excreted in urine samples, standard compounds
need to be used as a reference. Due to a lack of commercially available quercetin
and (-)-epicatechin conjugates for identification and quantification, synthetic
sulfates, glucuronides and methyl derivatives of quercetin or epicatechin need to be
synthesised as standards to identify and quantify quercetin or epicatechin
metabolites present in urine samples after the consumption of onion soup and 70%
cocoa dark chocolate.
As mentioned in Chapter 1, two research groups have studied previously the
quercetin and (-)-epicatechin metabolites in the circulating system. First, Mullen et
al. (2006) analysed plasma and urine samples from six human volunteers after the
consumption of 270 g of fried onions (containing 275 µmol quercetin 3,4di-O-
glucoside and quercetin 4-O-glucoside). Quercetin metabolites were detected in
both plasma and urine collected over a 24 hr period by using HPLC with a diode
array and a tandem mass spectrometric detector. However, the metabolic profile of
quercetin excreted in urine was different to the profile found in the plasma.
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Quercetin-3-O-glucuronide, two quercetin-glucuronide-sulfate, methyl-quercetin-
diglucuronide were found in urine but were absent or present only in small amounts
in the blood. Other main metabolites such as quercetin-diglucuronide, isorhamnetin-
3-O-glucuronide, and quercetin-3-O-glucuronide were also found in the urine. In
2012, Actis-Goretta et al. analysed (-)-epicatechin metabolites in plasma and urine
from 0 to 24 hr after the ingestion of 100 g dark chocolate (containing 79 mg or 272
µmol of (-)-epicatechin) in five volunteers. (-)-Epicatechin metabolites were
detected in both the plasma and the urine (24 hr collection) using LC–MS/MS–
MRM. (-)-Epicatechin metabolites, including glucuronides, sulfates, methyl sulfates,
and methyl glucuronides, excreted in urine were detected and were similar to those
found in the plasma. The total urinary excretion of (-)-epicatechin was 20±2% of the
intake. The metabolic profiles of quercetin and (-)-epicatechin excreted in urine,
arranging from the maximum to minimum amount, from Mullen et al.’s study (2006)
and Actis-Goretta et al.’s study (2012) study are shown in Table 5.1 and Table 5.2,
respectively.
Table 5.1: The amount of quercetin metabolites (µmol) excreted in urine from 0 to
24 hr after the ingestion of of 270 g fried onion by six volunteers.
(Adapted from Mullen et al., 2006)
Quercetin metabolites Total 0-24 hr (µmol)
Mean SE
Quercetin-diglucuronide 2.22 0.42
Quercetin-3'-O-glucuronide 1.85 0.19
Isorhamnetin-3-O-glucuronide 1.79 0.24
Quercetin-glucuronide-sulfate 1.38 0.16
Quercetin-glucuronide-sulfate 1.23 0.19
Methylquercetin-diglucuronide 1.00 0.16
Quercetin-3-O-glucuronide 0.91 0.15
Quercetin-glucoside-sulfate 0.82 0.16
Isorhamnetin-4'-O-glucuronide 0.70 0.11
Methylquercetin-diglucuronide 0.43 0.10
Quercetin-glucoside-sulfate 0.39 0.06
Quercetin-glucuronide-glucoside 0.16 0.02
Total 12.89 1.04
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Table 5.2: The amount of (-)-epicatechin metabolites (µmol) excreted in urine from
0 to 24 hr after the ingestion of 100 g dark chocolate by five volunteers (Adapted
from Actis-Goretta et al., 2012)
(-)-Epicatechin metabolites Total 0-24 hr (mol)
Mean SD
3'-O-methyl-(-)-epicatechin-5-sulfate 14.10 3.88
(-)-Epicatechin-3'--D-glucuronide 13.30 3.85
(-)-Epicatechin-3'-sulfate 8.53 2.71
(-)-Epicatechin-7--D-glucuronide 7.27 1.35
3'-O-methyl-(-)-epicatechin-7-sulfate 2.33 0.68
3'-O-methyl-(-)-epicatechin-4'-sulfate 1.67 0.62
4'-O-methyl-(-)-epicatechin-5-sulfate 1.37 0.34
3'-O-methyl-(-)-epicatechin--D-glucuronide 1.20 0.29
(-)-Epicatechin-5'-sulfate 1.15 0.20
3'-O-methyl-(-)-epicatechin--D-glucuronide 1.08 0.43
(-)-Epicatechin-4'--D-glucuronide 1.03 0.06
4'-O-methyl-(-)-epicatechin-7-sulfate 0.73 0.23
3'-O-methyl-(-)-epicatechin--D-glucuronide 0.73 0.10
(-)-Epicatechin-4'-sulfate 0.56 0.13
4'-O-methyl-(-)-epicatechin--D-glucuronide 0.56 0.08
Total 55.70 4.60
Based on the information of metabolic profiles of quercetin and (-)-
epicatechin from the two publications mentioned above, only the main conjugated
forms of these compounds were then synthesised in this study (Table 5.3).
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Table 5.3: The target quercetin and (-)-epicatechin metabolites to be synthesised in
this chapter.
Metabolite [ m/z-]
Quercetin metabolites
Quercetin-diglucuronide 653
Quercetin-glucuronide 477
Isorhamnetin-glucuronide 491
Methylquercetin-diglucuronide 667
Quercetin sulfate 381
(-)-Epicatechin metabolites
Methyl-(-)-epicatechin-sulfate 383
(-)-Epicatechin-glucuronide 465
(-)-Epicatechin-sulfate 369
Methyl-(-)-epicatechin-glucuronide 479
Several methods have been used to synthesise flavonoid conjugates such as
extracting from plants, isolating from blood or urine, synthesising using
microorganisms, and chemical or enzymatic syntheses. Numerous studies have
reported synthesis of quercetin or (-)-epicatechin conjugated metabolites using
chemical methods but other studies have been conducted using enzymatic synthesis
(Table 5.4). Donovan et al. (1999) synthesised 3 and 4 methylated catechin and
epicatechin by chemical synthesis followed by separating the synthesised
compounds using several methods. They found that HPLC with fluorescence
detection and GC with mass spectrometric detection are sensitive and selective for
analysing a small amount of these compounds in biological samples. Aside from
this, Day et al. (2001) synthesized quercetin 3-O-sulfate specifically using chemical
reactions between quercetin and sulfamic acid to determine the exact nature of the
plasma metabolites. Quercetin 3′-O-sulfate was synthesised again by Jones et al.
(2005) but using a different chemical, sulfur trioxide-N-triethylamine instead of
sulphamic acid. In 2006, Needs and Kroon also synthesised the human plasma
metabolites of quercetin using 4,7-di-O-benzylquercetin as a precursor and claimed
that this method was more convenient than the previous enzymatic method
(Boersma et al., 2002; O'Leary et al., 2003). In 2012, quercetin-3-O-sulfate,
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quercetin-4-O-sulfate and (-)-epicatechin-4-O-sulfate were scalable (hemi)
synthesised and characterised by Duenas et al. (2012). Four biological (-)-
epicatechin conjugates; 3′-O-glucuronide, 4′-O-glucuronide, 3′-O-sulfonate and 3′-
O-methyl-4′-O-sulfonate, relating to the B-ring of (-)-epicatechin were chemically
synthesised by Romanov-Michailidis et al. (2012) and then used as analytical-grade
standards for (-)-epicatechin analysis in a human study. A year later,
monoglucuronide and monosulfates of (-)-epicatechin, 3-O-methyl and 4-O-
methyl-(-)-epicatechin were also chemically synthesised by Zhang et al., (2013) but
using an orthogonally protected (-)-epicatechin intermediate which is a crucial
compound in the synthetic step. At present, most studies tend to focus on the
chemical synthetic method probably due to the potential for producing a higher yield
of conjugated compounds. For the enzymatic synthesis method, the first report was
produced by Shali et al. , 1991. They synthesised quercetin and catechin sulfate
using sulfotransferases from rat liver. In addition, mixed quercetin glucuronides
(quercetin-di-glucuronides, quercetin-3-O-glucuronide, quercetin-7-O-glucuronide,
quercetin-4-O-glucuronide and quercetin-3-O-glucuronide) were produced
enzymatically from pig liver by O'Leary et al. (2001). Then, Boersma et al. (2002)
investigated the regioselectivity of UGT by incubating luteolin and quercetin with
different sources of microsomal samples (liver or intestine from a rat or a human),
resulting in different forms of luteolin and quercetin glucuronides. In 2008, Duenas
et al., using a modified method described by Plumb et al. (2003), produced quercetin
and isorhamnetin glucuronides enzymatically using microsomal enzyme from pig
liver and also isolated quercetin-3-O-glucuronide (Q3GA) from green beans. Four
peaks of quercetin glucuronides (quercetin-di-glucuronides, quercetin-3-O-
glucuronide, quercetin-4-O-glucuronide and quercetin-3-O-glucuronide) were
identified after a 2 hr incubation period using microsomal pig liver. In 2012, Blount
et al. investigated the potential of recombinant human glucuronosyl transferases of
the UGT1A and UGT2B families to glucuronidate epicatechin or 3-O-methyl
epicatechin in vitro and found that UGT1A9 was the most effective to produce
epicatechin 3'-O-glucuronide. 3'-O-methyl-epicatechin 5-O-glucuronide was also
produced when incubating UGT1A9 with 3'-O-methyl-epicatechin. Although the
enzymes and cofactor concentrations in the enzymatic synthesis reaction were
probably a limiting factor for generating metabolites using the enzymatic method,
however, using animal tissues as sources of enzymes produced a structure of
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metabolites that were closer to the biological system than synthesis using chemical
reactions.
The main aim of this chapter, therefore, was to synthesise conjugated
metabolites of quercetin and epicatechin, specifically quercetin sulfate, quercetin
glucuronide, quercetin-di-glucuronide, 3 methyl quercetin glucuronide, methyl
quercetin di-glucuronide, epicatechin glucuronide, methyl epicatechin glucuronide,
methyl epicatechin, epicatechin sulfate and methyl epicatechin sulfate by enzymatic
synthesis. To achieve the aim of this study, glucuronides, sulfates, sulfates and
glucuronides were conjugated with methyls of quercetin or epicatechin which were
synthesised using enzyme from pig liver. Then, dried conjugated compounds were
re-dissolved in milliQ water, baseline and 24 hr urine before analysing with UPLC-
MS. The percentage yield of each enzymatic synthesised compound was finally
calculated. The relative relation time and m/z- of all synthesised compounds will be
used as a reference for quantification of quercetin and epicatechin metabolites
present in urine samples in Chapter 6.
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Table 5.4: Chemical and enzymatic synthesis of conjugated quercetin and (-)-
epicatechin found in several publications
Method Conjugated compounds Publications
Chemical
synthesis
3 and 4-O- methyl catechin
3 and 4-O- methyl-(-)-epicatechin
Donovan et al. (1999)
Quercetin 3-O-sulfate Day et al. (2001)
Quercetin 3′-O-sulfate Jones et al. (2005)
Quercetin 3-O-sulfate
Isorhamnetin 3-glucuronide
Quercetin 3-O-glucuronide
Quercetin 3-O-glucuronide
Needs and Kroon
(2006)
Quercetin-3-O-sulfate
Quercetin-4-O-sulfate
Epicatechin-4-O-sulfate
Duenas et al. (2012)
3-O-glucuronide-(-)-epicatechin
4-O-glucuronide-(-)-epicatechin
3-O-sulfonate-(-)-epicatechin
3-O-methyl-4-O-sulfonate-(-)-
epicatechin
Romanov-Michailidis
et al. (2012)
Glucuronide- (-)-epicatechin
Sulfate-(-)-epicatechin
3and 4-O-methyl-(-)-epicatechin
Zhang et al. (2013)
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Table 5.4 continued: Chemical and enzymatic synthesis of conjugated quercetin
and (-)-epicatechin found in several publications.
Enzymatic
synthesis
Quercetin sulfate
Catechin sulfate
Shali et al.
(1991)
Quercetin-di-O-glucuronide
Quercetin-3-O-glucuronide
Quercetin-7-O-glucuronide
Quercetin-3-O-glucuronideQuercetin-4-O-
glucuronide
O'Leary et al.
(2001)
Quercetin-3-O-glucuronide
Quercetin-7-O-glucuronide
Quercetin-3-O-glucuronideQuercetin-4-O-
glucuronide
Boersma et al.
(2002)
Quercetin di-O-glucuronide
Quercetin-3-O-glucuronide
Quercetin-4-O-glucuronide
Quercetin-3-O-glucuronide
Duenas et al.
(2008)
(-)-Epicatechin 3-O-glucuronide
3-O-methyl-(-)-epicatechin 5-O-
glucuronide
Blount et al.
(2012)
5.3 Materials and Methods
See section 2.4 for enzymatic enzymatic synthesis of the main quercetin and
(-)-epicatechin conjugates found in urine.
5.4 Results
To identify and quantify all metabolites excreted in urine samples, standard
conjugated quercetins or (-)-epicatechins need to be synthesised and used as a
reference.
5.4.1 Quercetin conjugates synthesis
Glucuronidation of flavonoids often occurs at the -OH group attacted to the
aromatic ring. In the case of quercetin, there are five hydroxyl groups in its structure
at position 3, 5, 7, 3 and 4 (Figure 5.1: A.), and then glucoronic acid, sulfate or
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methyl can be added to these positions, resulting in five possible different forms of
quercetin conjugates.
Figure 5.1: A. Five possible positions for uridine diphosphate glucuronosyl
transferase (UGT), sulfotransferase (SULT) and two possible positions for catechol-
O-methyl transferase (COMT) to conjugate glucuronic acid, sulfate and methyl
group to the structure of quercetin. B. Summary of the synthesised step of each
conjugated quercetin.
To synthesise quercetin-glucuronides, quercetin was used as a substrate and
converted to quercetin-glucuronides by UGT from microsomal pig liver to work
alongside alamethicin and UDPGA to act as a UGT activator and glucuronic donor,
respectively. Saccharolactone, a β-glucuronidase inhibitor, was also added into the 
reaction mixture and then the glucuronidated products were still maintained. The
glucuronidation reaction of quercetin was prepared and performed under the
conditions described in section 2.4.1. In this reaction, glucuronic acid can be further
conjugated by UGT using quercetin-glucuronide as a substrate. So, quercetin-di-O-
glucuronide also can be produced and was detected in this sample.
For quercetin-sulfates, quercetin also was used as a substrate but SULT from
cytosol pig liver played an important role by adding a sulfate group to quercetin
instead of UGT. SULT will transform the sulfuryl group from the universal sulfuryl
group donor, adenosine-3-phosphate-5-phosphosulfate (PAPS) to the hydroxyl
group of quercetin, resulting in quercetin sulfates. Sulfation of quercetin was
described in section 2.4.2 Quercetin glucuronide sulfate, which is another main
metabolite excreted in urine (Table 5.1), was not able to be synthesised from already
UGT UGT
Q  Q-G  Q-di-G
SULT
Q  Q-S
UGT UGT
3MeQ  3MeQ-G  3’MeQ-di-G
A. B.
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synthesised quercetin glucuronide and SULT. This was possibly due to conjugation
of quercetin glucuronide compound with the sulfate group; one more step may cause
instability of the quercetin glucuronide at some point during the sulfation synthesis
process.
For 3-O-methylated quercetin glucuronide, a commercial compound, 3-O-
methylated-quercetin (isorhamnetin) was used as a substrate. Again, UGT will add
glucoronic acid to the substrate to produce 3-O- methylated-quercetin-glucuronide
and also further produce 3-O-methylated-quercetin-diglucuronide in the same
reaction. The summary of synthesised steps of each conjugated quercetin is shown
in Figure 5.1B.
The products of each enzymatic synthesis were subsequently dried under
centrifugal evaporation and reconstituted with 100 μl of MilliQ water, baseline urine 
and 24 hr urine and further analysed on a UPLC-MS based on the relative retention
time and the ratio of mass to ion. In addition, control samples, glucuronidation or
sulfation of quercetin without substrate or enzyme from pig liver, was also prepared
by reconstituting in MilliQ water and analysing on UPLC-MS at the same time. The
scheme of quercetin glucuronidation and sulfation are shown in Figures 5.2 and 5.4
respectively. Figure 5.2 shows a chromatogram of quercetin glucuronide after
enzymatic synthesis in TIC mode (A) and specific m/z- at 477 (B). For TIC or the
total ion scan mode (Figure 5.2A), ethyl gallate (EG, Retention time = 14.1) and
taxifolin (T, Retention time = 18.7) were internal standards and added to every
sample. Ethyl gallate and taxifolin can be detected in all samples in this total ion
scan mode. However, as expected no peak of ethyl gallate and taxifolin were
detected in the ionization mode at m/z- at 477 which was specific for detecting
quercetin glucuronides. In Figures 5.2A and 5.2B, (a) and (b) are chromatograms of
control samples, glucuronidated quercetin without substrate and enzymes from pig
liver microsomes, respectively. Quercetin was not added to the reaction mixture (a),
thus no glucuronidated quercetin was detected in this sample. For (b), microsomal
pig liver suspension was absent and so quercetin as substrate was still found in this
sample. In Figure 5.2A (c), (d) and (e) some quercetin glucuronides were produced,
and after re-dissolving in MilliQ water, baseline or 24 hr urine, were observed in the
total ion scan mode. These data were confirmed in the specific ion mode in Figure
5.2B (c), (d), (e) and it was found that five different forms of quercetin glucuronides
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were produced and eluted at different retention times. These were 19.0 min for
quercetin glucuronide 1, 20.1 min for quercetin glucuronide 2, 21.1 for quercetin
glucuronide 3, 25.1 min for glucuronide 4 and 27.3 min for quercetin glucuronide 5.
To check whether there were any other matrixes in the baseline and 24 hr urine
affecting the properties of the synthesized compounds, dried samples were re-
dissolved in baseline and 24 hr urine samples. The results showed that the peak
height and the peak area of quercetin glucuronides re-dissolved in baseline (d) and
24 hr urine (e) were not different to those dissolved in milliQ water (c). Thus, the
matrix of baseline urine did not affect the chromatographic properties of
enzymatically synthesized quercetin glucuronides. In addition, to investigate how
much quercetin glucuronide was found in 24 hr urine after a single consumption of
onion soup, synthesised quercetin glucuronides were spiked in 100 µl of the 24 hr
urine sample of some volunteers. The result from chromatogram in Figure 5.2B (e),
however, revealed that the peak height and the peak area of this sample seemed the
same as synthesized quercetin glucuronides dissolved in baseline urine (Figure 5.2B
(d)). Furthermore, 100 µl of non-spiked baseline and 24 hr urine sample after onion
soup intake also were analysed at the same time as spiked samples. However, no
peaks of any synthesized standards were detected in this non-spiked urine sample
(chromatogram not shown). It is possible, due to a low volume of 24 hr urine
samples being used in this experiment, which this resulted in a low amount of
quercetin metabolites in the urine sample and therefore undetectable.
In the quercetin glucuronidation reaction, quercetin-di-O-glucuronides were
also produced and detected at m/z- at 653. The major two products, quercetin di-
glucuronide 1 and quercetin di-glucuronide 2, were observed and separated at 15.7
min and 19.8 min, respectively (Figure 5.3; c, d and e).
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Figure 5.2: Chromatogram of quercetin-glucuronides after enzymatic synthesis in
TIC mode (A) and specific m/z- at 477 (B). (a) and (b) are control. (c), (d) and (e)
are quercetin-glucuronides, re-dissolved in water, baseline urine and 24 hr urine,
respectively.
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Figure 5.3: Chromatogram of quercetin-di-glucuronides after enzymatic synthesis
in specific m/z- at 653. (a) and (b) are control. (c), (d) and (e) are quercetin-di-
glucuronides, re-dissolved in water, baseline urine and 24 hr urine, respectively.
The same process was applied to other enzymatically conjugated quercetin
derivatives. For quercetin sulfates, only two sulfated quercetin derivatives were
produced and observed in the sulfation reaction. They were eluted at 27.5 min and
34 min, representing sulfated quercetin 1 and sulfated quercetin 2 (Figure 5.4B; c, d
and e). For 3-O-methyl quercetin glucuronide, a commercial substrate, 3-O-methyl-
quercetin (or isorhamnetin) was converted into three different 3-O-methyl quercetin
glucuronides. These were separated and eluted at 24.6, 25.7 and 28 min, respectively
(Figure 5.5B; c, d and e). In addition, some O-methylated-quercetin-di-O-
glucuronides were also produced and detected at m/z- at 667. They eluted at 17.7
min for O-methylated-quercetin-di-O-glucuronide 1 and 18.9 for O-methylated-
quercetin-di-O-glucuronide 2 (Figure 5.6; c, d and e).
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Figure 5.4: Chromatogram of quercetin-sulfates after enzymatic synthesis in TIC
mode (A) and specific m/z- at 381 (B). (a) and (b) are control. (c), (d) and (e) are
quercetin-sulfates, re-dissolved in water, baseline urine and 24 hr urine, respectively.
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Figure 5.5: Chromatogram of 3-methyl-quercetin-glucuronides after enzymatic
synthesis in TIC mode (A) and specific m/z- at 491 (B). (a) and (b) are control. (c),
(d) and (e) are 3-methyl-quercetin-glucuronides, re-dissolved in water, baseline
urine and 24 hr urine, respectively.
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Figure 5.6: Chromatogram of methyl-quercetin-di-glucuronides after enzymatic
synthesis in specific m/z- at 667. (a) and (b) are control. (c), (d) and (e) are methyl-
quercetin-di-glucuronides, re-dissolved in water, baseline urine and 24 hr urine,
respectively.
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The chromatogram of all enzymatic quercetin metabolites dissolved in
milliQ water and detected in specific m/z- of each conjugate are shown in Figure
5.7. This data accompanied by the retention time of each conjugate form of
quercetin in Table 5.5 confirmed that all synthetic conjugates of quercetin were
correct, glucuronided forms were separated first followed by sulfated and
methylated forms.
Figure 5.7: Chromatogram of all enzymatic quercetin metabolites dissolved in
milliQ water and detected in specific m/z- of each conjugate. (EG and T act as
internal standard). Glucuronidated forms were eluted first followed by sulfated and
methylated forms.
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Table 5.5: Retention time of each conjugated form of enzymatic synthesised
quercetin and internal standards (EG: Ethyl gallate and T: Taxifolin), detected at
specific [m/z-].
Compound [m/z-] Peak
No
Retention
time,
(min)
EG 197 1 14.1
Q-di-G 653 1 15.7
2 19.8
3'-O-Me-
di-G
667 1 17.7
2 18.9
T 303 1 18.7
Q-G 477 1 19.0
2 20.1
3 21.1
4 25.1
5 27.3
Q-S 381 1 27.5
2 34.0
3'-O-Me-G 491 1 24.6
2 25.7
3 28.0
Q 301 1 34.3
3'-O-MeQ 315 1 46.9
- 137 -
5.4.2 (-)-Epicatechin conjugate synthesis
In the case of (-)-epicatechin, there are again five hydroxyl groups in the
structure (Figure 5.8A) similar to quercetin so that five possible forms of
glucuronided, sulfated or methylated quercetin or (-)-epicatechin could theoretically
be generated.
Figure 5.8: A. Five possible positions for uridine diphosphate glucuronosyl
transferase (UGT), sulfotransferase (SULT) and two possible positions for catechol-
O-methyl transferase (COMT) to conjugate glucuronic acid, sulfate and methyl
group to the structure of (-)-epicatechin. B. Summary of synthesised step of each
conjugated (-)-epicatechin.
Glucuronidation and sulfation of (-)-epicatechin were prepared under the
same conditions as described for quercetin glucuronides and quercetin sulfates
which were in sections 2.4.1 and 2.4.2, respectively. In the glucuronidation reaction,
(-)-epicatechin was converted to (-)-epicatechin glucuronides by UGT enzymes in
microsomal pig liver while in the sulfation reaction, (-)-epicatechin was converted to
(-)-epicatechin sulfates by SULT from cytosol pig liver. After drying, (-)-epicatechin
glucuronides and (-)-epicatechin sulfates were then used as substrate for COMT in
methylation reactions catalysed by cytosol from pig liver. Methylated (-)-epicatechin
also was synthesised using the same procedure and used as control. The summary of
synthesised steps of each conjugated (-)-epicatechin is shown in Figure 5.8B.
Again, the products of all enzymatic synthesis conjugates were subsequently
dried under centrifugal evaporation and reconstituted with 100 μl of MilliQ water, 
UGT COMT
EC  EC-G  Me-EC-G
SULT COMT
EC  EC-S  Me-EC-S
COMT
EC  Me-EC
A. B.
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baseline urine or 24 hr urine and further analysed on a UPLC-MS based on the
relative retention time and the ratio of mass to ion. In addition, control samples,
glucuronidation or sulfation of quercetin without substrate or enzyme from pig liver,
were also prepared by reconstituting in MilliQ water and analysing by UPLC-MS.
Then, glucuronidated (-)-epicatechins were analysed by UPLC-MS using a
two detector mode; total ion count (TIC) and specific ionization mode (SIM) at m/z-
= 465 for epicatechin glucuronide detection. The chromatogram of (-)-epicatechin
glucuronides after enzymatic synthesis is displayed in Figure 5.9. For the total ion
mode (Figure 5.9A), ethyl gallate (EG, retention time = 14.5) and taxifolin (T,
retention time = 19.2) were internal standards and added to every sample. Ethyl
gallate and taxifolin was detected in all samples in this total ion scan mode but, as
expected, no peak of ethyl gallate and taxifolin in specific ionization mode at m/z- at
465 was observed since this was specific for detecting (-)-epicatechin glucuronides.
In Figure 5.9A and 5.9B, (a) and (b) are chromatograms of control samples,
glucuronidation (-)-epicatechin without (-)-epicatechin and UGT from microsomal
pig liver, respectively. Substrate was not added to the glucuronidation reaction (a)
then no glucuronidated (-)-epicatechins were produced and detected in both TIC and
specific mode. In addition, no enzyme added to the glucuronidation reaction of (-)-
epicatechin (b) thus no (-)-epicatechin glucuronides were produced.
Figure 5.9A, (c) and Figure 5.9B, (c) synthesized epicatechin glucuronides,
re-dissolved in milliQ water, and are shown using different detector modes; TIC and
specific m/z- at 465. The specific ionization mode confirms that (-)-epicatechin
glucuronides were produced in four different forms eluting at retention time 10.2
min for (-)-epicatechin glucuronide 1, 10.5 min for (-)-epicatechin glucuronide 2,
11.0 min for (-)-epicatechin glucuronide 3 and 12.7 min for (-)-epicatechin
glucuronide 4, respectively. Again, dried conjugated compounds were also dissolved
in baseline and 24 hr urine. Similar results as obtained for the quercetin
glucuronidation were observed. The peak height and the peak area of (-)-epicatechin
glucuronides re-dissolved in baseline (d) and 24 hr urine (e) were not different to
those dissolved in milliQ water (c). Therefore, the matrixes in baseline urine did not
affect enzymatically synthesized quercetin glucuronides. Moreover, the results from
the chromatogram in Figure 5.9B (e) showed that the peak height and peak area of
this sample was no different to the synthesized peak height and the peak area of (-)-
epicatechin glucuronides dissolved in baseline urine (Figure 5.9B (d)). In addition,
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100 µl of non-spiked baseline and 24 hr urine samples after a single consumption of
70% dark chocolate were also prepared and analysed as the same time as the spiked
baseline and 24 hr urine samples. However, no peaks of synthesized conjugates were
detected in the 24 hr urine sample. This is likely to be due to the same reason as
explained previously. A low volume of 24 hr urine samples was used in this
experiment, resulting in a small amount of (-)-epicatechin metabolites contained in
urine making it undetectable.
Next, synthesized (-)-epicatechin-glucuronides were used as a substrate for
synthesizing methyl-(-)-epicatechin-glucuronides using an enzyme preparation
described in section 2.3.1. In this case, S-adenosyl-L-methionine was used as a
methyl donor. Dried conjugated compounds were prepared and analysed in the same
way as mentioned previously. In Figure 5.10, the chromatogram (c), (d), (e)
indicates that the methyl group from S-adenosyl-L-methionine added to 4 forms of
synthesized (-)-epicatechin-glucuronides, resulted in four methyl-(-)-epicatechin-
glucuronide products, separating at different retention times (12.8 min, 13.9 min,
14.8 min and 15.7 min, respectively). In addition, methyl-(-)-epicatechin also
synthesized using the same reaction as the methyl-(-)-epicatechin-glucuronide
synthesis. From the chromatogram in Figure 5.11 (c), (d), (e), only one form of
methylated (-)-epicatechin was produced at a retention time of 17.4 min. Taxifolin
which has m/z- at 303, is the same as methylated epicatechin, was also detected.
(-)-Epicatechin-sulfate was synthesised using (-)-epicatechin as a substrate.
From the chromatogram in Figure 5.12 (c), (d), (e), three forms of (-)-epicatechin-
sulfate were produced at retention times of 10.8 min, 13.9 min and 14.8 min,
respectively. Again, methyl-(-)-epicatechin-sulfate was synthesised using (-)-
epicatechin-sulfate as a substrate. Three methyl-(-)-epicatechin-sulfates were
produced, eluting at 13.6 min for methyl-(-)-epicatechin-sulfate 1, 15.5 min for
methyl-(-)-epicatechin-sulfate 2 and 17.5 min for methyl-(-)-epicatechin-sulfate 3
(Figure 5.13; c, d and e).
- 140 -
Figure 5.9: Chromatogram of (-)-epicatechin-glucuronides after enzymatic
synthesis in TIC mode (A) and specific m/z- at 465 (B). (a) and (b) are control. (c),
(d) and (e) are (-)-epicatechin-glucuronides, re-dissolved in water, baseline urine and
24 hr urine, respectively.
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Figure 5.10: Chromatogram of methyl-(-)-epicatechin-glucuronides after enzymatic
synthesis in TIC mode (A) and specific m/z- at 479 (B). (a) and (b) are control. (c),
(d) and (e) are methyl-(-)-epicatechin-glucuronides, re-dissolved in water, baseline
urine and 24 hr urine, respectively.
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Figure 5.11: Chromatogram of methyl-(-)-epicatechin after enzymatic synthesis in
TIC mode (A) and specific m/z- at 303 (B). (a) and (b) are control. (c), (d) and (e)
are methyl-(-)-epicatechin, re-dissolved in water, baseline urine and 24 hr urine,
respectively.
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Figure 5.12: Chromatogram of (-)-epicatechin-sulfates after enzymatic synthesis in
TIC mode (A) and specific m/z- at 369 (B). (a) and (b) are control. (c), (d) and (e)
are (-)-epicatechin-sulfates, re-dissolved in water, baseline urine and 24 hr urine,
respectively.
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Figure 5.13: Chromatogram of methyl-(-)-epicatechin-sulfates after enzymatic
synthesis in TIC mode (A) and specific m/z- at 383 (B). (a) and (b) are control. (c),
(d) and (e) are methyl-(-)-epicatechin-sulfates, re-dissolved in water, baseline urine
and 24 hr urine, respectively.
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The chromatogram of all enzymatic (-)-epicatechin metabolites dissolved in
milliQ water and detected in specific m/z- of each conjugate is shown in Figure
5.14. The different retention times of all synthesised (-)-epicatechins are illustrated
in Table 5.6. Again, these data confirm that all synthetic conjugates of (-)-
epicatechin were correct. Glucuronidated forms, more water soluble than sulfated
and methylated, were separated first followed by sulfated and methylated forms.
Figure 5.14: Chromatogram of all enzymatic epicatechin metabolites dissolved in
milliQ water and detected in specific m/z- of each conjugate. (EG and T act as
internal standard). Glucuronidated forms were separated first followed by sulfated
and methylated forms.
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Table 5.6: Retention time of each conjugated form of enzymatically synthesised (-
)-epicatechin and internal standards (EG: Ethyl gallate and T: Taxifolin), detected at
specific [m/z-].
Compound [m/z-] Peak No. Retention time,
(min)
EC-G 465 1 10.2
2 10.5
3 11.0
4 12.7
EC-S 369 1 10.8
2 12.4
3 13.0
Me-
EC-G
479 1 12.8
2 13.9
3 14.8
4 15.7
Me-
EC-S
383 1 13.6
2 15.5
3 17.5
Me-
EC
303 1 17.4
EC 289 1 13.4
EG 197 1 14.5
T 303 1 19.2
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5.4.3 The percentage yields of synthesised conjugates
The conversion rates of quercetin and (-)-epicatechin into their conjugated
products is shown in Table 5.7. For quercetin conjugate synthesis, quercetin
glucuronide showed the highest percentage yield (79.3±0.7%) in baseline followed
by 3-O-methylated-quercetin-glucuronides (39.1±0.5%) and quercetin sulfates
(23.3±0.7%). For (-)-epicatechin conjugates synthesis, methylated-(-)-epicatechin-
sulfate added in 24 hr urine has a greater percentage yield (98.9±0.2%) than (-)-
epicatechin glucuronide (58.0±6.0%) and methylated-(-)-epicatechin-glucuronides
(56.9±0.9%) followed by quercetin sulfate (47.6±2.5%). The lowest percentage
yield was methylated-(-)-epicatechin which was 14.8±0.0%.
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Table 5.7: Summary of the percentage yields of synthesised quercetin and (-)-
epicatechin conjugates in this study (each sample was performed biological
replicates).
Synthesised conjugates Peak No. % Yields Total (%)
Quercetin conjugates
75.8±0.0
Q-G added to MQ 1 0.9±0.0
2 12.2±0.0
3 9.9±0.0
4 3.9±0.0
5 13.9±0.0
Q-G added to baseline 1 0.8±0.0
79.3±0.7
2 13.7±0.2
3 10.3±0.2
4 39.3±0.2
5 15.2±0.2
Q-G added to 24 hr urine 1 0.7±0.1
77.8±2.2
2 14.0±0.5
3 9.5±0.1
4 39.5±0.9
5 14.2±0.7
Q-S added to MQ 1 5.5±0.0 33.1±0.02 27.6±0.0
Q-S added to baseline 1 5.5±0.4 23.3±0.72 17.8±0.2
Q-S added to 24 hr urine 1 6.4±0.2 34.1±0.72 27.7±0.5
3Me-Q-G added to MQ 1 1.0±0.0
24.6±0.02 10.9±0.0
3 12.7±0.0
3Me-Q-G added to baseline 1 1.5±0.0
39.1±0.52 17.7±0.0
3 19.9±0.5
3Me-Q-G added to 24 hr urine 1 1.4±0.1
39.3±1.52 17.5±0.4
3 20.4±1.0
Continued…
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Synthesised conjugates Peak No. % Yields Total (%)
Epicatechin conjugates
62.1±0.4
EC-G added to MQ 1 17.8±0.1
2 6.5±0.1
3 24.8±0.1
4 13.1±0.1
EC-G added to baseline 1 19.3±0.2
58.4±0.82 5.9±0.13 22.3±0.2
4 10.9±0.3
EC-G added to 24 hr urine 1 18.9±2.1
58.0±6.02 5.2±0.93 22.9±1.2
4 11.0±1.8
Me-EC-G added to MQ 1 14.0±0.4
62.2±1.12 24.7±0.23 20.3±0.4
4 3.1±0.1
Me-EC-G added to baseline 1 12.5±2.4
65.8±12.02 22.4±3.83 27.8±5.2
4 3.1±0.6
Me-EC-G added to 24 hr urine 1 9.8±0.1
56.9±0.92 25.0±0.03 19.5±0.8
4 2.5±0.0
Me-EC added to MQ 1 14.2±0.7 14.2±0.7
Me-EC added to baseline 1 15.5±0.5 15.5±0.5
Me-EC added to 24 hr urine 1 14.8±0.0 14.8±0.0
EC-S added to MQ 1 30.9±0.5
40.8±0.62 1.4±0.0
3 8.5±0.0
EC-S added to baseline 1 34.1±0.1
48.1±1.02 1.7±0.3
3 12.2±0.6
EC-S added to 24 hr urine 1 31.7±0.5
47.6±2.52 1.2±0.5
3 14.8±1.5
Me-EC-S added to MQ 1 6.0±0.3
97.6±1.12 75.4±0.4
3 16.3±0.4
Me-EC-S added to baseline 1 7.5±0.4
98.7±1.22 74.1±0.6
3 17.1±0.3
Me-EC-S added to 24 hr urine 1 7.9±0.1
98.9±0.22 75.1±0.1
3 15.9±0.0
Table 5 7 Summary of the percentage yields synthesised quercetin and (-)-
epicatechin conjugates in this study (Continued)
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5.5 Discussion
The important finding in the present study was that almost all conjugated
quercetin and (-)-epicatechin derivatives, except for quercetin-glucuronide-sulfates,
which were expected to be in urine were successfully synthesised using enzymatic
synthesis using microsomal and cytosolic preparations from pig liver. These are
sources of phase II enzymes; UGT, SULT and COMT. From the basic structure of
quercetin and (-)-epicatechin, glucuronic acid, sulfate or methyl groups were added
to the hydroxyl group, leading to five possible forms of conjugated products,
dependent on the activity and sources of phase II enzymes . Several sources of phase
II enzymes from different species such as rat, pig and human were used. However,
in this study pig liver was the best choice because it contains a high content of phase
II enzyme and is more similar to human liver than rat liver. Moreover, it is more
convenient than human liver. Shali et al. (1991) also stated that guinea pig liver can
produce quercetin sulfate and secrete into bile with a higher rate than values for the
rat. The specific position of conjugated quercetin or (-)-epicatechin in this study,
however, cannot be defined by UPLC-MS. A higher performance technique like LC-
MS/MS or NMR could be another way to identify their structure.
The results in this present study have shown that glucuronic acid from
UDPGA was conjugated to all five hydroxyl groups of quercetin, consequently
generating into five forms of quercetin glucuronides. Although peak No 1 in Figure
5.2 is a tiny peak, the specific m/z- at 477 corresponded to quercetin glucuronide.
Thus, this data confirmed that the first small peak is also quercetin conjugated with
glucuronide. In this study, the main conjugated quercetin and (-)-epicatechin were
synthesised which is greater than that described in other publications (Table 5.4).
O'Leary et al., (2001) focused on monoglucuronide of quercetin and revealed that
only four quercetin glucuronides; quercetin-3-O-glucuronide, quercetin-7-O-
glucuronide, quercetin-3-O-glucuronide and quercetin-4-O-glucuronide, were
generated by a cell-free extract of pig liver. There were 6.5 molar % of 3-O-
glucuronide-7-O-glucuronide, 85 molar % of 4-O-glucuronide, 6.5 molar % of 3-
O-glucuronide and 2 molar % of free quercetin. The apparent affinity of UGT from
a cell-free extract of pig liver to quercetin followed the order 4- 3- 7- 3 with no
conjugation at the 5-position, and the biological activity of these conjugates to
inhibit xanthine oxidase and lipoxygenase was still maintained (Day et al., 2000).
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The main form of quercetin glucuronide found by Day et al. 2000 was 4-O-
glucuronide, while Boersma et al., 2002 found 7-O-glucuronide. Boersma et al.,
(2002) assumed that it may due to the different concentrations of quercetin in the
reaction. In addition, the preferential position of glucuronidation is different in
different types of flavonoids and also varies according to the isoform of UGT. All
five forms of quercetin glucuronides produced and detected in this study may be due
to alamethicin, saccharolactone and ascorbic acid being added into the
glucuronidation reaction owing to enhanced activity of UGT and also preservation
of glucuronidated quercetin products. Alamethicin is a UGT activator leading to
higher yields. After quercetin glucuronides were produced, saccharolactone and
ascorbic acid, β-glucuronidase inhibitor and reducing agent in the glucuronidation 
reaction respectively, may assist to preserve the synthesised conjugates. These
assumptions are supported by the high percentage yield of each synthesised
conjugate. This study demonstrated that quercetin glucuronide was produced with a
maximum percentage yield of 79.3±0.7%. In addition, (-)-epicatechin glucuronide
and methylated-(-)-epicatechin-glucuronides were the second conjugates that
generated four forms with yields of 58.0±6.0% and 56.9±0.9%, respectively. The
rest of the conjugates were produced in only a few forms. Duenas et al. (2008)
demonstrated that quercetin metabolites are generated at different pH values using a
2 hr incubation time, however, pH at 8.3 in water improved quercetin glucuronide
yield up to 19% for quercetin 4-glucoronide and 7% for quercetin 3-glucuronide.
Although the conjugated position of synthesised quercetin glucuronides cannot be
distinguished in this study but their profile (see chromatogram of quercetin
glucuronides in Figure 5.2) can compare with the quercetin glucuronide profile
synthesised by Duenas et al. (2008). Based on the chromatogram of quercetin
glucuronides from Duenas et al., (2008), quercetin glucuronide 4 and quercetin
glucuronide 5 in this study should be quercetin 4-glucuronide and quercetin 3-
glucuronide, respectively. Then, the percentage yield of quercetin glucuronide 4 and
quercetin glucuronide 5 are 39.3±0.2 and 15.2±0.2, respectively (Table 5.7). This
data supported that glucuronidation of quercetin using the enzymatic method in this
study provide a better yield than the previous method optimised by Duenas et al,
2008.
As mentioned above, quercetin-glucuronide-sulfate synthesis was attempted
but was unsuccessful. Since sulfate is more chemically unstable than glucuronide or
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methyl groups, it can be assumed that sulfate moieties of quercetin-glucuronide-
sulfate may hydrolyse during synthesised step.
Similar research was carried out on the enzymatic synthesis of (-)-epicatchin
conjugates and showed that 3'-O-methyl-epicatechin 5-O-glucuronide was produced
when incubating recombinant human UGT1A9 with 3'-O-methyl-epicatechin to
50% yield after 24 hr (Blount et al., 2012). However, the findings of this present
study showed that the percentage yield of methylated-(-)-epicatechin-glucuronides is
62.2±1.1% after 1 hr incubation. Although, Blount et al. attempted to optimise the
condition of 3'-O-methyl-epicatechin 5-O-glucuronide synthesis by using room
temperature incubation and adding an extra glucuronic acid donor every 4 hr and
extra UGT1A9 of both initial reaction and every 4 hr but the percentage yield of (-)-
epicatechin conjugates synthesised based on the condition in this study still seems
higher than Blount et al. (2012). In addition, Blount et al. (2012) synthesised 3'-O-
methyl-epicatechin-5-O-glucuronide by methylating (-)-epicatechin or (-)-
epicatechin glucuronide first then subsequently by glucuronidation. The opposite
line was also performed but no glucuronidated methyl epicatechin was produced.
However, this study uses the later procedure and successful synthesis.
Conjugation with glucuronic acid to quercetin and (-)-epicatechin structure
leads to increase a water solubility higher than conjugation with sulfate and methyl.
Thus, glucuronided forms were separated first followed by sulfated and methylated
forms (Figure 5.7 and Figure 5.14). Again, these data confirmed that all synthetic
conjugates of quercetin and (-)-epicatechin were correct and could be used for urine
analysis in next study.
5.6 Conclusion
Due to the absence of commercially available relevant conjugated quercetin
and (-)-epicatechin derivatives, the main conjugates of these compounds, in different
forms, were synthesised using an improved enzymatic method. Five quercetin and
five (-)-epicatechin conjugates were successfully synthesised with a higher
percentage yield compared to previous reports. These synthesised compounds will
be used as standards in Chapter 6.
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Chapter 6 Determination of Quercetin, (-)-Epicatechin and Main
Metabolites in Urine Samples from Healthy Volunteers
6.1 Abstract
Previously, the metabolic profile of flavonoids after a single consumption of
flavonoid-rich foods, pure compunds or supplements have been studied by several
research groups. Each flavonoid has their own pattern of metabolites and
inter-individual variation. However, in daily life, humans do not consume only a
single type of flavonoid per meal. When two flavonoids like quercetin and (-)-
epicatechin are co-administered, these two flavonoids may interact with each other
during absorption and distribution, especially with regard to phase II enzyme
conjugation. Then, the phase II metabolites of quercetin and (-)-epicatechin may
change and affect their bioactivities. The main aim of this chapter was to assess an
absorption and metabolism of quercetin and (-)-epicatechin using urine as a
biomarker. Baseline and 24 hr urine samples were taken from twenty seven
volunteers and were collected after consumption of red onion soup, 70% cocoa dark
chocolate and co-consumption at three different times. Due to the low percentage
urinary excretion of quercetin and (-)-epicatechin detected in Chapter 4,
accompanied by a low amount of quercetin and (-)-epicatechin spiked with synthetic
conjugated standard in 24 hr urine samples in Chapter 5, the baseline and 24 hr urine
samples were first concentrated by freeze-drying before protein precipitation,
filtration and injection into UPLC-MS. In the case of onion intake, eight conjugated
quercetin metabolites were identified. Glucuronic acid conjugated with quercetin
was the major urinary metabolite and there were three different forms. In addition,
the total metabolites of quercetin excreted in the urine of each volunteer was very
different. For the single consumption of 70% cocoa dark chocolate, six urinary (-)-
epicatechin metabolites were detected and the main form was methylated (-)-
epicatechin. In contrast to the metabolic profiles of quercetin, the total metabolites
of (-)-epicatechin did not show a vast variation in each volunteer. After co-
consumption, all urinary quercetin and (-)-epicatechin metabolites were found to be
the same as those metabolites after single consumption. Interestingly, the total
quercetin metabolites were also apparently increased in four of the volunteers. For
total (-)-epicatechin metabolites, there were no large differences. The total (-)-
epicatechin metabolites in some volunteers increased, while others were decreased
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and did not change between single and after co-consumption. These differences
were possibly due to the variation of phase II enzymes in each volunteer.
6.2 Introduction
A number of studies investigated the metabolic profile of flavonoids after
consumption of a supplement or a single food. Each flavonoid has their own pattern
of metabolites and inter-individual variation. Eighteen urinary quercetin metabolites
after the ingestion of fried red onions by six volunteers were quercetin-
diglucuronides, quercetin-glucoside-sulfates, quercetin-4-O-glucuronide and
quercetin-3-O-sulfate, quercetin-3-O-glucuronide, quercetin-3-O-glucuronide,
quercetin diglucuronide, quercetin glucuronide glucoside, quercetin glucuronide
sulfates, quercetin glucoside sulfates, isorhamnetin-3-O-glucuronide, isorhamnetin-
4-O-glucuronide and methylquercetin diglucuronides (Mullen et al., 2006). In
addition, (-)-epicatechin metabolites in urine after the ingestion of 100 g dark
chocolate by five volunteers were found as fifteen forms; three (-)-epicatechin-
glucuronides, three (-)-epicatechin-sulfates, five O-methyl-(-)-epicatechin-sulfates
and four O-methyl-(-)-epicatechin-glucuronides (Actis-Goretta et al, 2012).
It has been suggested that glucuronidation, sulfation and methylation in the
gut and/or liver result in poor oral bioavailability of flavonoids. The metabolic
profile of flavonoids may modify the protective effects and other biological activites
in humans. For example, Khan et al. (2012) found that regular cocoa consumption
alters lipid profile by significantly increasing plasma HDL cholesterol levels and
decreasing oxidised LDL concentrations in high-risk coronary heart disease subjects,
associated with increases in the phase II metabolites level in urine and the
microbial-derived metabolites of cocoa flavonoids.
However, foods are consumed by humans not as a single serving but
normally as mixtures. Only a few research groups have studied the effect of the type
of consumed foodstuffs on the metabolite patterns in human. Borges et al. (2010)
studied the bioavailability of combinations of polyphenolic compounds in a
polyphenol-rich juice drink. This juice contained green tea flavan-3-ols, grape seed
and pomace procyanidins, apple dihydrochalcones, procyanidins and chlorogenic
acid, citrus flavanones and grape anthocyanins. They found that the metabolic
profile of flavanones, dihydrochalcones and chlorogenic acids in plasma and urine
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after acute consumption of polyphenol rich beverage were not significantly different
when compared to other single component studies. However, they noticed that there
were quantitative differences between (epi)catechin and (epi)gallocatechins
metabolites. In addition, they suggested that although the absorption of these flavan-
3-ols were not influenced by other phenolic compounds, this difference is possibly
due to some competition between phase II enzymes; uridine-5-diphosphate
glucuronyltranferases, sulfotransferases and catechol-O-methyltransferases,
resulting in differences in the plasma and urinary flavan-3-ol metabolic profiles. Lee
and Mitchell (2012) studied the glycosidic moiety which is a key factor influencing
the absorption and elimination of flavonoids. Two dietary sources of quercetin,
apple peel and onion powder, containing quercetin but linked with different types of
sugar moiety, and also a mixture of these two powders, were fed to healthy
volunteers (eight female and eight male). They found that consuming onion powder
alone led to faster absorption, higher plasma concentration and better bioavailability
than single consumption of apple peel powder. For a mixture of apple peel and
onion powder, the absorption rate of this mixture was intermediate between the
absorption rate of apple peel and onion powder. Thus, the result from this research
group showed that feeding two different sources of quercetin glycosides to healthy
volunteers at the same time can modify pharmacokinetic parameters and also
metabolic profiles in the circulation. The effect of other key factors, food matrix and
dose ingestion, on the bioavailability and also biological effects of (-)-epicatechin
was performed by Hollands et al. (2013). Although, they did not provide a co-
consumption of food samples to volunteers, they demonstrated that a whole apple
puree, containing not only (-)-epicatechin but other flavonoids (quercetin glycosides,
phloretin glycosides, and chlorogenic acid) reduced the bioavailability of (-)-
epicatechin compared to (-)-epicatechin-rich extracted drink from apple. In addition,
consuming a double dose of epicatechin-rich apple extract increased more than two
fold the (-)-epicatechin bioavailability. Recently, the co-consumption of two types of
dietary flavonoids was reported (Nakamura et al., 2014). A combination meal of
sautéed onion and tofu, containing quercetin and isoflavones, was fed to five healthy
volunteers and then the plasma metabolic profile of quercetin and isoflavones were
analysed. Glucuronidated and methylated quercetin were most abundant a after
single serving of quercetin while glucuronide and sulfate conjugates of isoflavone,
were major metabolites after tofu ingestion. In the case of combined ingestion, only
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quercetin sulfate was detected along with a reduction of sulfated isoflavones. In both
HepG2 cells and Caco-2 cells, they also found that quercetin is a better substrate for
UGT and SULT than genistein isoflavone.
From these data, different chemical structures of flavonoids in foods have
important consequences on bioavailability. In addition the affinity of phase II
enzyme for various flavonoid substrates affects their absorption and bioavailability.
One of the current trends in nutrition is to focus on metabolomics, the study of
metabolites or chemicals in the biological system which can provide an overview of
the metabolic status (Llorach et al., 2012). Thus, it would be interesting to
investigate the interaction between the metabolic profiles of the exogenous
metabolome or all metabolites derived from the ingestion of foods like quercetin and
(-)-epicatechin. To obtain the metabolomic data of quercetin and (-)-epicatechin,
Ultra Performance Liquid Chromatography coupled with Mass Spectrometry
(UPLC-MS) was used in this study.
The main aim of this study was to investigate the metabolism and excretion
of quercetin and epicatechin after co-consumption of onion soup and dark chocolate
by healthy volunteers (n=27). The hypothesis of this study is that inhibitory
interaction between quercetin and (-)-epicatechin will occur after co-administration
of these two flavonoids. This interaction may change an individual compound’s
absorption and urinary metabolites of other flavonoids. In this case the flavonol
quercetin may affect absorption and metabolism of flavanol (-)-epicatechin by
modifying (inducing or inhibiting) the phase II enzyme activity, resulting in higher
or lower bioavailability of (-)-epicatechin.
Due to the low level of analytes, the baseline and 24 hr urine required
concentrating by freeze-drying and protein precipitation, filtration prior to further
analysis by the Ultra Performance Liquid Chromatography coupled with Mass
Spectrometry. Then, to understand the effect of phase II enzymes on bioavailability
of quercetin and (-)-epicatechin, their main metabolites of quercetin (quercetin-
sulfate, quercetin-glucuronide, isorhamnetin-glucuronide) and (-)-epicatechin
(methyl-(-)-epicatechin-sulfate, (-)-epicatechin-glucuronide, (-)-epicatechin-sulfate,
methyl-epicatechin-glucuronide) were identified in human urine without enzyme
hydrolysis. Thus, a more complete picture of these two compounds relating to
bioavailability and possible correlation to bioefficiency can be obtained.
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6.3 Materials and Methods
See Section 2.5.5, 2.5.6 and 2.5.8 for determination main metabolites of
quercetin and (-)-epicatechin in urine samples from 27 healthy volunteers.
6.4 Results
6.4.1 Urine metabolites of quercetin after a single consumption of red onion
soup in healthy volunteers
To identify all metabolites found in urine, the relative retention time (relation
time of compounds/relation time of internal standard) and the mass to ion ratio of
synthesised standards from previous chapters were used as a reference. In this study,
eight conjugates of quercetin metabolites identified as three forms of quercetin
glucuronides, two forms of quercetin sulfates, quercetin-di-O-glucuronides, 3-O-
methyl-quercetin-O-glucuronide and 3-O-methyl-quercetin-di-O-glucuronide were
investigated in urine from human volunteers who consumed a single dose of red
onion soup. The Ultra Performance Liquid Chromatography coupled with Mass
Spectrophotometer results confirmed the occurrence of metabolites eluting at
different retention times. First, three peaks of quercetin glucuronides were observed
in urine samples. The first quercetin glucuronide was eluted at a retention time of 21
min (Figure 6.1A). The second quercetin glucuronide was eluted at retention time of
22 min but in some volunteers this peak was co-eluted at retention times of 22 and
23 min. Therefore, peak areas of these forms were combined and calculated together
(Figure 6.1B). The last quercetin glucuronide form was found most in all volunteers
and eluted at a retention time of 29 min (see Figure 6.1C).
To distinguish whether which glucuronidated form was produced and
excreted in urine, known standard compounds which we already have in the
laboratory were used to spike the urine sample of some volunteers. In volunteers 4,
5, 10 and 13, a high peak of quercetin glucuronide at a retention time of 22 and 23
min were found. Then, the 24 hr urine sample of volunteer 4, which had the highest
peak, was spiked with quercetin-3-O-glucuronide and the peak eluted at the
retention time of 22 and 23 min was not quercetin-3-O-glucuronide but actually was
peak No 1, eluting at 21 min (see Figure 6.2). These peaks were also found in a few
volunteers in low amounts (see Figure 6.1A). In volunteer 9, the highest peak of
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quercetin glucuronide retention time at 29 min was found in this volunteer. Then, a
standard compound of quercetin-7-O-glucuronide was spiked in this 24 hr urine and
found that this peak eluted at 29 min was not quercetin-7-O-glucuroide. A small
peak of spiked quercetin-7-glucuconide was appeared at 20.4 min.
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Figure 6.1: Three main quercetin glucuronides were found in the urine samples of
volunteers. A. quercetin-3-O-glucuronide, B. quercetin-O-glucuronide 1 (retention
time at 22, 23 min) and C. quercetin-O-glucuronide 2 (retention time at 29 min).
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Figure 6.2: Chromatogram of quercetin-glucuronides found in volunteer 4 spiked
(a) without and (b) with quercetin-3-O-glucuronide standard and detected at a
specific mass to ion ratio (m/z- = 477).
Figure 6.3 Chromatogram of quercetin-glucuronides found in volunteer 9 spiked
(a) without and (b) with quercetin-7-O-glucuronide standard and detected at a
specific mass to ion ratio (m/z- = 477).
15 20 25 30
0.0
0.5
1.0
1.5
2.0
2.5
15 20 25 30
0.0
0.5
1.0
1.5
2.0
2.5
(a) without Q3G
A
bs
ol
ut
e
In
te
ns
ity
,[
m
/z
- =
47
7]
x
10
5
Q3G(b) with Q3G
Retention time (min)
20 30 40
0.0
0.5
1.0
1.5
2.0
20 30 40
0.0
0.5
1.0
1.5
2.0
(a)
A
bs
ol
ut
e
In
te
ns
ity
,[
m
/z
-=
47
7]
x
10
5
Q7G
(b)
Retention time (min)
(a) Volunteer 4
spiked without Q3G
(b) Volunteer 4
spiked with Q3G
1
(a) Volunteer 9
spiked without Q7G
(b) Volunteer 9
spiked with Q7G
- 161 -
In this study, two forms of quercetin sulfates were also found in urine
samples, eluting at retention times of 27 min and 31 min, respectively (Figure 6.4).
Additionally, the spiked urine sample in volunteer 13 confirmed that the peak eluted
at a retention time of 31 min is quercetin 3-O-sulfate (Figure 6.5).
Figure 6.4: Two main quercetin-sulfates found in urine samples of
volunteers. A. quercetin-O-sulfate (retention time at 27 min) and B. quercetin-
3-O-sulfate (retention time at 31 min).
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Figure 6.5: Chromatogram of quercetin-glucuronide found in volunteer 13 spiked
(a) without and (b) with quercetin-3′-O-sulfate standard and detected at a specific
mass to ion ratio (m/z- = 381).
Furthermore, other quercetin conjugates (quercetin-di-O-glucuronide, Rt = 20 min;
3-O-methyl quercetin-O-glucuronide, Rt = 26 and 27 min; 3-O-methyl quercetin-
di-O-glucuronide, Rt = 18 min) were also excreted and found in urine in only small
amounts. All combined urinary quercetin metabolites, arranged in order of the main
quercetin glucuronide (Rt = 29 min), in each volunteer is shown in Figure 6.6A.
From this bar chart, a huge difference of quercetin metabolites excreted in urine was
observed in each volunteer who consumed onion soup only. Additionally, the
glucuronidated form of quercetin was most abundant in urine followed by sulfated
quercetin and methylated quercetin (74%, 21% and 5%, respectively (Figure 6.6B)).
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Figure 6.6: A. All eight urinary quercetin metabolites were found in 24 hr urine
samples of each volunteer. B. The percentage of average amount of major quercetin
metabolites for all volunteers (on the left). These amounts can be converted into
three main forms (on the right).
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6.4.2 Urine metabolites of (-)-epicatechin after a single consumption of 70%
cocoa dark chocolate in healthy volunteers
For a single consumption of 70% cocoa dark chocolate, six (-)-epicatechin
metabolites were found in urine; methylated-(-)-epicatechin-sulfate, methylated-(-)-
epicatechin-glucuronide, methylated-(-)-epicatechin, (-)-epicatechin-sulfates (two
forms) and (-)-epicatechin-glucuronide. In this case, methylated-(-)-epicatechin-
sulfate was found most (Figure 6.7A, Rt = 15 min) followed by (-)-epicatechin-
sulfate (Figure 6.8B, Rt = 12-13 min). (-)-Epicatechin-glucuronide, eluting at 12
min, also found in the urine samples of almost all volunteers (Figure 6.9) but lower
than the amount of methylated (-)-epicatechin-sulfate and epicatechin-sulfate.
A tiny amount of other (-)-epicatechin metabolites; methylated-(-)-
epicatechin-glucuronide (Rt = 13 min), methylated-(-)-epicatechin (Rt = 18 and 20
min) and also (-)-epicatechin-sulfate (Rt = 11 min) were detected in a few volunteers
(Figure 6.7B and 6.7C).
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Figure 6.7: Three different methylated forms of (-)-epicatechin were found in urine
samples, after a single consumption of 70% cocoa dark chocolate, in each volunteer.
A. methyl-(-)-epicatechin-sulfate, eluting at 15 min, B. methyl-(-)-epicatechin-
glucuronide, eluting at 13 min and C. methyl-(-)-epicatechin, eluting at 18 min and
20 min.
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Figure 6.8: Two sulfated forms of (-)-epicatechin were found in urine samples,
after a single consumption of 70% cocoa dark chocolate, in each volunteer. A. (-)-
epicatechin-sulfate 1, eluting at 11 min, B. (-)-epicatechin-sulfate 2, eluting at 12
and 13 min.
Figure 6.9: Glucuronidated forms of (-)-epicatechin were found in urine samples,
after a single consumption of 70% cocoa dark chocolate, in each volunteer. The
retention time was 12 min.
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Again, all combined urinary (-)-epicatechin metabolites, arranged in order of
the main methylated (-)-epicatechin sulfate (Rt = 15 min), in each volunteer is
shown in Figure 6.10A. From this bar chart, urinary (-)-epicatechin metabolites after
a single consumption of 70 % cocoa dark chocolate were not vastly different in each
volunteer. However, unlike quercetin metabolites, after a single consumption of
70% dark chocolate, methylated forms of (-)-epicatechin were found in most urine
samples followed by sulfated (-)-epicatechin and glucuronidated (-)-epicatechin
(60%, 37% and 3%, respectively (Figure 6.10B)).
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Figure 6.10: A. All six urinary (-)-epicatechin metabolites found in 24 hr urine
samples from each volunteer. B. The percentage of the average amount of major (-)-
epicatechin metabolites for all volunteers (on the left). These amounts can be
converted into three main forms (on the right).
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6.4.3 Urine metabolites of quercetin after co-consumption of onion soup and
70% cocoa dark chocolate in healthy volunteers
After co-consumption of onion soup and 70% cocoa dark chocolate, all
urinary quercetin metabolites were found to be the same as those metabolites after
consuming a single dose of red onion soup except 3-O-methyl quercetin-di-O-
glucuronide (Rt = 18 min). Again, all quercetin metabolites excreted in urine varied
in different volunteers (Figure 6.11A). In addition, the glucuronidated form of
quercetin was still the major form found in urine. There were 65% of glucuronidated
quercetin, 32% of sulfated quercetin and 3% of methylated quercetin (Figure 6.11B).
The total urinary quercetin metabolites between single and co-consumption
were compared. The bar chart from Figure 6.12B shows that the mean of total
quercetin metabolites after a single consumption was different from the mean of
total quercetin metabolites after co-consumption but not significantly (p-value =
0.057). The line graph of the total urinary quercetin metabolites between single and
co-consumption also constructed and revealed that the total urinary quercetin
metabolites were increased in volunteers 7, 9, 10, 19 after co-consumption of red
onion soup and 70% cocoa dark chocolate (Figure 6.13A). However, it is quite
difficult to interpret the results of other volunteers using this line graph. Thus,
another type of line graph, the difference of total quercetin urinary metabolites
between co- and single consumption, was prepared (Figure 6.13B). From this data,
the total quercetin urinary metabolites were increased after co-consumption of two
types of food. Furthermore, it can be divided into 3 levels; high level for volunteers
7 and 10, intermediate level for volunteers 9 and 19 and low level for the rest, except
volunteer 13. In volunteer 13, the total quercetin metabolites decreased after co-
consumption of red onion soup and 70% cocoa dark chocolate.
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Figure 6.11: A. Seven urinary quercetin metabolites found in 24 hr urine samples
from each volunteer. B. The percentage of the average amount of major quercetin
metabolites for all volunteers (on the left). These amounts can be converted into
three main forms (on the right).
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Figure 6.12: A. All urinary quercetin metabolites after (a) single and (b) co-
consumption. B. Comparison of total urinary quercetin metabolites between single
and co-consumption. There was no difference between the mean of single and co-
consumption, p-value = 0.057
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Figure 6.13: A. Trend of total quercetin urinary metabolites from single to co-
consumption in each volunteer. B. The difference in total quercetin urinary
metabolites between co-and single consumption.
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6.4.4 Urine metabolites of (-)-epicatechin after co-consumption of onion soup
and dark chocolate in healthy volunteers
After co-consumption of onion soup and 70% cocoa dark chocolate, all
urinary metabolites were found to be the same as those metabolites after consuming
a single dose of 70% cocoa dark chocolate. All urinary (-)-epicatechin metabolites
did not show a massive variation from one volunteer to another (Figure 6.14A). In
addition, methylated-(-)-epicatechin was still the main form detected in urine. There
were 53%, 40% and 7% for methylated-(-)-epicatechin, sulfated-(-)-epicatechin and
glucuronidated-(-)-epicatechin, respectively (Figure 6.14B).
The total urinary (-)-epicatechin metabolites between single and co-
consumption were compared (Figure 6.15B). This bar chart illustrates that the mean
of total (-)-epicatechin metabolites after a single consumption was no different to the
mean of total (-)-epicatechin metabolites after co-consumption, p-value is 0.095.
The line graph of the total urinary (-)-epicatechin metabolites between single and co-
consumption (Figure 6.16A) and the difference of total (-)-epicatechin urinary
metabolites between co- and single consumption (Figure 6.16B) are represented and
show that the total urinary (-)-epicatechin metabolites vary. The highest increase in
the total (-)-epicatechin urinary metabolites after co-consumption of red onion soup
and 70% cocoa dark chocolate was observed in volunteer 24. The total (-)-
epicatechin urinary metabolites also increased in volunteer 4, 6, 7, 18 and 19. In
other volunteers, the total (-)-epicatechin metabolites had changed, increasing or
decreasing, but in moderation.
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Figure 6.14: Six urinary (-)-epicatechin metabolites found in 24 hr urine in each
volunteer. B. The percentage of the average amount of major quercetin metabolites
for all volunteers (on the left). These amounts can be converted into three main
forms (on the right).
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Figure 6.15: A. All urinary (-)-epicatechin metabolites after (a) single and (b) co-
consumption B. Comparison of total urinary quercetin metabolites between single
and co-consumption. There was no difference between the mean of the single or co-
consumption, p-value = 0.095
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Figure 6.16: A. The total urinary (-)-epicatechin metabolites of 24 hr urine
collection after a single consumption of red onion soup and co-consumption red
onion and 70% cocoa dark chocolate in each volunteer. B. The difference of total (-
)-epicatechin urinary metabolites between co-and single consumption.
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6.4.5 Comparison of estimated amount of three different forms between single
consumption and co-consumption of onion soup and dark chocolate in healthy
volunteers
The estimated amount of three different forms after consumption of onion
soup and co-consumption is compared (Figure 6.16A). This pie chart shows that
glucuronidated quercetin and methylated quercetin excreted in urine decreased,
while sulfated quercetin increased after consuming red onion soup and 70% cocoa
dark chocolate.
For 70% cocoa dark chocolate and co-consumption, this pie chart illustrates
that methylated (-)-epicatechin decreased, whereas, glucuronidated and sulfated (-)-
epicatechin improved after consuming red onion soup and 70% cocoa dark
chocolate (Figure 6.16B).
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Figure 6.17: Comparison of three different conjugated forms; glucuronidated,
sulfated and methylated forms, between single and co-consumption. A. Single
consumption of red onion soup and co-consumption. B. Single consumption of 70%
cocoa dark chocolate and co-consumption.
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6.5 Discussion
6.5.1 Single consumption of red onion soup
For a single consumption of red onion soup, eight conjugated quercetin
metabolites; three forms of quercetin glucuronides, two forms of quercetin sulfates,
quercetin-di-O-glucuronides, 3-O-methyl-quercetin-O-glucuronide and 3-O-methyl
quercetin-di-O-glucuronide was identified in this study. These metabolites are also
the predominant ones out of eighteen urinary quercetin metabolites found by Mullen
et al, (2006). They found quercetin-diglucuronide was the major metabolite in urine
followed by quercetin-glucoside-sulfates, quercetin-4-glucuronide and quercetin-3-
sulfate. In our study, quercetin glucuronides were the major urinary metabolites and
found in three different forms, while, quercetin-diglucuronide was the major
metabolite in Mullen et al.’s (2006) study. These major metabolites were different,
possibly due to the differences in the amount of quercetin intake. In our study we
provided a lower amount of quercetin (50 g of red onion soup containing 109 µmol
of quercetin in 130 ml) to volunteers than Mullen et al. (2006). They provided 270 g
of fried onions, containing 275 µmol quercetin 3, 4di-O-glucoside and quercetin 4-
O-glucoside. Thus, the initial amount of substrate for uridine diphosphate
glucuronosyl transferase in glucuronidation of Mullen et al. (2006) study is high
enough to produce quercetin conjugates and further conjugated with glucuronic acid,
resulting di-O-glucoside form. The second most common urinary metabolite in our
study was quercetin-3-sulfate, while, quercetin glucoside sulfates was the second
most metabolite excreted in urine found in Mullen et al.’s (2006) study. In this study
quercetin-3-sulfate was confirmed by spiking into the 24 hr urine sample with
synthesised standard quercetin-3-sulfate which was available in the laboratory. This
data agree with Mullen et. al, (2006) that although it did exist in urine, it was a low
amount and insufficient for quantification. In the case of quercetin-glucoside-
sulfates, it may be excreted and found in urine in our volunteers but due to being
unsuccessful in synthesising quercetin-glucoside-sulfates in Chapter 5 and the lack
of commercial standard then these quercetin glucoside sulfates were not investigated
in all volunteers. For red onion soup consumption, quercetin seems to have a better
affinity to uridine diphosphate glucuronosyl transferase (UGT) than sulfotransferase
(SULT) and catechol-O-methyl transferase (COMT). That is the reason why the
glucuronides form found in most urine samples followed by sulfate form and a tiny
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amount in methylated form. The result from this study showed 74% for
glucoronided forms, 21% for sulfated forms and 5% for methylated forms. In
addition, the different activity of each uridine diphosphate glucuronosyl transferase
isoform and also the position of O-glucuronidation of uridine diphosphate
glucuronosyl transferase resulted in different products and different conjugated
forms, respectively. In 2002, Boersma et al. revealed that isoenzyme of uridine
diphosphate glucuronosyl transferase were involved in the glucuronidation of
quercetin. Moreover, individual uridine diphosphate glucuronosyl transferase can
convert quercetin into different percentages of metabolites. For example, Boersma et
al. (2002) found that UGT1A1 and UGT1A8 found most in the human intestine can
convert quercetin to its product around 30% (6% for 7-O-Glucuronide, 0% for 3-O-
Glucuronide, 9% for 4-O-Glucuronide and 85% for 3-O-Glucuronide) and 20%
(13% for 7-O-Glucuronide, 8% for 3-O-Glucuronide, 9% for 4-O-Glucuronide and
70% for 3-O-Glucuronide), while, UGT1A9 (50% for 7-O-Glucuronide, 26% for 3-
O-Glucuronide, 5% for 4-O-Glucuronide and 19% for 3-O-Glucuronide) found
most in humans and its conversion rate was 36%. In addition, the results from our
study showed that the total metabolites of quercetin excreted in urine by each
volunteer was largely different. This difference could be due to the polymorphism of
uridine diphosphate glucuronosyl transferase in each volunteer. For example,
UGT1A1 is a highly polymorphic isoform, deficiency in its expression or activity
may lead to genetic and developed diseases.
6.5.2 Single consumption of 70% cocoa dark chocolate
For the single consumption of 70% cocoa dark chocolate, methylated-(-)-
epicatechin-sulfate was mainly found in urine samples similar to the results obtained
by Actis-Goretta et al. (2012). They found 3-O-methyl-(-)-epicatechin-5-sulfate
metabolites most in 24 hr urine after the single consumption of 100 g of chocolate.
Thus, (-)-epicatechin seems to be a suitable substrate for catechol-O-methyl
transferase (COMT) and sulfotransferase (SULT) than uridine diphosphate
glucuronosyl transferase (UGT). Then, methylated forms of (-)-epicatechin were
found most in urine samples followed by sulfated (-)-epicatechin and glucuronidated
(-)-epicatechin. There were 60%, 37% and 3%, respectively. However, data from
Actis-Goretta et al. (2012) showed 43% of methylated forms followed by 39% of
glucuronidated and 18% sulfated form of epicatechin excreted in 24 hr. The
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methylated and sulfated form in our study seems to be higher than Actis-Goretta et
al. (2012) but glucuronidated forms are much lower. This difference may possibly
be due to the amount of (-)-epicatechin fed to volunteers and also the number of
volunteers attending in this study. A greater amount of substrate such as (-)-
epicatechin in the circulation may enhance more the activity of phase II enzymes
and the large number of volunteers will give more precise metabolic results.
Furthermore, this study found that the total metabolites of (-)-epicatechin after a
single consumption of 70% cocoa dark chocolate did not show a vast variation in
each volunteer.
6.5.3 Co-consumption of red onion soup and 70% cocoa dark chocolate
After co-consumption of red onion soup and 70% cocoa dark chocolate,
interestingly, the total quercetin metabolites was apparently increased in volunteer 7,
9, 10, 19. For (-)-epicatechin metabolites, there were no obvious differences. The
total (-) epicatechin metabolites of some volunteers were increased, while, others
were decreased and did not change between single and after co-consumption. From
the review papers, the percentage of urinary excretion of quercetin is 4.7%, while it
was 21% for (-)-epicatechin (Mullen et. al, 2006; Actis-Goretta et al., 2012) In this
study, the amount of (-)-epicatechin found in urine was higher than quercetin. Thus,
the results of this study support the previous publication. The urinary quercetin
metabolites in all volunteers were vastly different when compared to urinary (-)-
epicatechin metabolites. From the huge difference in their urinary excretion,
quercetin seems not to be eliminated by the kidney with the same efficacy as (-)-
epicatechin. It is possibly due to the polymorphism of phase II enzyme in some
volunteers. In addition, different groups of the population may have a different
pattern of metabolites, in this case a group of Caucasian people were used to study,
possibly leading to the unique metabolic profile. The relationship between the
polymorphic of phase II enzyme like COMT and the urinary excretion of polyphenol
has been investigated by Inoue-Choi et al. (2010). They found that subjects who
carry the homozygous low-activity (LL) associated COMT genotype significanly
reduce the urinary metabolites of tea polyphenols (EGC and EC) and its metabolites
(4-MeEGC, M4, and M6) after daily drinking of green tea approximately 35-45%
compare to HH genotype. In addition, they suggested that the remaining metabolites
may stay longer in the circulation and derive greater benefits for health. However,
Miller et al. (2012) also investigated the influence of COMT genotype on plasma
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metabolites of green tea catechins in humans and found that they were indifferent to
the metabolic profiles of the plasma catechin between COMT groups. Thus, COMT
polymorphic has no effect on the absorption and elimination of green tea catechin,
epigallocatechin gallate (EGCG).
6.5.4 Problems and solutions of concentrated urine samples to Electrospray
Ionisation (ESI)
Due to the low percentage of urinary excretion of quercetin and (-)-
epicatechin detected in Chapter 4, accompanied by a low amount of quercetin and (-
)-epicatechin spiked with synthetic conjugated standard in 24 hr urine in Chapter 5,
thus the baseline and 24 hr urine samples were then concentrated by freeze-drying
first. Concentrated urine samples may cause ion suppression or reduce a detector
response of Electrospray Ionisation (ESI), the most common atmospheric pressure
ionisation technique, used in LC-MS system in this study. The presence of other
species (endogenous or exogenous species) in the sample matrix (in this case is
urine) can reduce the ionisation efficiency of a sample by competing for ionisation
or inhibiting the efficiency of ionisation then has an effect on detector response.
First, a high concentration of concentrated urine in this study led to saturating the
droplet surface, reduced charge excess then loss of detector response. Second,
although concentrated urine contains a high concentration of quercetin or (-)-
epicatechin and is easy to detect with MS, this concentrated urine also contains a
high concentration of interference, leading to an increase in surface tension and
viscosity, reducing in desolvation or solvent evaporation, and consequentely
affecting ionisation efficiency. Finally, the non-volatile species ex. protein or salt,
found in urine can cause co-precipitation of analyte in the droplet thus preventing
ionisation. To evaluate the effect of other matrix in urine sample on ion suppression,
baseline urine was used as a control in every single sample. In addition, to avoid an
ion suppression, protein precipication was used to remove all protein species from
concentrated urine followed by filtrating this urine again with 0.2 µM to make the
sample clearer. In addition, to avoid or prevent co-elution of suppressing species, the
chromatograpic separation was modified in this study. Finally, LC and MS sources
need to be cleaned every 24 hr throught the running time in LC-MS to make sure the
machine work effectively.
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6.6 Conclusion
In this study, eight urinary metabolites of quercetin and six urinary
metabolite of (-)-epicatechin from human urine samples collected at 24 hr were
identified by UPLC-MS. Major metabolite of quercetin found most in urine is
quercetin glucuronide in both single and co-consumption of onion soup. While,
methylated form of (-)-epicatechin most abundant form in urine after single and co-
consumption of 70% dark chocolate. To our knowledge, this is the first study on the
metabolites profile of quercetin and (-)-epicatechin in human. Then, the precise
biological activities or mechanism of these metabolites should be study further.
- 184 -
Chapter 7 Summary and Future Perspectives
7.1 Summary of thesis findings
In summary, the findings of this study showed that red onions contain a
higher amount of quercetin than yellow onions in agreement with most publications.
As mentioned previously, homogenisation was an efficient method for extracting
quercetin glycosides than vortex and sonication. Thus, using this extraction method
may produce a higher yield and can be applied for the quantification of the content
of other flavonoids in food samples.
The result from the in vitro study showed that an extract of pig liver
displayed COMT activity towards (-)-epicatechin and quercetin, producing their
methylated products; 3-O-methylated-(-)-epicatechin, 4-O-methylated-(-)-
epicatechin and 3-O-methylated-quercetin. In addition, (-)-epicatechin seems to
generate methylated forms better than quercetin. The results in chapter 6 also
revealed that methylated conjugates occur in higher amounts in urine after
consumption of (-)-epicatechin. These data are in agreement with in vitro data which
indicated that a preference of COMT towards (-)-epicatechin.
In addition, sulfatase activity study showed that interfering substances in
urine probably inhibit its activity. Then, co-treatment urine samples with β-
glucuronidase and sulfatase cannot be used but all conjugated metabolites of
quercetin and (-)-epicatechin found in the urine must be analysed directly. Thus, the
full picture of all quercetin and (-)-epicatechin metabolites will be obtained.
To identify and quantify these metabolites, all conjugated quercetin and (-)-
epicatechin found in urine must firstly be synthesised. Five quercetin conjugates and
five (-)-epicatechin conjugates were successfully synthesised with a sufficient
percentage yield of the synthesised conjugates. For the first time, 3-O-methyl-
quercetin-di-glucuronides were also produced and detected in the glucuronidation
reaction of 3-O-methyl-quercetin-glucuronides. In addition, methylated-(-)-
epicatechin-glucuronides and methylated-(-)-epicatechin sulfates were originally
synthesised by (-)-epicatechin-glucuronides and (-)-epicatechin sulfates which were
the products of (-)-epicatechin glucuronidation and (-)-epicatechin sulfation
reaction, using COMT from cytosol pig liver. These enzymatic conjugates are not
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only used for identifying quercetin and (-)-epicatechin (in chapter 6). Furthermore,
these enzymatic conjugates can be use to study the biological effect of quercetin or
(-)-epicatechin metabolites in cells or other tissue in the future.
In this study, eight urinary metabolites of quercetin and six urinary
metabolite of (-)-epicatechin from human urine samples collected at 24 hr were
identified by UPLC-MS. The major metabolite of quercetin found most in urine is
quercetin glucuronide in both single and co-consumption of onion soup. While, the
methylated form of (-)-epicatechin is the most abundant form in urine after single
and co-consumption of 70% dark chocolate. To our knowledge, this is the first study
on the metabolites profile of quercetin and (-)-epicatechin in human. Then, the
precise biological activities or mechanism of these metabolites should be study
further.
7.2 Future Perspectives
To fulfil this research work, the biological effects of quercetin or (-)-
epicatechin and its metabolic conjugated products should be investigated in cell
culture with or without phase II enzyme expression. As reviewed, COMT will
generate 3 or 4 methylated (-)-epicatechin from (-)-epicatechin. The overexpression
of COMT may lead to the higher product of 3 or 4methylated (-)-epicatechin,
resulting in the NADPH inhibition and have a health benefit in the endothelial
function.
In addition, COMT also link with DNA methylation. Some polyphenol like
EGCG can inhibit COMT and subsequent to inhibit DNA methyltransferase indirect
way. The Figure 7.1 shows SAH can inhibit DNMT and then can interrupt or reverse
the carcinogen process of cancer. Thus, this is another aspect which needs to be
considered.
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COMT
Catechol polyphenol --> methylated form
SAM SAH
Cytosine --> methylated cytosine
DNMT
In the case of quercetin, it has exhibited a wide range of beneficial biological
activities including act as drug bioavailability enhancers. The bioavailability, blood
levels and efficacy of various drugs such as diltiazem and digoxin were increased by
quercetin. In addition, the absorption of flavonoid like epigallocatechin gallate was
enhanced after consumption red onion supplement, containing as well a rich source
of quercetin (Kesarwani, Gupta and Mukerjee 2013). Thus, co-consumption of
quercetin with other types of flavonoids may enhance its bioavailability and
biological activity.
Figure 7.1: The relationship between catechol-O-methyltransferase (COMT) and
DNA methyltransferase (DNMT)
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